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Summary 
The primary cilium is a cellular organelle that can regulate the behaviour of many mitotic 
progenitor cells, and even some post mitotic cell types.  Oligodendrocyte progenitor cells 
(OPCs) express genes associated with primary cilia assembly, disassembly and signalling. 
However, whether OPCs have primary cilia assembled on their surface and are functionally 
influenced by signalling at this organelle is unknown.  In this thesis, I show that OPCs are 
ciliated, both in vitro and in vivo, while mature oligodendrocytes are not.  Furthermore, OPCs 
disassemble and reassemble their primary cilia as they progress through the cell cycle, and 
this organelle is a critical regulator of OPC proliferation and oligodendrogenesis in 
adulthood.   
In order to examine the importance of the primary cilium for OPC function, the kinesin family 
member 3a (Kif3a) gene, critical for cilium assembly, was deleted from OPCs in vitro.  Kif3a-
deletion significantly reduced the number of OPCs with assembled primary cilia on their 
surface and decreased OPC proliferation (Chapter 3).  As Pdgfrα-CreERT2 transgenic mice 
target DNA recombination to OPCs, without significantly affecting PDGFRα+ cells in other 
tissues and organs (including the kidney, spleen, liver, intestine, heart, gastrocnemius, 
sciatic nerve, pituitary gland and adrenal gland)  (Chapter 4), these mice were selected to 
conditionally delete Kif3a from OPCs, to examine the importance of this organelle in vivo 
(Chapter 5).  Consistent with the in vitro findings, Kif3a-deletion from OPCs reduced the 
number of OPCs that had assembled primary cilia on their surface in the corpus callosum 
(CC) and reduced proliferation by ~30% in the CC and ~50% in the motor cortex.  While
Kif3a-deleation had no effect on OPC density, it halved the number of new oligodendrocytes
produced in both the CC and the motor cortex.  As the reduced proliferation rate of Kif3a-
deleted OPCs does not account for the substantial decrease in new oligodendrocyte
number, these data indicate that the primary cilium also promotes oligodendrocyte
differentiation and / or new oligodendrocyte survival in the brain.
Genetically ablating OPCs, disrupting OPC function and preventing oligodendrogenesis can 
have behavioural consequences ranging from increased anxiety and depressive behaviours 
to reduced motor performance and impaired motor learning.  However, when 
oligodendrogenesis was reduced in the CC and motor cortex over a 6-week period, by the 
conditional deletion of Kif3a from OPCs in vivo, no such behavioural phenotype was 
observed.  These data indicate that deleting Kif3a from OPCs in the adult central nervous 
system (CNS), which does not remove OPCs from the brain, and only moderately reduces 
oligodendrogenesis, is not sufficient, at least in the short-term, to have overt behavioural 
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consequences.  However, these experiments also pose interesting questions about the 
function of OPCs, and whether oligodendrogenesis is their only role in the mature CNS.  
Overall this research demonstrates that primary cilia are present on the surface of OPCs but 
absent from mature, myelinating oligodendrocytes and that preventing cilium assembly 
reduces both OPC proliferation and oligodendrogenesis.  I also determined that preventing 
cilium assembly and reducing oligodendrogenesis did not affect normal CNS function by 7 
weeks post gene-deletion. 
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Chapter 1: Literature review 
1.1 The nervous system 
The nervous system coordinates both voluntary and involuntary actions, such as deliberate 
movements and reflexive responses (Gibson and Ma, 2011).  They contain neurons, which 
extend axons to connect to distal target cells and form networks that carry information, in the 
form of action potentials, around the body.  The nervous system can be broken down into 
three major divisions, the central nervous system (CNS), the peripheral nervous system and 
the enteric (gastrointestinal) nervous system (Frantz, 2012).  The CNS, which is the focus on 
in this thesis, is made up of the spinal cord, the optic nerve and the brain, while the 
peripheral nervous system comprises neurons and ganglia outside of the CNS, and conduct 
action potentials between the CNS and peripheral tissues and organs (Catala and Kubis, 
2013).   
The CNS contain multiple cell types in addition to neurons, including vascular cells and 
supporting cells called glia.  The three major CNS glial cell types are astrocytes, 
oligodendrocytes and microglia.  Astrocytes perform many critical functions within the CNS, 
they provide nutrients to axons (Müller et al., 2014; Tang et al., 2014)  and maintain the 
extracellular ion balance (Walz, 2000).  By contrast, microglia are phagocytic cells often 
referred to as the immune cells of the CNS, as they prune synapses (Paolicelli et al., 2011) 
and clear myelin debris (Skripuletz et al., 2013; Zhu et al., 2016). Oligodendrocytes, which 
are the topic of this thesis, are the myelinating (insulating) cells of the CNS (Baumann and 
Pham-Dinh, 2001).  They extend multiple processes to ensheath and add myelin to multiple 
axon segments.  This close association between oligodendrocytes and axons, enables rapid 
information transfer, but also allows oligodendrocytes to provide critical trophic support to 
axons (Dougherty et al., 2000; Du and Dreyfus, 2002; Wilkins et al., 2003; Bradl and 
Lassmann, 2010), making them critical for healthy CNS function.  Ongoing myelination is 
important for the maintenance of a healthy CNS.  Errors in myelination have been implicated 
in impaired motor function ( Liao et al., 2014; Schneider et al., 2016) as well as depression 
(Regenold et al., 2007; Williams et al., 2015) and anxiety (Birey et al., 2015).  Changes in 
myelin are also associated with learning and memory acquisition (Zhang et al., 2012; 
McKenzie et al., 2014; Kim et al., 2015). 
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1.2 Developmental myelination 
During CNS development, oligodendrocyte progenitor cells (OPCs) are born from stem cells 
located within the ventricular zone of the embryonic brain and spinal cord (reviewed in 
Richardson et al., 2006; 2011).  The majority of spinal cord OPCs are derived from OLIG2+ 
stem cells in the motor neuron progenitor (pMN) domain, and these OPCs migrate, 
proliferate and differentiate to give rise to ~85% of the mature oligodendrocytes present in 
the adult spinal cord (Zhou et al., 2001).  OPCs derived from more dorsal spinal cord stem 
cell domains produce the smaller number of mature oligodendrocytes for the adult spinal 
cord (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al., 2005), that preferentially 
myelinate the corticospinal and rubrospinal tracts, despite these regions being inhabited by 
ventrally-derived OPCs earlier in development (Tripathi et al., 2011).   
In the developing brain, OPCs similarly arise from stem cells in distinct dorsal and ventral 
stem cell zones, including those in the neuroepithelium of the medial ganglionic eminence, 
the anterior entopeduncular region (Kessaris et al., 2006), the lateral ganglionic eminence 
and the cortex (Kessaris et al., 2006).  OPCs express a number of proteins that can be used 
to distinguish them from other cell types in the CNS, including oligodendrocytes (Fig. 1.1). 
For example, neural / glial antigen 2 (NG2), a chondroitin sulphate proteoglycan, is 
expressed by other cell types outside the CNS, including vascular mural cells, cells of 
mesenchymal lineages and stem cells in the skin (Levine et al., 1986; Trotter et al., 2010), 
but within the CNS it is exclusively expressed by OPCs and pericytes.  Pericytes are 
contractile cells located in the walls of blood vessels, and while they express NG2, they do 
not readily bind the anti-NG2 antibody in fixed tissue, such that NG2 is a specific 
immunohistochemical marker of OPCs (Mishra et al., 2014).  Platelet derived growth factor 
receptor alpha (PDGFRα) is a transmembrane receptor that is activated by binding of its 
ligand, platelet derived growth factor (PDGF)-A.  In the CNS, PDGFRα is exclusively 
expressed by OPCs, and when activated, can promote their proliferation (van Heyningen et 
al., 2001), migration (Baroti et al., 2016) and survival (Watzlawik et al., 2013).  The use of 
these proteins as markers to identify OPCs, has led to OPCs being referred to as NG2-glia 
or PDGFRα+ cells in the literature. 
Once generated, all OPCs proliferate (Clarke et al., 2012).  They are capable of both 
symmetric and asymmetric cell division, resulting in two identical OPCs or one OPC and one 
cell destined to differentiate into a mature, myelinating oligodendrocyte, respectively 
(Sugiarto et al., 2011; Zhu et al., 2011; Hill et al., 2014).  As OPCs differentiate into 
oligodendrocytes, they undergo a drastic change in morphology, extending many processes 
to contact axons and commence myelination (Kukley et al., 2010), and these changes are 
!
!
!
!
!
Figure!1.1:!Schematic!of!OPC!differentiation!
OPCs% are% identified% by% their% expression% of% the% NG2% proteoglycan% and% the%
mitogenic% receptor% PDGFRα.% % These% proteins% are% downregulated% early% in%OPC%
differentiation% into% premyelinating% oligodendrocytes.% % PreCmyelinating% and%
myelinating% oligodendrocytes% express% MBP,% MOG% and% galactacerebrosidase.%%
SOX10%and%OLIG2%are%expressed%throughout%the%lineage.%! %
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associated with altered gene expression within the cell.  OPCs rapidly down-regulate the 
expression of proteins associated with their progenitor cell function, including NG2 and 
PDGFRα, and begin to express myelin-associated proteins.  While myelin is a double layer 
of plasma membrane that is ~70% lipids, it is also ~30% protein - as myelin associated 
proteins are embedded in the membrane to anchor the many lipid bilayers together for 
stability.  The most abundant of these proteins include proteolipid protein (PLP), myelin 
oligodendrocyte glycoprotein, 2’, 3’-cyclic nucleotide 3’-phosphodiesterase, myelin 
associated glycoprotein and myelin basic protein (MBP) (Dubois-Dalcq et al., 1986) 
(Nishiyama et al., 2009) (Fig. 1.1) – many of which are used as markers to identify 
oligodendrocytes in the CNS. 
While OPCs and oligodendendrocytes have distinct gene expression profiles, reflecting their 
immature and mature functions respectively, they also share genes common to the 
oligodendrocyte lineage.  Two proteins commonly used to identify all cells of the 
oligodendrocyte lineage, are the transcription factors SOX10 and OLIG2 (Nishiyama et al., 
2009) (Fig. 1.1).  SOX10 is a member of the SOX family of transcription factors, and while it 
is expressed by OPCs and oligodendrocytes in the CNS, it is also expressed by Schwann 
cells, the myelinating glia of the peripheral nervous system (Wegner, 2001).  Similarly, in the 
embryonic CNS, OLIG2 is expressed by stem cells in the OLIG2 domain of the developing 
spinal cord (Liu and Rao, 2004), as well as OPCs throughout the CNS (Ortega et al., 2013).  
However by adulthood, OLIG2 expression is restricted to cells of the oligodendrocyte lineage 
and it has not been reported to be expressed outside of the CNS (Rowitch et al., 2002). 
During development, neurons extend axons towards their target cells, but the axons also 
grow in girth (Cajal et al., 1995; Raper and Mason, 2010).  Axon myelination typically starts 
when axon diameter reaches ~0.2µm (Waxman and Bennett, 1972; Voyvodic, 1989).  When 
an oligodendrocyte process contacts an axon it triggers polarisation of the plasma 
membrane, which itself triggers the initial stages of myelination (Simons and Trotter, 2007).  
As myelination starts, the oligodendrocyte process begins to wind itself around the axon.  
The tip of this process, known as the leading edge, continues to wrap itself around the axon 
pushing underneath the previously deposited layers (Snaidero et al., 2014, reviewed by 
Hughes and Appel, 2016).  As the leading edge wraps around the axon it squeezes the 
cytoplasmic material out of the oligodendrocyte process, leaving the axon surrounded by 
layers of ‘empty’ cell membrane.  As this is occurring, the myelin membrane extends 
laterally, spreading out wider towards the nodal regions so that it covers a greater area of 
axon. 
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Each myelin segment added to an axon is an internode.  Each oligodendrocyte is capable of 
simultaneously laying down internodes on multiple different axons, and each myelinated 
axon has a series of internodes laid down by multiple oligodendrocytes along its length.  The 
number of myelin internodes on an axon, and their length can vary, depending on the 
location of the neuron and its role (Bechler et al., 2015).  As myelin is a highly insulating 
substance, it increases the resistance and decreases the capacitance of the axon, at the site 
of the internode.  Internodes are interspersed by unmyelinated gaps called nodes of 
Ranvier.  Each node is 0.5-1µm in length and contains a high concentration of voltage-gated 
sodium channels (Purves, 2012).  When a neuron is depolarized to threshold, these 
channels open and allow sodium ions to enter the axon, generating the action potential.  
When travelling along a myelinated axon, the action potential is regenerated at each node of 
Ranvier, in a process called saltatory conduction, that allows the action potential to jump 
from node to node.  In this way, an action potential travels along an unmyelinated axon at 
speeds between 0.5 and 10m/s, but along a myelinated axon can reach 150m/s (Purves, 
2012).  As myelin it critical to achieving increased conduction speeds, it is critical to 
vertebrate CNS function.   
In humans, myelin development can be measured using a number of neuroradiological 
techniques such as T1 and T2 weighted magnetic resonance imaging (MRI) as well as fluid-
attenuated inversion recovery, diffusion-weighted imaging, diffusion-tensor imaging (DTI) 
and proton MR spectroscopy (Barkovich, 2000; Guleria and Kelly, 2014).  Myelination is first 
observed in the dorsal brainstem prior to birth at about 26-30 weeks of gestation.  After birth, 
in the first couple of months of life, myelination spreads to the middle cerebellar peduncle 
and posterior limb of the internal capsule (Barkovich and Raybaud, 2012).  This continues 
into the anterior limb of the internal capsule and the corpus callosum (CC) before 6 months 
of age, and the occipital white matter develops before the age of 1 year.  Frontal white 
matter is the final region to develop, with the deep frontal white matter developing by 16 
months of age and the subcortical frontal white matter developing by 24 months or 2 years of 
age (Barkovich and Raybaud, 2012).  At this point the myelination pattern is structurally 
similar to that of an adult human (Guleria and Kelly, 2014), however myelination continues 
throughout childhood and “complete” myelination is not achieved until 25-30 years of age 
(Fields, 2008).  Furthermore, continued myelin deposition has been observed beyond 30 
years of age in response to learning new tasks (Scholz et al., 2009).   
In the mouse, the vast majority of myelination occurs in the early postnatal period.  It starts in 
the ventral spinal cord at embryonic day (E)17, and continues in the rostral to caudal 
direction.  In the dorsal spinal cord, myelination starts at the cervical enlargement and 
continues in both the rostral and caudal directions (Foran and Peterson, 1992).  In the brain, 
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the deep regions of the cerebellum are the first to be myelinated, before myelin spreads 
towards the pial surface.  Myelination of the optic nerve starts proximal to the retina at 
postnatal day (P)7 and continues rapidly towards the optic chiasm, with dense myelination 
evident along the retinal end of the optic nerve by P8 (Foran and Peterson, 1992). While few 
myelinating oligodendrocytes are present in the optic chiasm at P7 itself, the rate of 
myelination is slow, with complete myelination achieved at P23. The rate of myelination 
along the optic nerve also slows towards the optic chiasm, at P11 the optic nerve is 4µm 
long, and fully myelinated, with the exception of a less than 0.5µm section immediately next 
to the optic chiasm.  The entire optic nerve, from the retina to the optic chiasm, is not 
uniformly myelinated until P15 (Foran and Peterson, 1992). However, myelination stops 
abruptly approximately 200µm from the eye.   Myelin deposition continues throughout life in 
the mouse CNS, even in the fully myelinated optic nerve (Young et al., 2013).   
1.3 Oligodendrogenesis in the mature CNS 
OPCs were first identified when Raff et al. (1983) found a novel neural precursor cell type in 
the P6 rat optic nerve.  This cell was capable of differentiating into two different cell types 
depending on the culture medium used.  Culture medium containing fetal calf serum (FCS) 
would stimulate growth into a type 2 astrocyte, but serum-free culture medium would result 
in oligodendrogenesis.  The new cell type was called an O2A progenitor cell due to its ability 
to differentiate into either an oligodendrocyte or a type 2 astrocyte.  O2A progenitors cultured 
from the rat optic nerve express PDGFRα, and respond to PDGF by proliferating, but lose 
their PDGFRα expression and PDGF responsiveness once they begin to differentiate (Hart 
et al., 1989).  Pringle et al. (1992) found that O2A progenitors in the developing rat brain and 
optic nerve at E16 also expressed PDGFRα and that this PDGFRα expression in the CNS 
was exclusive to these cells, with neurons, mature oligodendrocytes and other glial cells all 
lacking PDGFRα expression.  By tracing O2A progenitors from early postnatal development 
through to six months of age they were able to observe their migration throughout the 
developing CNS and into adulthood, where a small population of PDGFRα+ O2A progenitors 
were found to persist, evenly distributed throughout the brain (Pringle et al., 1992, Dawson 
et al., 2000).  The true identity and purpose of these cells was not identified until a number of 
years later.    
1.3.1 Oligodendrogenesis occurs throughout the mature rodent CNS 
Rivers et al. (2008) generated Pdgfrα-CreERT2::Rosa26-YFP transgenic mice to label and 
track the fate of the PDGFRα+ cells in the adult brain.  Pdgfrα-CreERT2::Rosa26-YFP mice 
received tamoxifen (Tx) at P45 or P180, inducing yellow fluorescent protein (YFP) 
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expression in approximately half of the PDGFRα+ cells (Rivers et al., 2008).  The proportion 
of YFP+ cells that expressed PDGFRα decreased overtime, suggesting that these cells were 
differentiating.  By dye-filling the YFP+ cells and performing immunohistochemistry, many of 
the YFP+ PDGFRα-negative cells in the cortex and CC were shown to have the distinct 
morphology of pre-myelinating and myelinating oligodendrocytes, and their cell bodies were 
positive for the oligodendrocyte proteins CNPase and MBP (Rivers et al., 2008).  These 
experiments demonstrated that the PDGFRα+ NG2+ cells, present in the adult mouse brain, 
were indeed OPCs. 
Using an alternative lineage-tracing approach, Dimou et al (2008) crossed Olig2-CreERT2 
mice with the lacZ/EGFP or Rosa26-YFP cre-sensitive reporter mice, and administered Tx to 
the offspring at ~P75.  Tx administration fluorescently labelled a subset of OLIG2+ cells in 
the cerebral cortex – the vast majority of which co-labelled with NG2, and only a small 
fraction were CC1+ oligodendrocytes (Dimou et al., 2008).  However, at P75+65, the 
proportion of reporter+ cells that were NG2+ OPCs had dropped to ~19% in the white matter, 
and the proportion of reporter+ cells that were CC1+ oligodendrocytes had increased to about 
82% (Dimou et al., 2008).  Many studies have subsequently shown that OPCs can generate 
new oligodendrocytes in the brain, spinal cord and optic nerve of mice (Nishiyama et al., 
2009; Kang et al., 2010; De Biase et al., 2011; Clarke et al., 2012; Young et al., 2013; 
Auderset et al., 2016).  
1.3.2  Oligodendrogenesis occurs in the adult human brain 
In humans, it is difficult to examine changes in myelination that occur at a cellular level.  
However, OPCs have been shown to reside and proliferate in the healthy adult human brain 
and in response to multiple sclerosis (MS) lesions (Dawson et al., 2000).  However, nuclear 
weapons testing in 1955, which released C14 atoms into the atmosphere, has made it 
possible to “birth date” cells in any carbon-based life form.  Using accelerator mass 
spectrometry, Yeung et al. (2014) used C14 levels to determine the age of myelin and 
oligodendrocyte nuclei within the CC of post-mortem tissue, collected from people aged 
between 0.2 and 92 years of age.  In people of all ages, myelin was observed to have a C14 
concentration, corresponding to the levels observed near their time of death (Yeung et al., 
2014).  This suggests that myelin is only ever a few years old and that it is continuously 
renewed.  However, the C14 concentration in the oligodendrocyte nuclear extract was similar 
to the atmospheric C14 levels present in the first few years of life, suggesting that most 
oligodendrocytes were born early in life and survived long-term.  However, individuals born 
before the nuclear testing, also had C14 concentrations higher than the atmospheric C14 
levels prior to the nuclear testing, suggesting that some oligodendrocytes are born later in 
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life.  It was suggested that ~0.32% of oligodendrocytes are new each year (Yeung et al., 
2014), and given the very large number of oligodendrocytes present in the human brain, this 
still represents significant oligodendrocyte generation.  However, these findings also indicate 
that this rate of oligodendrogenesis is unlikely to account for the rapid changes in 
myelination observed in response to learning in humans (Bengtsson et al., 2005; Scholz et 
al., 2009), and suggest that humans may have a different mechanism to modify myelin to the 
one demonstrated in rodents. 
1.4  What is the purpose of ongoing myelination in adulthood? 
The exact role that adult-born oligodendrocytes and new myelin play in regulating CNS 
function is unknown, but this novel from of neural plasticity has the potential to modify circuit 
function and influence behaviour, or alternatively, could play a maintenance role, replacing 
oligodendrocytes and myelin that are lost over the lifespan. 
A number of human studies have shown that myelination in the adult human brain can 
change in response to learning and training.  Bengtsson et al. (2005) utilised DTI to compare 
the pattern of brain myelination in people who had studied piano with those who had not, 
and found that extensive piano practice induced changes to white matter tracts such as the 
CC and internal capsule, that correlated with the hours of practice, but not with age.  
Similarly, adults who undertake four weeks of juggling training have increased fractional 
anisotropy of the white matter underlying the right anterior intraparietal sulcus, suggesting 
new myelin was added to the brain region activated by the task i.e. involved in hand-eye-
coordination (Scholz et al., 2009).   
To determine whether motor learning not only increased myelination, but required the 
generation of new oligodendrocytes, McKenzie et al. (2014) selectively ablated myelin 
regulatory factor (Myrf) from adult OPCs, using Pdgfrα-CreERT2 :: Myrf fl/fl transgenic mice.  
In the absence of the transcription factor MYRF, OPCs are unable to mature into 
oligodendrocytes and begin myelination (McKenzie et al., 2014).  Control and Myrf-deleted 
mice were placed on a complex running wheel, with an irregular rung pattern, so that they 
had to undergo motor learning to adjust their running style and gait to account for the 
missing rungs (McKenzie et al., 2014).  The daily average and maximum running speeds 
were lower in the Myrf-deleted mice, relative to controls.  However, there was no significant 
difference in the time spent on the wheel, suggesting the lower speeds were not the result of 
decreased motivation.  Furthermore, there was no difference in their performance on a 
rotorod, suggesting that they were not motor impaired (McKenzie et al., 2014).  High speed 
video showed that the gait of the Myrf-deleted mice was less rhythmic than that of the 
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controls.  When retested one month later, the difference between the two genotypes 
remained (McKenzie et al., 2014).  These data suggest that learning a complex motor task 
requires oligodendrogenesiss (McKenzie et al., 2014). 
As many CNS axons are unmyelinated, even in adulthood, it is possible, that the myelin 
addition that occurs in response to learning is de novo myelination – the addition of myelin to 
previously unmyelinated axons (Fig. 1.2).  The possibility that previously unmyelinated 
axons can become myelinated throughout life, is also supported by a transmission electron 
microscopy study, showing that in the CC and cingulate bundle of the mature primate brain, 
the number of unmyelinated axons decreases with increasing age (Bowley et al., 2010; 
Wang and Young, 2014).  However, de novo myelination has not been experimentally 
demonstrated – likely due to the lack of genetic markers available to distinguish 
unmyelinated, partially myelinated and myelinated axons.   
It is also possible that newborn oligodendrocytes replace those lost across the lifespan, as 
they do, for example, following injury (Lucchinetti et al., 1999; Tripathi et al., 2010; Zawadzka 
et al., 2010; Kang et al., 2013) (Fig. 1.3).  Demyelination, which is the loss of or damage to 
the protective myelin sheath surrounding an axon, can be caused by inflammation, viral 
infection, hypoxia, metabolic dysfunction, or physical injury, such as focal compression 
(Love, 2006).  Myelin loss, results in a reduced action potential conduction velocity, which in 
turn can result in reduced sensation, movement and cognition, as well as other symptoms 
depending on which neurons are affected (Karussis, 2014).  Furthermore, demyelination can 
be associated with axon degeneration, and the accrual of permanent disability.  The most 
prevalent demyelinating disease is MS, which affects 2-2.5 million people globally (Dua et 
al., 2008).  MS is characterised by the presence of large, demyelinating lesions in the CNS.  
A number of genetic and environmental risk factors are associated with the susceptibility of 
this disease, in which the bodies’ own T-cells target myelin self-antigens (Allegretta et al., 
1990; Zhang et al., 1994), however, the event that triggers the immune cascade is unknown.  
A range of neurological symptom can be associated with MS, including physical, cognitive 
and occasionally psychiatric problems.  The autonomic, visual, motor and sensory systems 
are most often affected, but the symptoms are highly dependent on the affected axons.   
It is well established that remyelination i.e. the replacement of lost myelin sheaths, can occur 
in people with acute or early MS (Lucchinetti et al., 1999).  During this process OPCs 
migrate to the lesion site and proliferate (Maki et al., 2013).  They then differentiate into 
oligodendrocytes and lay down new myelin sheaths on the demyelinated axons.  
Remyelinated lesions can be seen as shadow plaques histologically (Lassmann, 1983), as 
the new myelin sheaths are thinner and shorter than those originally covering the axons 
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(A)! When! a! mature,! myelinating! oligodendrocyte! (green)! dies,! an! OPC! or! pre;
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fine;tune!conduction!velocity.!!!
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(Hanafy and Sloane, 2011, reviewed by Olsen and Akirav, 2015).  In mice, OPCs also 
proliferate and generate new oligodendrocytes, in response to demyelinating injuries 
induced by: the induction of experimental autoimmune encephalomyelitis (EAE; Tripathi et 
al., (2010); the focal injection of lysolecithin or ethdium bromide (Zawadzka et al., (2010); 
and the expression of human genes producing pathology reminiscent of amyotrophic lateral 
sclerosis (Kang et al., 2013) and Alzheimer’s disease (Behrendt et al., 2013).  However, in 
the amyotrophic lateral sclerosis model, the newly generated pre-myelinating 
oligodendrocytes failed to mature into myelinating oligodendrocytes to repair the myelin 
damage (Kang et al., 2013).   
As new oligodendrocytes can replace those that die in response to some demyelinating 
injuries, it has also been proposed that new oligodendrocytes could replace those that die in 
the normal, healthy CNS (Fig. 1.3).  However, recent evidence suggests that 
oligodendrocyte loss in the healthy mouse CNS is minimal.  Mature oligodendrocytes, 
present in the P60 mouse brain, labelled using Opalin-iCreERT2 :: Rosa26YFP mice, largely 
remain at P600 (Tripathi et al., 2017), suggesting that oligodendrocytes are remarkably long-
lived.  Oligodendrocyte loss was observed in some CNS regions, such as the optic nerve 
and spinal cord (Tripathi et al., 2017), but the magnitude of this loss was small, suggesting 
that the ~6.5% of optic nerve oligodendrocytes, added between 4 and 6 months of age 
(Young et al., 2013), are not simply required to replace those that are lost.  However, as the 
internodes laid down by adult-born oligodendrocytes are shorter than those laid down in 
development (Young et al., 2013), their alternative purpose could be to modify the pattern of 
myelin to, for example, fine tune conduction velocity (O’Rourke et al., 2014) (Fig. 1.3). 
1.5 Growth factors and morphogens that regulate oligodendrogenesis 
While the early stages of axon contact are intrinsically regulated by the developing 
oligodendrocyte, myelination is subsequently influenced by extrinsic factors, such as the 
electrical activity of neurons (reviewed in Bechler and ffrench-Constant, 2014).  Key growth 
factor and morphogen signalling pathways that regulate myelination include the platelet-
derived growth factor (PDGF), hedgehog (Hh), wingless / integrated (Wnt), Notch and bone 
morphogenic protein (BMP) / Id pathways (Wine-Lee et al., 2004; Feigenson et al., 2009; 
Ruat et al., 2012).   
1.5.1 PDGF is a critical regulator of oligodendrogenesis 
PDGF-A and PDGF-B are growth factors that form homo- and hetero-dimers, and bind to 
and activate PDGFRα and PDGFRβ, to regulate cell growth and proliferation (reviewed in 
Shim et al., 2010).  In development, OPCs traverse large distances to populate the CNS, 
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before proliferating and differentiating into mature, myelinating oligodendrocytes (Vora et al., 
2011), and OPCs also migrate in the mature CNS, into demyelinating lesion sites to initiate 
remyelination (Boyd et al., 2013).  PDGF treatment is known to increase OPC migration, with 
even transient exposure to PDGF-A driving migration for up to 72 hours (Milner et al., 1997).  
By increasing PDGF-A levels within a demyelinated lesion, it is also possible to induce OPC 
migration to the lesion site, increase OPC proliferation and enhance remyelination (Yao et 
al., 2017).   
The importance of PDGF signalling in promoting OPC proliferation, is reflected by the 
phenotype of PDGF-A knockout mice, which have fewer PDGFRα+ OPCs in comparison to 
their wildtype littermates, and have reduced oligodendrocyte number and myelin production 
(Fruttiger et al., 1999).  However, this phenotype is likely to be the result of multiple functions 
of PDGF signalling, which not only promotes OPC proliferation, but is also a pro-survival 
factor for OPCs in vitro and in vivo.  The treatment of cultured OPCs with PDGF results in an 
increase in both OPC proliferation and oligodendrocyte number (Grinspan et al., 1993) and 
the over-expression of PDGF-A in vivo, results in an increased number of OPCs (Calver et 
al., 1998; van Heyningen et al., 2001).  However, the effects of serum starvation, which 
induces cell death in both OPCs and newly born oligodendrocytes in culture, can be 
reversed by the addition of PDGF to the culture medium (Barres et al., 1992).  Similarly, 
increased PDGF signalling in the developing optic nerve, results in a 90% decrease in 
newborn oligodendrocyte death and a doubling of oligodendrocyte number (Barres et al., 
1992).   
1.5.2 FGF signalling in oligodendrogenesis 
The fibroblast growth factor (FGF) family of growth factors regulate a number of cellular 
processes including proliferation, differentiation and organogenesis (reviewed in Ornitz and 
Itoh, 2015).  It has 22 members, which bind to one of four FGF receptors (FGFR)1-4.  At 
least 18 FGFs are expressed in the brain, across different developmental stages and brain 
regions (Ford-Perriss et al., 2001), and they are produced by several CNS cell types, 
including neurons and astrocytes, which each produce multiple members of the FGF family, 
in particular FGF1 and FGF2.  Cells of the oligodendrocyte lineage express FGF receptors 
(Bansal et al., 1996; Fortin et al., 2005), with FGFR1, the receptor for FGF1 and FGF2, 
being expressed throughout the lineage (Fortin et al., 2005), while FGFR2 is expressed 
more highly by oligodendrocytes, relative to OPCs (Fortin et al., 2005).  While FGFR3 is 
reportedly expressed by OPCs (Fortin et al., 2005), adult OPCs are not labelled in Fgfr3-
CreERT2 transgenic mice (Young et al., 2010).   
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The binding of FGF9 to FGFR2 on oligodendrocytes encourages differentiation, leading to 
increased process length (Fortin et al., 2005), while FGF2 is important for the initial 
generation of OPCs during CNS development (Furusho et al., 2011), but also binds to the 
lineage-wide receptor FGFR1, to stimulate OPC proliferation and inhibit differentiation 
(McKinnon et al., 1990; Bansal, 2002; Fortin et al., 2005).  Interestingly, Furusho et al. 
(2012) found that knocking out Fgfr1 and Fgfr2 did not affect the initiation of myelination, but 
did affect the regulation of myelin sheath thickness.  From the second postnatal week 
Fgfr1/Fgfr2 null animals had thinner myelin sheathes, a phenotype which persisted 
throughout adulthood (Furusho et al., 2012).  Consistent with in vitro reports (Fortin et al., 
2005), Fgfr1/Fgfr2 null animals were also found to have a reduced transcription of myelin 
associated genes (Furusho et al., 2012).  However, Fgfr1 or Fgfr2 knockdown can 
ameliorate the effect of cuprizone-induced demyelination, with reduction of either gene 
resulting in increased remyelination and increased recovery of running velocities on the 
complex running wheel (Mierzwa et al., 2013), suggesting that FGF signalling is actually 
inhibitory for repair following demyelination.  However, as a cuprizone-induced callosal 
lesion is remyelinated by resident OPCs as well as OPCs newly generated from 
subventricular zone (SVZ) neural stem cells (Xing et al., 2014), these data also suggest that 
FGFR1 and FGFR2 are not critical for SVZ-derived oligodendrogenesis in adulthood.  
1.5.3 Wnt signalling regulates OPC differentiation and myelination in the CNS 
The Wnt protein family are secreted lipoproteins.  Wnt signalling can occur either through the 
canonical or non-canonical arms of the Wnt pathway.  The canonical Wnt pathway is 
dependent upon β-catenin, while the two non-canonical arms of the pathway, the planar cell 
polarity pathway and the Wnt/calcium pathway, are both β-catenin independent (Veeman et 
al., 2003).  In unstimulated cells, β-catenin is phosphorylated in a destruction complex with 
axin, adenomatous polyposis coli (APC) and glycogen synthase 3β (GSK3β) and marked for 
ubiquitination and subsequently proteolytic degradation (Stamos and Weis, 2013).  The 
canonical arm is activated by the binding of Wnt to the frizzled (Fz) receptor or a receptor 
complex consisting of Fz and its co-receptor low-density lipoprotein receptor-related protein 
5/6, which transmits the Wnt signal to dishevelled (Dvl) a protein directly downstream of Fz 
(He et al., 2004; Feigenson et al., 2009), which acts as a switch between the canonical and 
non-canonical pathways.  When Wnt is bound to Fz, the canonical pathway is initiated, 
starting with the disruption of the GSK3β-axin-APC destruction complex by translocation to 
the plasma membrane along with a negative regulator of axin (Reichsman et al., 1996).  The 
negative regulator becomes associated with axin, dephosphorylating it and destabilising the 
destruction complex (Reichsman et al., 1996).  Activation of Dvl leads to inhibition of the 
GSK3β of the destruction complex and release of β-catenin, allowing for its accumulation 
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and localisation to the nucleus.  Once in the nucleus, β-catenin can induce a cellular 
response by activating specific target genes (Clevers, 2006). 
Wnt signalling regulates multiple stages of OPC development, including OPC specification 
from stem cells, OPC differentiation, myelination and remyelination (reviewed in Guo et al., 
2015; Gaesser and Fyffe-Maricich, 2016).  Wnt signalling is a crucial regulator of the 
specification of OPCs during development, but the exact response of OPCs to Wnt signalling 
differs depending on developmental stage.  Activation of β-catenin in the pMN domain of the 
developing spinal cord inhibit the generation and migration of OPCs from this zone (Dai et 
al., 2014), while the inhibition of Wnt signalling after OPC generation impairs 
oligodendrogenesis (Dai et al., 2014).  These data suggest that Wnt signalling inhibits OPC 
specification early in development, but is necessary for differentiation later in development.  
In vitro studies have shown that inhibition of Wnt signalling can result in an increase in OPC 
proliferation (Ye et al., 2010), a decrease in proliferation (Chew et al., 2011) or have no 
effect on proliferation at all (Feigenson et al., 2009). When viewed in vivo however, Wnt 
signaling had no effect on OPC proliferation (Fancy et al., 2009; Feigenson et al., 2009). 
Although the evidence linking Wnt signaling with myelination is strong, the exact relationship 
between Wnt signalling and the regulation of myelination is contradictory, with inhibition of 
Wnt signalling resulting in both the inhibition and promotion of myelination, depending on the 
genetic manipulations used (reviewed in Gaesser and Fyffe-Maricich, 2016).  Early studies 
showed that activating the Wnt signalling pathway inhibited oligodendrogenesis (Fancy et 
al., 2009; Feigenson et al., 2009) and that deleting agonists such as APC, lead to an 
increase in oligodendrocyte development, but ultimately hypomyelination (Lang et al., 2013).  
Deleting β-catenin from the oligodendrocyte lineage may also have differing effects 
depending on the developmental stage.  Deleting β-catenin from OLIG1+ cells prior to E10.5 
in the mouse, results in fewer oligodendrocytes (Dai et al., 2014), while deletion from OPCs 
and oligodendrocytes after E12.5 has no effect on oligodendrocyte number (Lang et al., 
2013).  Interestingly, deleting β-catenin from astrocyte progenitors using a hGFAP-Cre 
mouse line at E13.5 reduced oligodendrocyte number (Gan et al., 2014), indicating that Wnt 
signalling in the surrounding cells may be a more important regulator for driving 
oligodendrogenesis than intracellular Wnt signalling.  These data suggest that Wnt signalling 
is important for the regulation of myelination, although whether it is a positive driver of 
oligodendrogenesis or an inhibitor is still up for debate.  
1.5.4 Shh regulates myelination and remyelination in the CNS 
Sonic hedgehog (Shh), along with Indian hedgehog and Desert hedgehog, is one of three 
members of the Hh family.  Shh signalling is vital for organogenesis and tissue patterning 
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during vertebrate development (reviewed in Xavier et al., 2016) and influences the the 
proliferation of adult neural stem cells (Wechsler-Reya and Scott, 1999; Kenney and 
Rowitch, 2000; Palma et al., 2005), and cancer development (reviewed in Skoda et al., 
2017).   
In the developing spinal cord, gradients of growth factors, including Hh and Wnt, create 
distinct progenitor domains.  As Shh is secreted ventrally from the floor plate (Tekki-Kessaris 
et al., 2001) and Wnt is secreted dorsally from the roof plate, two opposing gradients of 
signalling molecules are created.  The Hh gradient results in the creation of five distinct 
domains that can be identified in the ventral half of the ventricular spinal cord, p3, pMN, p1, 
p2 and p0, and six in the dorsal spinal cord, dP6, dP5, dP4, dP3, dP2 and dP1 (Fig. 1.4).  
(Dessaud et al., 2008).  The combination of homeodomain transcription factors that are 
expressed in each domain, determines the identity of the cells arising from it, with each 
domain producing one or more neuronal subtypes (Wine-Lee et al., 2004).   
The majority of spinal cord OPCs are derived from the pMN domain and these OPCs give 
rise to around 85% of the mature oligodendrocytes in the adult spinal cord (Zhou et al., 
2001).  As the pMN is the second closest of the 11 domains to the source of Shh secretion, 
this exposes the domain to a high concentration of Shh.  This is also true in zebrafish, where 
both Shh and Indian hedgehog have been shown to be important for OPC specification 
during embryonic development (Park et al., 2004; Chung et al., 2013).  It has, however, been 
proposed that the two Hh pathways are performing individual, contrasting roles, with Indian 
hedgehog regulating neural progenitor proliferation and Shh driving proliferation, although 
both are necessary for the specification of OPCs from neural progenitors (Chung et al., 
2013).  This is true also for the specification of OPCs from postnatal stem cell niches in the 
brain, where Shh activates the Shh receptor smoothened (SMO), to increase OPC 
production (Tong et al., 2015).   
In addition to driving oligodendrocyte specification, Shh addition to human embryonic 
forebrain-derived mixed glial cultures, increased OPC proliferation (Ortega et al., 2013).  
Similarly, OPC proliferation was enhanced in spinal cord explant cultures, derived from rats 
that had experienced a contusion injury and been treated with the Shh agonist Ag11.1, 
relative to mice treated with vehicle (Bambakidis et al., 2010).  This proliferative response 
appears to require the multi-ligand receptor megalin (also known as LRP2), as blockade of 
this receptor prevents the Shh-mediated increase in OPC migration and proliferation (Ortega 
et al., 2012).  Megalin can be found on the surface of CNS astrocytes, where it can 
endocytose or exocytose Shh in order to mediate the proliferative response of OPCs (Ortega 
et al., 2012).  In addition to mediating proliferation, Shh can promote oligodendrocyte 
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differentiation and myelination.  For example, cortically-derived rat OPC cultures treated with 
Shh have a higher rate of oligodendrocyte differentiation when compared to untreated 
controls (Wu et al., 2012).  Additionally, inhibition of Shh signalling using cyclopamine, an 
inhibitor of the Shh receptor SMO, results in decreased expression of myelin associated 
genes such as MBP and myelin associated glycoprotein, that can be rescued by activating 
SMO with the agonist SAG (Wang and Almazan, 2016).   
Shh signalling is a strong driver of OPC proliferation, oligodendrogenesis and myelination in 
response to various models of demyelination, including: lysolecithin injection (Ferent et al., 
2013); cuprizone-induced demyelination (Sanchez and Armstrong, 2018); traumatic brain 
injury in both the cortex and the CC (Mierzwa et al., 2014); spinal cord hemi-section 
(Thomas et al., 2014), and EAE (Zhang et al., 2015).  OPCs react rapidly in response to 
demyelinating injury, increasing rates of proliferation and oligodendrogenesis (Levine, 1994; 
Hughes et al., 2013) and evidence suggests this relationship is due, at least partially, to Shh 
signalling. 
Following a traumatic axonal injury, the OPC population in the mouse CC is increased in the 
SVZ and cortex of Gli1-CreERT2 :: Rosa26-YFP mice, where it is maintained until 6 weeks 
post-injury, but were unable to observe a change in the OPC population in the CC (Mierzwa 
et al., 2014).  Increasing Shh signalling, by injecting the Shh pathway agonist SAG was 
found to further increase the OPC population in the SVZ of the Gli1-CreRTT2::R26YFP mice 
after injury, although there was still no change in OPC numbers in the CC (Mierzwa et al., 
2014).  These data suggest that Shh is important for driving the increase in OPC proliferation 
in response to injury in the SVZ for up to six weeks in the SVZ, but may not be in the CC. 
Lysolecithin injection into the CC of 6-8 week old Plp-GFP mice, produced a significant 
increase in OPC number and proliferation, alongside increased transcription of Shh by cells 
of the oligodendrocyte lineage (Ferent et al., 2013).  Adenoviral over expression of Shh in 
the lesion site, further increased OPC proliferation, oligodendrogenesis and remyelination , 
while Shh inhibition was found to have the opposite effect (Ferent et al., 2013), suggesting 
that promoting Shh signalling could be therapeutically enhanced to treat demyelinating 
disease.   
Fingolimod, an immunomodulatory drug that targets the sphingosine-1-phosphate receptor 
(Miron et al., 2008; 2010), and is commonly prescribed for MS, has been reported to 
influence Shh signalling.  Following EAE induction in mice, Fingolimod treatment increases 
OPC proliferation, oligodendrogenesis and myelin gene expression, relative to saline treated 
controls (Zhang et al., 2015).  Fingolimod treatment significantly increased the expression of 
Shh, its receptor SMO, and Gli1, and when Shh action was blocked by cyclopamine 
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administration, the effects of Fingolimod treatment on OPC behaviour and 
oligodendrogenesis were negated (Zhang et al., 2015).  These data suggest that Shh 
signalling in the oligodendrocyte lineage drives OPC proliferation, oligodendrogenesis and 
myelination in the rodent CNS in vivo, and demonstrates that Shh signalling mediates the 
response of oligodendrocyte lineage cells to Fingolimod treatment in a model of 
demyelinating disease. 
While there are many growth factor signalling pathways that influence oligodendrogenesis 
(reviewed in Waly et al., 2014), the Wnt, PDGF, FGF and Shh signalling pathways signal at 
or influence signalling at the primary cilium (Huangfu et al., 2003; Christensen et al., 2008; 
Lancaster et al., 2011; Zaghloul and Brugmann, 2011; Ruat et al., 2012).  The primary cilium 
is an organelle that protrudes from the surface of many vertebrate cells.   
1.6 The primary cilium 
Vertebrate cilia are classified as motile and non-motile cilia (Satir and Christensen, 2007; 
Pedersen and Rosenbaum, 2008).  Motile cilia are often present in clusters or bundles, 
found in wet, high mucous environments such as the respiratory epithelium (Enuka et al., 
2012) or female reproductive tract (Enuka et al., 2012), and move in a synchronous manner, 
generating physical flow or movement (Lewin, 2007).  The cytoskeleton of a motile cilium 
consists of nine microtubule doublets arranged in a ring called an axoneme, with a central 
pair of singlet microtubules - this is known as a 9+2 arrangement and all microtubules 
protrude from the basal body, a structure similar to the centrosome (Satir and Christensen, 
2007).   
Non-motile or primary cilia also have a cytoskeleton of nine microtubule doublets, but they 
lack the central pair of singlets that are required for cilliary movement, and instead have a 
9+0 arrangement (Satir and Christensen, 2007).  Primary cilia are also considerably smaller, 
being only 1-5µm in length.  The mammalian primary cilium was first identified by KW 
Zimmermann (1898) as being assembled on a number of mammalian cells types and in 
several organisms, including human tissue.  Zimmermann noted that in rabbit kidney tissue, 
every cell possessed a primary cilium (Zimmermann, 1898), and not only did the first 
transmission electron microscopy images of the primary cilium came from epithelial kidney 
cells, but the first reports defining the primary cilium as a sensory organelle, came from 
studies using tubule epithelial cells from the kidney, and the first evidence of ciliopathies 
began with studying polycystic kidney disease in a cilium knockdown Oak Ridge polycystic 
kidney (ORPK) mouse model (Bloodgood, 2009). 
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Despite its small size, the primary cilium is very important.  Dysfunction of primary cilia or the 
associated proteins can lead to a large number of disorders termed ciliopathies.  Ciliopathies 
produce clinically diverse symptoms, including errors in the left/right body axis, polydactyly, 
abnormal neural tube patterning and polycystic kidneys (Berbari et al., 2009).  Genetically, 
ciliopathies can be less diverse, as different mutations in the same gene can produce 
distinctly different clinical symptoms, suggesting that the severity of the mutation can 
influence the clinical symptoms.  Ciliopathy research is growing rapidly, as more diseases 
are being linked to defective ciliary function.  While the function of many of genes identified 
as carrying mutations in confirmed ciliopathies are still unknown, others such as inositol 
polyphosphate-5-phosphatase E (Bielas et al., 2009) and intraflagellar transport protein 88 
(IFT88) (McIntyre et al., 2012), are known to be responsible for ciliary signalling or the 
assembly and disassembly of primary cilia, respectively. 
Cilia are assembled through an ordered pathway of distinct steps (Sorokin, 1968).  Typically 
cilia formation begins following a cell division, when the cell is exiting the cell cycle, during 
the G0 or G1 (Ishikawa and Marshall, 2011).  Assembly starts when the basal body 
differentiates from the centrosome as the cell exits the cell cycle.  The basal body associates 
with membrane vesicles en route to the cell surface, and once the basal body is anchored to 
the cell membrane, the vesicles fuse to the plasma membrane establishing the ciliary 
membrane compartment (Sorokin, 1968).  The basal body then nucleates α-tubulin and β-
tubulin heterodimers, leading to outgrowth of the axonemal microtubules and creating a 
protrusion from the cell surface.  In the transition zone, which is the region of the cilium distal 
of the basal body (Sánchez and Dynlacht, 2016), the outer doublets begin to form and 
continue exclusively at the distal end of the cilium (Rosenbaum and Child, 1967).  As protein 
synthesis cannot occur inside the cilium, proteins are carried into the cilium by intraflagellar 
transport (IFT).  Proteins are transported along the microtubule cytoskeleton to and from the 
cilia tip by IFT motor proteins in order to facilitate cilium elongation and assembly (Pedersen 
and Rosenbaum, 2008).  The cilium remains highly dynamic, with new tubulin being laid 
down constantly and old tubulin being removed, in order to maintain the cilium at a constant 
length (Marshall and Rosenbaum, 2001). 
As the cell re-enters the cell cycle after G0 and prior to M phase, primary cilium disassembly 
occurs in two ‘waves’, with the first occurring during the G1 phase and the second prior to 
mitosis (reviewed in Sánchez and Dynlacht, 2016).  Although disassembly has been 
extensively studied, the process is not well understood.  It has been proposed that 
disassembly is triggered by an interaction between the enzyme Aurora A, a centrosomal 
kinase, and histone deacetylase 6 (HDAC6), which in turn acts upon tubulin to collapse the 
primary cilium.  However, as tubulin acetylation is not associated with microtubule 
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stabilisation, deacetylation would not be expected to weaken the microtubule cytoskeleton 
and collapse of the cilium (Palazzo et al., 2003).  Additionally HDAC6 knockout mice only 
have a weak phenotype as opposed to the severe disease phenotype and embryonic 
lethality that would be expected to be observed if cilia disassembly was not occurring (Zhang 
et al., 2008).  In addition to regulating HDAC6, Aurora A has also been shown to activate 
inositol phosphate 5-phosphatase (INPP5E) (Plotnikova et al., 2015) which in turn produces 
phosphatidylinositol 4-phosphate (PtdIns(4)P).  Accumulation of INPP5E and PtdIns(4)P has 
been observed in unciliated cells, but is absent in those with assembled primary cilia  (Xu et 
al., 2016), indicating that INPP5E and PtdIns(4)P may be playing a role in the inhibition of 
ciliogenesis through an unknown mechanism. 
In the assembly and maintenance of the cilium, axonemal subunits are transported from the 
cell body to the cilium tip via anterograde transport.  Once the cargo has been delivered the 
IFT particles return to the cell body using retrograde transport systems.  During cilia 
disassembly in the unicellular flagellate Chlamydomonas, an increased rate of cargo free IFT 
particles enter the primary cilium, suggesting the number of axoneme subunits being 
delivered to the cilium tip decreases.  There is also an increase in the number of axoneme 
subunits being transported out of the cilium (Pan and Snell, 2005).  However, in mammalian 
PTK1 cells, the entire axoneme is released into the cytoplasm before centriole length is 
decreased, reducing cilium length (Rieder et al., 1979), and suggesting that cilia 
disassembly can occur through IFT-independent mechanisms. 
1.7 The role of primary cilia in nervous system development 
An understanding of the proteins expressed by primary cilia and the genes involved in 
primary cilia assembly and disassembly has allowed researchers to study and disrupt the 
generation of primary cilia in a cell specific manner to reveal the critical role of this organelle 
in neural development.      
1.7.1 Signalling at the primary cilium alters neural stem cell proliferation and 
differentiation in adulthood 
While it is unknown whether the primary cilium is critical for oligodendrogenesis, signalling at 
the primary cilium is vital for the maturation and differentiation of a number of other stem and 
progenitor cell types in the CNS (Han et al., 2008; Carter et al., 2012).  During embryonic 
tissue patterning, neurogenesis is reliant upon the same Shh gradient that influences OPC 
specification (see 1.5.4), with different neuronal subtypes generated from different stem cell 
domains.  Inhibition of cilium assembly in the developing CNS result in developmental 
deformities in the brain (Gorivodsky et al., 2009; Goetz and Anderson, 2010).  Shh signalling 
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at the primary cilium regulates neuroepithelial progenitor cell division, by inhibiting miR-219, 
which promotes the polarization and proliferation of these cells, during zebrafish 
development (Hudish et al., 2016).  Additionally, the primary cilium is important for the 
development of retinal ganglion cells in the Zebrafish (Lepanto et al., 2016), and the ablation 
of ciliogenesis in these cells, reduces their proliferation, reduces neural retina volume and 
delays retinal development (Lepanto et al., 2016).  Knockdown of miR-219 was also found to 
accelerate primary cilium growth (Hudish et al., 2016).  These data indicate that signalling at 
the primary cilium is vital for the correct proliferative and neurogenic response of neural 
progenitors during CNS development. 
Clium assembly is also a regulator of adult neural stem cell proliferation and neurogenesis in 
the subgranular zone of the dentate gyrus in mice (Han et al., 2008).  Kinesin family member 
3A (Kif3a) is a gene encoding a kinesin subunit, that is exclusively associated with primary 
cilia assembly.  The conditional deletion of Kif3a from glial fibrillary acidic protein (GFAP)+ 
cells, prevents neural stem cells from generating a primary cilium.  Primary cilia were 
identified on stem cells in the dentate gyrus of P0 control mice, but those in the Kif3a deleted 
mice had stunted ciliogenesis, such that the primary cilia comprised only of a basal body and 
transition fibers under a short expansion membrane, without an axoneme (Han et al., 2008).  
Stem cell proliferation was reduced in the dentate gyrus of these mice, and the disorganized 
dentate gyrus was suggestive of a defect in postnatal granule neurogenesis (Han et al., 
2008). 
hGFAP-Cre::Kif3afl/fl transgenic mice also had defective Hh signalling.  Quantitiative 
polymerase chain reaction (PCR) and in situ hybridization indicated that expression of the 
Hh target gene Gli1, was reduced in the dentate gyrus of hGFAP-Cre::Kif3afl/fl mice 
compared to controls (Han et al., 2008).  Furthermore, β-galactosidase reporter activity 
confirmed that the Shh receptor Patched (Ptchd) was expressed by cells in the hippocampus 
of control mice, but absent from the hippocampus of Kif3a deleted mice (Han et al., 2008).  
These data indicate that the primary cilium and Hh signalling are vital for the proliferation of 
neural stem cells in the subgranular zone of the dentate gyrus, and consequently 
neurogenesis and the cellular organization of this brain region. 
In order to examine the role of primary cilia in regulating adult neurogenesis, Tong et al. 
(2014) performed stereotaxic injections of Cre recombinase (Cre)-overexpressing 
adenovirus, into the ventral SVZ of Kif3afl/fl :: Z/EG mice at P0, which simultaneous deletes 
the Kif3a gene, preventing cilium assembly, and expresses green fluorescent protein (GFP) 
in the recombined cells.  This technique targeted a small population of radial glia in the 
ventral SVZ, allowing for normal development of the gross brain anatomy (Tong et al., 2014).  
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Reduced cilium assembly was not evident until P30 and as a result mice were given 
injections of bromodeoxyuridine (BrdU) from P40-P45 to label dividing cells.  Mice were 
sacrificed at P60 and the number of recombined cells which lacked primary cilia, but had 
undergone cell division since P40 were quantified (Tong et al., 2014).  Radial glia-derived 
ventral SVZ stem cells were less able to differentiate into deep granule neurons in the 
olfactory bulb of Kif3afl/fl::Z/EG when compared with control mice, suggesting that signalling 
at the primary cilium is important for differentiation in these cells.   
1.7.2 Signalling at the primary cilium is important for neuronal function 
Primary cilia are also on the surface of mature neurons.  As neurons are not capable of 
proliferation or differentiation, it is likely that they perform a different role here, than on 
proliferative precursor cells, however what that is, remains unclear.  In the developing 
neocortex, cilium assembly is initiated on neuronal cells during late fetal development, as the 
basal body can be observed docked to the cell surface (Arellano et al., 2012).  However, 
elongation of the cilium cytoskeleton is not observed until P4 (Arellano et al., 2012).  Primary 
cilia can be identified on the surface of excitatory pyramidal neurons and inhibitory 
interneurons, but preventing cilium assembly had no affect on neuronal migration, 
organisation or polarity (Arellano et al., 2012).  By contrast, in adult-born hippocampal 
neurons, cilium assembly occurs as the migrating neurons reach their final destination 
(Kumamoto et al., 2012).  In these neurons, cilia ablation severely affects dendritic 
refinement and synapse formation, suggesting that primary cilia are important for the 
connectivity of adult-born neurons (Kumamoto et al., 2012), although the exact signalling 
pathways affected remains unknown. 
The activation of Shh signalling in rat hippocampal neurons initiates axon extension (Yao et 
al., 2015), suggesting that Shh may play a role at the primary cilia of mature neurons.  
However, axon elongation by ciliated and unciliated neurons suggested a cilia-independent 
mechanism of Shh signalling in neurons.  By contrast, in the peripheral nervous system, Hh 
signalling at the primary cilium is heavily implicated in modulating the ciliary localisation of 
odorant receptors essential to the function of olfactory sensory neurons in drosophila 
(Sanchez et al., 2016).  More specifically, inactivation of the Shh receptor Smo, which 
translocates to the cilium surface during Hh signalling, impairs the olfactory response of flies, 
while inactivation of the Shh receptor Ptchd, increased olfactory responsiveness, suggesting 
that Ptchd activation typically inhibits olfactory receptor binding (Sanchez et al., 2016), 
making the primary cilia critical for olfactory neuron function. 
Communication is important for oligodendrocytes. While oligodendrocytes have been shown 
to communicate with neurons through the primary cilium, they are also capable of cilium 
37 
 
independent signalling pathways. For instance, oligodendrocytes have been shown to 
express receptors for neurotransmitters such as GABAA, which can be found on the cell 
surface (Hamilton et al., 2017).    
1.7.3 Primary cilia promote Schwann cell progenitor proliferation 
Shh signalling at the primary cilium is a critical regulator of myelination in the peripheral 
nervous system (Yoshimura and Takeda, 2012).  In the peripheral nervous system, 
myelination is performed by Schwann cells, that myelinate a single segment of a single 
axon, by wrapping their entire cell body around the axon.  When Schwann cell progenitors 
are co-cultured with dorsal root ganglion neurons, they differentiate into mature Schwann 
cells and myelinate the axons.  Following Schwann cell differentiation, the number of cells in 
the cultures expressing molecular markers associated with assembled primary cilia 
decreases, and the primary cilia can no longer be detected on the cell surface (Yoshimura 
and Takeda, 2012).  These data indicate that primary cilia are disassembled as Schwann 
cells differentiate, indicating that the mature myelinating cells, at least in the peripheral 
nervous system, are not subject to further regulation by this organelle.   
Treating the co-cultures with desert hedgehog, but not Shh, significantly upregulated Gli1 m 
messenger ribonucleic acid (mRNA) expression and increased the number of myelin 
segments per culture (Yoshimura and Takeda, 2012).  This indicates that Hh signalling at 
the primary cilium can promote peripheral myelination by increasing the proliferation of 
Schwann cell precursors, resulting in a larger pool of cells that can differentiate and 
myelinate or accelerates Schwann cell differentiation.  
1.8 The primary cilium as a regulator of CNS myelination 
1.8.1 Could PDGF signalling at the primary cilium regulate CNS myelination? 
In fibroblasts, PDGFRα signalling occurs at the primary cilium (Schneider et al., 2005).  
During the growth arrest phase, when cilia are assembled, PDGFRα expression is 
upregulated and localised to the primary cilium.  However, in Tg737orpk fibroblasts, that carry 
a mutation in the mouse homologue of IFT88, rendering them unable to assemble primary 
cilia, PDGFRα is no longer upregulated (Schneider et al., 2005).  While this is a single study, 
it indicates that, under some circumstances, PDGFRα signalling, which is an important 
regulator of CNS myelination, can be localised to the primary cilium.  Due to the extensive 
expression of PDGFRα throughout the cell body of OPCs, PDGFRα signalling is not solely 
localised to the primary cilium.  However, if PDGFRα signalling also occurs at the primary 
cilium, it is unclear whether this would produce a distinct cellular response. 
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1.8.2 FGF signalling at the primary cilium regulating CNS myelination 
While knockdown of Fgfr1 or the Fgf in zebrafish reduces expression of IFT88, a protein 
essential for cilium assembly and ciliogenesis (Neugebauer et al., 2009), and results in 
primary cilia shortening, it is unclear whether these primary cilia alteration are associated 
with the dysregulates organ patterning and laterality that is also part of this phenotype (Hong 
and Dawid, 2009; Neugebauer et al., 2009; Yamauchi et al., 2009).  However, these data 
identify FGF as regulating primary cilia parameters, and given the strong link that exists 
between FGF signalling and oligodendrogenesis and myelination (see section 1.5.2), it is 
possible that FGF exerts an influence on this lineage by modulation of the primary cilia 
structure.  
1.8.3 Can Wnt signalling at the primary cilium regulate CNS myelination? 
Evidence for Wnt signalling at the primary cilium has been mixed.  Many studies have 
implicated canonical Wnt signalling at primary cilia, however primary cilia ablation has been 
shown to enhance the sensitivity of cells to Wnt signalling, suggesting that the primary cilium 
has an inhibitory effect upon Wnt signaling (Huang and Schier, 2009; Ocbina et al., 2009).  
Knockdown of BBS1, BB4 and MKKS, three genes associated with Bardet-Beidl syndrome 
(BBS), results in primary cilia loss and a heightened response to Wnt in cultured cells 
(Gerdes et al., 2007), and the presence of a primary cilium reduced canonical Wnt signalling 
in mouse embryonic fibrobasts (MEFs) and embryonic stem cells (Corbit et al., 2008).  
Lancaster et al. (2011) found that MEFs, in which cilium retraction was induced, showed 
exaggerated Wnt activity relative to control cells.  Similarly enhanced Wnt activity was 
observed in MEFs with a nonsense mutation in the Dnchc2 gene, which lacked primary cilia 
development and dentate granule cells, expressing a recessive form Kif3a, preventing cilia 
assembly, displayed higher levels of β-catenin relative to wild type controls indicating 
increased canonical Wnt signalling (Kumamoto et al., 2012).   
Furthermore, in MEFs lacking primary cilia, β-catenin and jouberin (Jbn)  (a protein required 
for ciliogenesis) localised to the nucleus of the cell, while in ciliated MEFs β-catenin and Jbn 
were found to be localised to the basal body (Lancaster et al., 2011).  These data suggest 
that the primary cilium mediates canonical Wnt signalling by compartmentalising β-catenin 
and Jbn.  Activation of the Wnt signalling pathway by Wnt binding to the receptor Fz causes 
Jbn to interact with β-catenin.  Jbn and β-catenin then translocate to the nucleus.  In a 
ciliated cell, this translocation is inhibited by retrograde IFT, which restricts Jbn and β-
catenin localisation to the primary cilium.  In an unciliated cell the nuclear translocation of 
Jbn and β-catenin is uninhibited (Lancaster et al., 2011). 
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1.8.4 Evidence for Hh signalling at the primary cilium regulating CNS myelination 
In vertebrate cell types, the Hh signalling pathway involves two trans-membrane proteins, 
the Hh receptor Ptchd and the transducer SMO, and the Gli family of transcription factors, 
Gli1-3 (Ruat et al., 2012).  In the absence of the Hh ligand, Ptchd localises to the base of the 
cilium where it prevents Smo from binding to the cell membrane.  The Gli transcription 
factors form a complex with kinesin family member seven, an anterograde kinesin motor 
involved in IFT, allowing them to be transported to the cilium tip.  Suppressor of fused 
(SUFU) is located at the cilium tip where it promotes the truncation of Gli family members 
into their repressor forms known as GliR.  GliR is transported back to the nucleus, using the 
IFT dynein motor, where it inhibits the transcription of the target genes (Ruiz i Altaba et al., 
2007) (Fig. 1.5). 
In the presence of Shh, the inhibition of Smo by Ptchd is relieved allowing Smo to interact 
with β-arrestin (β-Arr) and translocate into the cilium where it accumulates.  The 
accumulation of Smo relieves the repression exerted on the Gli transcription factors by 
SUFU converting the Gli family transcription factors into their activator forms, known as GliA.  
Activated GliA translocates from the cilium tip to the nucleus to activate (or repress) the 
transcription of Hh target genes (Ruat et al., 2012) (Fig. 1.5). 
The reliance of Shh signalling on the primary cilium and the importance of Shh signalling in 
OPCs, strongly implicates primary cilia in regulating CNS myelination.  However, the 
importance of the primary cilium in regulating OPC and oligodendrocyte function has not 
been explored. 
1.8.5 Signalling at the primary cilium regulates CNS myelination 
While the importance of primary cilia for CNS myelination has not been investigated directly, 
disruption of the primary cilium has been shown to affect the development of NG2+ 
PDGFRα+ cells in the periventricular zones of a Bbs1M390R/M390R
 
mouse model of the human 
ciliopathy BBS (Carter et al., 2012).  The M390R mutation of the Bbs1 gene, affects the 
basal body of the primary cilium and results in abnormal cilia development and mice carrying 
this mutation develop ventriculomegaly between P0 and P3, and have twice as many 
apoptotic OPCs in the CC as control mice by P7 (Carter et al., 2012).  Quantification of 
BrdU+ NG2+ PDGFRα+ cells in the SVZ, also showed that Bbs1M390R/M390R
 
mice had 
approximately 50% fewer proliferating OPCs relative to wildtype controls. 
The treatment of Bbs1M390R/M390R
 
mice with lithium reduced the cross sectional area of the 
ventricles by ~50% relative to mice treated with sodium chloride, and doubled the number 
proliferating cells detected (Carter et al., 2012).  Lithium treatment phosphorylates AKT and 
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SUFU! is! located! at! the! cilium! tip! where! it! promotes! Gli! truncation! into! the!
repressor!form!(GliR).!!GliR!is!transported!to!the!nucleus,!via!the!IFT!dynein!motor,!
where! it! inhibits! the! transcription!of! the! target!genes.! ! (B)! In! the!presence!of! the!
Shh!ligand,!inhibition!of!Smo!by!Ptchd!is!relieved,!allowing!Smo!to!interact!with!βJ
arrestin! (βJArr)! and! translocate! into! and! accumulate! in! the! cilium.! ! The!
accumulation!of!Smo!relieves!the!repression!exerted!on!the!Gli!transcription!factors!
by! SUFU,! allowing! conversion! of! the!Gli! transcription! factors! into! their! activator!
form,!GliA.! !GliA,!bound!to!the!Kif7!motor,!are!transported!to!the!cilium!tip!where!
they! accumulate.! ! Activated! GliA! translocate! from! the! cilium! tip! to! the! nucleus,!
where! they! activate! transcription! of! Hh! target! genes.! ! Adapted! from! Ruat! et! al.!
(2012).!!!
!
 
!
!!
!
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GSK3β, key downstream effectors of, the PDGFRα signalling pathway.  This effect would be 
consistent with the importance of PDGFRα signalling for cells of the oligodendrocyte lineage.  
However, lithium treatment, and the phosphorylation of GSK3β, would also affect a number 
of other signalling pathways, including some that have been shown to associate with the 
primary cilium such as Notch and Wnt (Espinosa et al., 2003).  So while this study links OPC 
development and primary cilia, the signaling mechanism are unknown. 
1.9 Hypotheses and aims 
The presence of a primary cilium on oligodendrocyte lineage cells has never been directly 
investigated.  Both gene and protein expression studies suggest that OPCs have the 
capacity to assemble primary cilia the only way to directly identify the role of the primary 
cilium in the oligodendrocyte lineage is through preventing primary cilium assembly or 
blocking pathways which are reliant upon the primary cilium.  Signalling at the primary cilium, 
and regulation of the primary cilium, involves many of the signaling pathways that also 
instruct the behaviour of cells of oligodendrocyte lineage.  PDGFRα is a key regulator of 
OPCs, particularly their survival and proliferation; FGF plays a vital role in the regulation of 
myelin thickness; Wnt regulates oligodendrocyte differentiation and myelination, and Shh is 
important for OPC specification and proliferation.  Of these pathways, Shh signalling is most 
reliant upon the primary cilia in vertebrate cell types.  However, due to the collective 
importance of these signaling pathways to for CNS myelination, I hypothesise that primary 
cilia regulate OPC proliferation.  Furthermore, I hypothesise that primary cilia are essential 
for oligodendrogenesis in the healthy CNS.  To test each of these hypotheses, I will achieve 
the experimental aims detailed below. 
Hypothesis 1: That primary cilia regulate OPC proliferation 
Aim 1: To determine whether OPCs assemble primary cilia in vitro and in vivo.  
I will first determine whether OPCs express genes associated with primary cilium assembly 
and signalling by performing in situ hybridisation on mouse primary OPC cultures.  Cilium 
assembly, by OPCs and oligodendrocytes, will be examined by performing 
immunocytochemistry and immunohistochemistry. 
Aim 2: To determine whether primary cilia status is influenced by cell cycle entry   
I will perform live imaging of cultured OPCs, with fluorescently-tagged primary cilia, to 
dynamically evaluate primary cilia assembly and disassembly over time, and in relation to 
cell cycle transition.  To examine this in vivo, proliferating cells will be acutely labelled with 
EdU, and immunohistochemistry performed to identify OPCs currently or recently in s-phase 
of the cell cycle, and determine their primary cilia status. 
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Aim 3: To determine whether Kif3a (and cilia assembly) is critical for OPC proliferation 
Primary OPC cultures from Pdgfrα-histGFP::Kif3afl/fl mice will be treated with tat-Cre to 
delete Kif3a and prevent primary cilia assembly, before 5-ethynyl-2’-deoxyuridine (EdU) is 
added to the culture medium to identify proliferating cells.  The number of EdU+ OPCs will be 
quantified in control and Kif3a-deleted cultures.   
Hypothesis 2: that primary cilia are essential for oligodendrogenesis in the healthy 
CNS 
Aim 4: To induce DNA recombination selectively in adult OPCs 
PDGFRα, which is often used to identify OPCs, is also expressed by a number of cell 
populations outside of the CNS – populations that may also rely on primary cilia for their 
correct function.  To determine whether Pdgfrα-CreERT2 transgenic mice could be used to 
selectively target deoxyribonucleic acid (DNA) recombination in OPCs, adult Pdgfrα-
CreERT2::Rosa26-YFP transgenic will be given Tx and DNA recombination assessed in 
PDGFRα-expressing cells in a number of tissues and organs. 
Aim 5: To assess the effect of conditional Kif3a-deletion on oligodendrogenesis 
Pdgfrα-CreERT2::Rosa26-YFP::Kif3afl/fl mice will receive Tx in adulthood, to conditionally 
ablate cilia assembly by OPCs.  The number of newborn oligodendrocytes added to the 
brain will be identified by immunohistochemistry and quantified over time in control and 
Kif3a-deleted mice. 
Aim 6: To determine whether acutely reducing adult oligodendrogenesis affects motor 
coordination or visual acuity 
I will compare the performance of Pdgfrα-CreERT2::Kif3afl/fl and control transgenic mice 
across a series of motor and visual acuity tests including gait analysis, grip strength testing 
and the optokinetic visual acuity test. 
Aim 7: To determine whether acutely reducing adult oligodendrogenesis alters short-term 
memory, anxiety-like behaviours or depression  
I will compare the performance of Pdgfrα-CreERT2::Kif3afl/fl and control transgenic mice in the 
T-maze and novel object recognition task, to examine short-term memory.  Anxiety-like state 
will be tested using the elevated plus maze, the open field test and the marble bury test and 
depression will be tested using the forced swim test.  
  
42 
 
Chapter 2: Methods 
2.1  Transgenic mice 
Pdgfrα-CreERT2 (Kang et al., 2010), Pdgfr-H2BGFPknock-in mice (referred to as Pdgfrα-
histGFP) (Hamilton et al., 2003) Plp-CreERT2 (Doerflinger et al., 2003) and Rosa26-YFP 
(Srinivas et al., 2001) transgenic mouse lines were obtained from Jackson Laboratories, 
Kif3afl/fl (Marszalek et al., 1999) mice were obtained from the University of California, Davis 
and the Sox10-GFP mouse line was a kind gift from Professor William D Richardson (UCL) 
and maintained on a C57Bl6 background.  Pdgfrα-CreERT2, Pdgfrα-histGFP and Plp-
CreERT2 (Doerflinger et al., 2003) mouse lines were maintained as heterozygous lines, 
renewed by mating with C57Bl6 mice (also from Jackson Laboratories), while the Kif3afl/fl and 
Rosa26-YFP transgenic mice were maintained as homozygous lines.  All offspring were 
weaned at P28, but housed with gender-matched littermates after weaning to ensure normal 
myelin development (Makinodan et al., 2012).  Mice were housed in individually ventilated 
OptimiceTM cages (Animal Care Systems, USA), on a 12-hour light-dark cycle, with food and 
water available ad libitum.  Male and female mice were used for this study and all 
experiments were approved by the University of Tasmania Animal Ethics Committee (13741 
and 16151). 
2.2  Genotyping 
Pdgfrα-histGFP and Sox10-GFP neonates were genotyped by light to determine GFP 
expression.  For all other genotyping ear biopsies were collected from transgenic mice at 
~P20 and used to obtain genomic DNA as previously described (O’Rourke et al., 2016).  
Each biopsy was digested in 100mM Tris-HCl / 5mM EDTA / 200mM NaCl / 0.2% SDS / 
0.48mg/ml proteinase K (ThermoFisher Scientific; AM2542) overnight at 55°C.  The cellular 
and histone proteins were precipitated by exposure to 6M ammonium acetate (Sigma; 
A1542) and incubation on ice for 15 minutes (min).  After centrifugation, the genomic DNA 
(gDNA) was precipitated from the supernatant with isopropyl alcohol (Sigma; I9516).  The 
DNA pellet was washed in 70% Ethanol (Sigma; E7023), and resuspended in sterile MilliQ 
water.  50-100ng of gDNA was used as the template and a region of the gene of interest 
amplified by PCR, in a 25µL reaction, also containing 0.5µL of each primer (100nmol/mL; 
GeneWorks) and 12.5 µL GoTaq® green master mix (Promega, M7123) in MilliQ water.   
To genotype mice expressing the Rosa26-YFP transgene we used three primers: Rosa26 
wildtype 5’ AAAGTC GCTCT GAGTT GTTAT; Rosa26 wildtype 3’ GGAGC GGGAG 
AAATGG ATATG and Rosa26 YFP 5’ GCGAA GAGTT TGTCC TCAACC and a PCR 
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program of: 94°C for 4’; 37 cycles of 94°C for 30”, 60°C for 45”, and 72°C for 60”, followed 
by 72°C for 10 min.  If present, the Rosa26-YFP PCR product is a 550bp fragment of the 
wildtype Rosa26 gene and a 250bp product corresponding to the Rosa26 gene locus 
containing the loxp-stop-loxp-YFP transgene.   
Kif3afl/fl transgenic mice were genotyped by PCR using three primers: Kif3a_1 5’ AGG GCA 
GAC GGA AGG GTG G, Kif3a_2 5’ TCT GTG AGT TTG TGA CCA GCC and Kif3a_3 5’ 
TGG CAG GTC AAT GGA CGC AG under the following conditions: 94°C for 4’, followed by 
34 cycles of 94°C for 30”, 62°C for 45”, and 72°C for 60”, and a final 10 min at 72°C.  This 
PCR has the potential to produce two DNA products - one product of ~350bp corresponding 
to expression of the wildtype Kif3a gene and an ~130bp (Marszalek et al., 2000) larger 
product corresponding to expression of the Kif3afl/fl allele.   
The PCR designed to detect expression of the gene coding for Cre recombinase was used 
to genotype both Pdgfrα-CreERT2 and Plp-CreERT2 mouse lines, and produced a 500bp 
product in the presence of Cre and no product when Cre was absent.  The Cre PCR was 
carried out using the following primers: Cre 5’  CAGGTC TCAGG AGCTA TGTCC AATTT 
ACTGA CCGTA; Cre 3’ GGTGTT ATAAG CAATC CCCAGAA under the following 
conditions: 94°C for 4’, followed by 34 cycles of 94°C for 30”, 62°C for 45”, and 72°C for 60”, 
and a final 10 min at 72°C.   
2.3  Tx administration 
Tx (Sigma, T5648-5G) was reconstituted to 40 mg/ml in corn oil and sonicated for ≥ 1 hour 
until dissolved.  Mice received 300mg/kg Tx by oral gavage, administered daily for 4 
consecutive days, from postnatal day 57 (P57).  Mice were weighed and monitored daily.  
No side-effects of Tx administration were observed.  Our dosing regimen provides the 
maximal amount of Tx that can be tolerated by young adult mice without observing adverse 
side-effects (Rivers et al., 2008).  Mice did not lose ≥10% of their starting body weight.  
Examining the tissue from 3 days after the final Tx dose (P57+7) allows recombination to 
occur and the fluorescent reporter to be expressed.  
2.4  Perfusion fixation 
Mice were terminally anaesthetised with a 30mg/kg intraperitoneal (i.p.) injection of sodium 
pentobarbitone (Ilium, Troy Laboratories, NSW, Australia).  Once unconscious, but prior to 
respiratory failure, the chest cavity was opened to expose the heart.  A small incision was 
made in the right atrium of the heart and the perfusion needle inserted into the left ventricle.  
4% paraformaldehyde (PFA) (w/v) (Sigma, P6148) in phosphate buffered saline (PBS) was 
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perfused through the vasculature at approx. 9ml/min.  Following fixation, tissues of interest 
were dissected.  Brains were sliced into 2mm thick coronal slices using a brain matrix, and 
immersion fixed for 90 min at room temperature.  All other tissue was removed and 
immersion fixed for 90 min at room temperature.  Tissue was cryopreserved in 20% sucrose 
(w/v) (Sigma, S0389) in PBS overnight at 4°C prior to embedding in optimal cutting 
temperature cryomatrix (Thermo Scientific, 6769006) and storage at -80°C.  
2.5  Cell culture  
2.5.1  Generating mixed glial cultures 
The protocol for generating mixed glial cultures was based on the protocol previously 
published in Young et al. (2013).  P0-P5 Pdgfrα-histGFP and Pdgfrα-histGFP x Kif3afl/fl 
transgenic mouse pups were genotyped with blue light to confirm histGFP fluorescence and 
then decapitated, the brains removed and cortices isolated into Earle’s balanced salt solution 
(EBSS, Invitrogen, 14155-063).  Cortices were chopped into pieces of approximately 2mm 
were collected into 2mL EBSS and treated with 50µl 0.25% (w/v) trypsin (Sigma, T4799) in 
EBSS at 37°C for 15-20 min (Pringle et al., 1996).  50µl 5.25mg/ml DNAse1 (Sigma, 5025) 
in MilliQ was added followed by 2mL EBSS / 10% FCS (Invitrogen, 10099-141).  Tissue 
pieces were allowed to settle before the medium was removed and replaced with 2mL of 
EBSS.  The tube was tapped sharply to dissociate cells, and tissue pieces allowed to settle 
before the medium was transferred to a clean tube.  This process was repeated, and tissue 
pieces remaining after the second transfer were gently triturated before being transferred.  
The pooled cell suspension was passed through a 40µm cell sieve (BD, 352340) and 
centrifuged for 5 min at 500rcf, before the supernatant was removed and the pellet gently 
resuspended in 16mL of complete OPC medium (Appendix 1) and plated in 3 wells of a 6 
well plate.  Each well was pre-treated with >30,000 MW poly-D-lysine hydrobromide (PDL, 
Sigma, P7405) (2.6.3 PDL pre-treatment).  Cultures were incubated at 37°C and 5% CO2 . 
2.5.2  Purifying OPCs by fluorescence activated cell sorting 
7 days in vitro (DIV) primary mixed glial cultures were rinsed twice in EBSS before 2ml of 
50% EBSS / 50% TryplE (Thermofisher Life Technologies, 12604013) was applied to each 
well, and plates were incubated at 37°C and 5% CO2 for 15-20 min, to allow the cells to 
dislodge from the plastic.  200µl FCS was added to each well to inactivate trypsin and the 
well contents were gently triturated before being pooled and centrifuged at 500g for 5 min.  
The supernatant was removed and the pellet resuspended in 3ml 50% EBSS / 50% FCS 
and passed through a 40µm cell sieve.  ~50µl of the cell suspension was reserved 
(propidium iodide (PI) negative control for flow cytometry) and the remainder treated with PI 
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(Sigma, P4170), diluted in PBS to a final concentration of 0.02mg/ml.  OPCs (GFP+, PI 
negative cells) were purified from the glial cell suspension using a Beckman Coulter MoFlo 
Astrios cell sorter (Beckman Coulter, CA, USA) and collected into 2ml complete OPC media.   
After sorting, the OPC suspension was centrifuged at 500g for 5 min, the supernatant 
removed and the pellet resuspended in 1mL of complete OPC medium.  The number of 
viable OPCs was quantified using a haemocytometer (Sigma, z359629) and trypan blue 
(Sigma, T8154) exclusion.  OPCs were plated onto PDL-coated 13mm #1 glass coverslips 
(Lomb, CSC131GP) in 24 well plates, at a density of 30,000 cells / well in 500µl of complete 
OPC medium for immunocytochemistry or protein lysate collection.  Alternatively cells were 
plated on PDL-coated 35mm glass bottom culture dishes with a 14mm glass diameter (In 
Vitro Scientific, D35-14-1-N) at a density of 20,000 cells per dish in 2ml of complete OPC 
medium for live imaging.  Cultures were incubated at 37°C and 5% CO2. 
2.5.3  PDL pre-treatment 
Prior to plating mixed glial or sorted OPC cultures cell substrates (culture wells, coverslips 
and turning dishes) were pre-treated with 0.05mg/mL >30,000 MW poly-D-lysine 
hydrobromide (PDL)(Sigma, P7405) for a minimum of 1 hour.  PDL was then removed and 
the substrate rinsed twice in sterile MilliQ before being left to dry completely inside a 
biosafety cabinet. 
2.5.4  HEK293T cell culture 
HEK293T cells were grown in Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, 
10566-016) containing 10% FCS and 1% penicillin / streptomycin (Invitrogen, 15140122)  
and incubated at 37°C and 5% CO2.  The medium was changed at least twice a week or 
more frequently if the phenol red pH indicator indicated that the medium was becoming 
acidic (yellow).   
Cells were subcultured when they reached a confluence of 75-90% (approx. once per week).  
Cells were treated with 50% TryplE in EBSS until they dislodged from the bottom of the dish 
with light swirling.  The medium was transferred into a centrifuge tube and centrifuged at 
500g for 5 min.  The supernatant was removed and the pellet resuspended in fresh medium.  
Approx. 1/10 of the resuspended cells were seeded into a fresh flask and topped up with 
fresh media.  
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2.5.5  Tat-Cre treatment of cultured cells 
A solution of 1, 2 or 4 mg/ml tat-Cre (Excellgen, EG-1001) was made up in OPC complete 
medium and used to replace the existing culture medium of 8-10 DIV sorted OPC cultures or 
10 DIV mixed glial cultures, plated onto 13mm glass coverslips in a 24 well plate.  Wells 
contained 150µl of complete OPC media and were topped-up to 300µl with the tat-Cre-
containing medium, to a final concentration of 0.5µM, 1µM or 2µM.  Cultures were incubated 
at 37°C and 5% CO2 for 90 min, before the medium was removed and replaced with 500µl 
complete OPC media, and incubated for a further 72h before being fixed, used for live 
imaging or harvested for Western blot analysis. 
2.5.6  Fixation of cultured cells 
Culture medium was gently removed and replaced with ice-cold 4% PFA and incubated on 
ice for 5 min, before being replaced with ice-cold methanol, and incubated for a further 5 
min.  Methanol was removed and 3 x PBS washes performed.  Cells were stored in PBS at 
4°C until required for immunocytochemistry 
2.5.7  Transfection of cultured cells 
HEK cells were transfected using an Effectene transfection kit (QIAGEN, 301425) according 
to manufacturer’s instructions, using 0.3-2µg of plasmid DNA per transfection. 
Cultured OPCs were transfected using a NeuroMag magnetofection kit (OZ Biosciences, 
MN50200) according to manufacturer’s instructions, using 0.5-1µg of plasmid DNA and 0.5-
1µl of NeuroMag solution per transfection.  A medium change was performed 1-2 hours after 
transfection. 
2.5.8  Preparation of cells for live imaging 
1-2 hours prior to live imaging, the culture medium was replaced with live imaging medium 
(Appendix 1).  The live imaging protocol is described in section 2.11.2. 
2.6  EdU administration 
2.6.1  In vitro administration of EdU 
Stocks of 2.5mg/ml 5-ethynyl-2’-deoxyuridine (EdU; E10415) in EBSS were stored at -20°C.  
Culture medium was gently removed from 8-10 DIV OPC cultures or 10 DIV mixed glial 
cultures (13mm coverslips; 24 well plate) and replaced with complete OPC medium 
containing 2.5µg/ml EdU.  Cultures were maintained at 37°C and 5% CO2. 
47 
 
2.6.2  Oral administration of EdU 
To perform long-term labelling of proliferating OPCs in vivo, EdU was administered to adult 
mice via the drinking water at a concentration of 0.2mg/ml as previously described (Clarke et 
al., 2012).  EdU is light sensitive, and was administered via opaque water bottles (Optimice, 
C79135A) and replenished every 48 hours.   
2.6.3  i.p injection of EdU 
To acutely label a population of OPCs transitioning through s-phase of the cell cycle, adult 
mice received 3 x 20µl i.p injections of EdU (1mg/ml in PBS), at 2 hourly intervals, with the 
final injection being given 2 hours prior to perfusion fixation.  This protocol labels OPCs 
entering s-phase over a 6 hour period.   
2.7  Protein quantification by western blot 
2.7.1   Collecting cells for protein lysates 
Cultured cells were rinsed twice with ice-cold PBS. 75-100µl of radioimmunoprecipitation 
assay (RIPA) buffer (Appendix 1) was added to the first well and the cells scraped off.  The 
RIPA buffer and cells were then transferred to the next well and this was repeated until the 
cells were collected from 4 wells of a 12 well plate.  Cell lysates were centrifuged at 
13,000rpm for 5 min and the supernatant transferred to a fresh tube.  Lysates were stored at 
-80°C until use. 
2.7.2  Bradford assay 
Bovine serum albumin (BSA; Sigma A7030) was diluted in MilliQ to create 2, 1, 0.5, 0.25 and 
0.125 mg/ml standards.  5µl of each standard, RIPA-only and each protein lysate was 
assayed in triplicate.  25µl of the reagent mix, containing 1ml of protein assay reagent A 
(BioRad, 500-113) and 20µl protein assay reagent S (BioRad, 500-115), and 200µl of protein 
assay reagent B (BioRad, 500-115), was added to each well, and incubated at ~21°C for 15 
min, before being read on a spectramax plate reader (Molecular Devices).  The protein 
concentration of each lysate was determined from the standard curve. 
2.7.3  Western blotting 
Western blots were performed using a Bolt® western blotting system with pre-cast gels (BIO-
RAD, Hercules, CA).  Samples were mixed with 4x sample buffer (Thermofisher/Invitrogen, 
B0007), 500mM dithiothereitol (DTT; Sigma, D0632) and MilliQ and incubated at 70°C.  
Samples were run on an 8-12% precast sodium dodecyl sulfate (SDS) gel (Life 
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Technologies, NW04125BOX) with 2-(N-morpholino)ethanesulfonic (MES) running buffer 
(Life Technologies, B0002) for 22 min at 200V. 
After the SDS gel was run, proteins were transferred onto a polyvinylidene fluoride (PVDF) 
membrane (BioRad, 162-0177) using a Bolt® transfer cassette.  Each side of the cassette 
was assembled with two sponges and two pieces of filter paper soaked in transfer buffer 
(Appendix 1) before the protein gel and transfer membrane were sandwiched between the 
two halves.  Once the cassette was loaded it was placed into the chamber and covered with 
transfer buffer.  The protein was transferred from the gel to the membrane at 20V, over a 60 
min period. 
Once transfer was complete the membrane was blocked in 5% milk/tris buffered saline-
Tween20 (TBS-T) (Appendix 1) for 1 hour at room temperature.  Membrane was then 
incubated with primary antibodies (Appendix 2: Table 3) in milk/TBS-T on an orbital mixer at 
4°C, overnight.  The antibody-containing solution was removed, and three 10 min TBS-T 
washes performed.  Membrane were incubated with secondary antibodies (Appendix 2: 
Table 3) in milk/TBS-T on an orbital mixer at 4°C, overnight, before 3 x 10 min TBS-T 
washes were performed. 
Detection substrates (Millipore, WBKLS0500) were combined in a 1:1 ratio and warmed to 
approx. 37°C.  Membranes were placed face up on the imager with the detection substrate 
mix poured over the top and covered with a sheet of acetate.  The membrane was imaged 
using an Amersham imager 600 (GE Healthcare, Chicago, IL) and auto exposure, with the 
exposure time adjusted as necessary to prevent over-exposure.  The membrane was 
removed and washed in PBS.  If a second staining round was necessary, the membrane 
was covered with stripping buffer (Thermofisher, 46430) and incubated for 5 min at room 
temperature on an orbital shaker.  The membrane was washed three times in TBS-T and the 
process repeated from blocking. 
2.8  Plasmid DNA amplification 
The pEGFP-Arl13b plasmid was generously donated by Dr Judith Paridaen in the Huttner 
lab (Max Planck Institute, Dresden, Germany) and n-terminal (Clontech, 632523) and c-
terminal (Clontech, 632524) mCherry fusion vectors purchased from Clontech (Mountain 
View, CA). 
2.8.1  Transformation 
DSHΔ chemically competent E.coli were thawed on ice.  1µl of 500ng/µl plasmid DNA, 50µl 
ice-cold KCM (10mM KCl, 30mM CaCl2, 50mM MgCl2), and 50µl of thawed DSHΔ cells were 
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combined and incubated at 42°C for 60 sec, and rapidly transferred to ice for a further 5 min.  
1ml of antibiotic-free luria broth (LB; Appendix 1) was added and the tube, and incubated at 
37°C for 45 min.  Cells were spun down in a benchtop centrifuge at 700 rpm for 1 min to 
pellet, and all but 100µl of medium removed.  Cells were then plated onto agar plates 
(Appendix 1) containing 100µg/ml Kanamycin (Thermo Fisher, 11815024) and incubated at 
37°C overnight.  Bacterial plates were then stored at 4°C to prevent further growth. 
2.8.2  DNA minipreps and glycerol stocks 
Individual colonies were picked from bacterial plates, using a 200µl pipette tip with the end 
partially melted.  Each tip was dropped into a 50µl centrifuge tube, with 15ml of LB 
(Appendix 1) containing 100µg/ml Kanamycin.  Tubes were then incubated at 37°C on a 
shaker overnight or until the LB had turned cloudy.  2-3ml of bacterial broth was pelleted by 
centrifugation and and the DNA extracted using a QIAprep spin miniprep kit (QIAGEN, 
27104) according to the manufacturer’s instructions.  DNA was eluted into MilliQ H2O and 
stored at -20°C.  For long-term storage of the transformed bacterial clones, 150µl of glycerol 
(Sigma, G2025) and 800µl of the bacterial broth were combined in a 1ml cryotube and 
stored at -80°C. 
2.8.3  Digesting and ligating plasmid DNA 
Plasmid DNA was digested using N.E.B. enzymes and buffers (New England Biolabs, 
Ipswich, MA).  5-10µg of DNA was digested by with 5µl of the required enzyme in 10µl of the 
appropriate 10x enzyme buffer and 10µl of 1:10 BSA, made up to 100µl with nuclease free 
water and incubated at 37°C for two hours.  As a precaution, to guard against the self-
ligation of any partially digested vector products, the linearized DNA was treated with 
Antarctic Phosphatase (New England Biolabs, Ipswich, MA) as per the manufacturer’s 
instructions. 
2.9  RNA probe synthesis and in situ hybridisation 
2.9.1  Generating an RNA probe template 
Stab cultures of E.coli containing plasmids coding for SMO, sentan (SNTN), intraflagellar 
transport protein 81 (IFT81), patched 2 (PTCHD2), Kif3a and PDGFRα were purchased from 
Source Biosciences (Nottingham, UK)(table 2.1).  Each clone was streaked onto a 0.5% 
(w/v) agar plate containing the appropriate antibiotic and incubated at 37°C overnight (see 
table 2.1 for antibiotics).  DNA was amplified, purified and digested using methods described 
in 2.8.  The restriction enzyme selected, cut the DNA at the 5’ end of the coding sequence 
(see table 2.1 for restriction enzymes).   
 Plasmid Vector Enzyme 1 Enzyme 2 Buffer Antibiotic 
resistance 
pEGFP-
Arl13b-C1 
pEGFP-C1 Kpn1 Pst1 N.E.Buffer 2 Kan 
pmCherry-C1 pmCherry-
C1 
Kpn1 Pst1 N.E.Buffer 2 Kan 
pmCherry-N1 pmCherry-
N1 
Kpn1 Pst1 N.E.Buffer 2 Kan 
Kif3a clone pFLC1 Not1 - N.E.Buffer 3 Amp 
Ift81 clone pYX-Asc Sal1 - N.E.Buffer 3 Amp 
Smo clone pCMV-
SPORT6 
Sal1 - N.E.Buffer 3 Amp 
Ptchd2 clone pYX-Asc EcoR1 - EcoR1 Amp 
Sntn clone pCR-
Blunt2-
TOPO 
Not1 - N.E.Buffer 
3.1 
Kan 
 
 
Table 2.1 Restriction digests used for digesting plasmids  
Table showing restriction digests performed when generating mCherry plasmids and 
In situ probes.  Columns show the generated plasmid that was being digested, the 
vector that the plasmid was contained in, the enzymes used and the buffer the digest 
was performed in. 
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The linearised DNA template was purified using a QIAquick PCR purification kit 
(QIAGEN,28104) according to the manufacturer’s instructions.  Briefly, buffer PB was added 
to the digested DNA in a ratio of 5:1.  The solution was transferred to a spin column, placed 
within a collection tube and centrifuged for 30-60 seconds at 13,000rpm.  The eluent was 
discarded.  750µl of buffer PE was added to the spin column and centrifuged for 30-60 
seconds at 13,000rpm.  The flow through was discarded and the spin column centrifuged for 
a further 1 min at 13,000rpm.  The spin column was transferred to a clean microcentrifuge 
tube and 30µl MilliQ added to the membrane.  The samples were incubated for 1 min and 
centrifuged for 1 min at 13,000rpm to elute the linearised DNA.  The quality of the DNA 
template was evaluated by running 5µl on a 1% agarose gel at 100V for 30 min.  
2.9.2  RNA probe synthesis 
Ribonucleic acid (RNA) probes were synthesised from linearised DNA template using either 
T7, T3 or SP6 RNA polymerase (Promega, M0251S, P4024 and M0251S) according to the 
manufacturer’s instructions.  For each synthesis reaction, 2µl of water was combined with 
5µl of template DNA, 5µl of 5x transcription buffer, 7.5µl of DTT (Sigma Aldrich, D0632), 
2.5µl of the digoxigenin (DIG) labelling mix (Roche, 11277073910, 1µl of RNAsin (Promega, 
N26611) and 2µl of the required RNA polymerase (table 2.1), and incubated at 37°C for 2 
hours.  75µl of diethyl pyrocarbonate (DEPC)-treated MilliQ water was added to each 
reaction and the probe stored on ice until its quality could be verified, by running 5µl of the 
RNA probe on a 1% agarose gel at 100V for 30 min.  Quality RNA probes were stored at -
80°C until required.   
2.9.3  In situ hybridisation 
The RNA probe was combined 1:500 with pre-heated hybridisation solution (Appendix 1) 
and incubated at 70°C for 5 min.  300µl of the RNA probe-hybridisation buffer solution was 
applied to each 13mm coverslips, containing 7-10 DIV OPCs, placed in the central wells of a 
12 well plate, with the cell surface facing up.  1ml of PBS was added to all empty wells and 
Parafilm (Beemis, PM996) placed over the top of the plate before the lid was placed on.  The 
plate was sealed with masking tape and incubated overnight at 65°C in a hybridisation oven.  
The RNA probe-hybridisation solution was removed, replaced with 1ml pre-heated wash 
solution (Appendix 1) and incubated at 65°C for 30 min.  Three additional 30 min wash steps 
were performed at 65°C followed by 2 x 10 min maleic acid buffer-Tween 20 (MABT) 
(Appendix 1) washes at ~21°C.  MABT was removed, replaced with 500ml in situ blocking 
solution (Appendix 1) and incubated at ~21°C for 1 hour.  Anti-DIG- alkaline phosphatase 
(AP) (Roche, 11093274910), was applied in blocking solution at 1:1500 and incubated 
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overnight at 4°C.  Antibody was removed and 3 x 15 min MABT washes performed at ~21°C, 
followed by 2 x 5 min washes in 1x pre-staining buffer (Appendix 1).  Pre-staining buffer was 
removed and replaced with staining buffer (Appendix 1), and the plate covered with foil and 
incubated at 37°C in a hybridisation oven for 2 hours or until a blue colour was visible, 
before the reaction was stopped by replacing the staining buffer with MilliQ.  Coverslips were 
EtOH dehydrated, dipped in xylene and mounted using DPX (Sigma, 44581). 
2.10  Mouse behavioural testing 
2.10.1  Handling and habituation 
Mice were handled and weighed daily from P40 until the commencement of optomotor 
training (P54-P56), after which point, mice were weighed weekly.  Before all motor tests, 
mice were transferred to the test room at least 60 min prior to testing.  For the forced swim 
test, mice were moved to the testing room 1 hour prior to the light cycle change and testing 
did not begin until 1 hour after.  The elevated plus maze, T-maze, open field test and novel 
object recognition test were conducted during the dark cycle i.e. when the mice were awake 
and active.  During this habituation period, any lights that would illuminate the arena during 
testing, were turned on.  
2.10.2  Optokinetic reflex testing 
The rotating optomotor drum is 30cm in diameter and consists of a series of alternating black 
and white lines at spatial frequency of 0.26 cycles per degree (cpd), which is the most 
effective frequency for optokinetic reflex testing in C57Bl6 mice (Abdeljalil et al., 2005).  
Each mouse was placed on a raised central podium within a dimly lit, closed arena and 
allowed to habituate for 5 min with the drum stationary.  Any mouse that left the podium was 
placed back on the podium during this period.  After habituation, the drum was turned on, so 
that the stripes moved clockwise (CW) and counterclockwise (CCW) for two minutes each 
way, with a 1 min break between directions.  The start direction alternated between trials, to 
remove order bias.  Each trial was video recorded for later analysis.  Mice were trained for 2 
days and baseline recorded prior to Tx gavage.  Following Tx administration mice underwent 
optokinetic reflex testing weekly.  To analyse optokinetic reflex performance the number of 
‘head movements’ made by the mouse over the 2 min period was recorded for each 
direction.  A head movement was defined as clear movement of the head in the direction of 
the rotating stripes, followed by a short, rapid ‘reset’ head movement in the opposite 
direction. 
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2.10.3  Gait analysis 
Gait analysis was performed using a DigigaitTM Imaging System (Mouse Specifics, USA).  
Mice were habituated to the treadmill with the treadmill lights on for five min.  The treadmill 
was then activated, and mice were video recorded as they ran at 18cm/s, 22cm/s and 
26cm/s.  Mice ran at each speed for approximately 30 seconds before being slowly ramped 
up to the next testing speed.  Mice were then allowed to rest before testing was repeated at 
an incline of 3° and then a decline of -3°.  Gait analysis was carried out on video segments, 
in which mice ran for 2-3 seconds without obvious acceleration using Digigait analysis 
software (Mouse Specifics, MA, USA).  Digigait testing was performed once prior to Tx 
gavage and at 7, 14, 21, 28, 35 and 43 days post gavage.     
2.10.4  Grip strength 
Grip strength can be used as a measure of decline in muscle strength and coordination 
(Clark et al., 2018).  The protocol was adapted from Clark et al. (2018) and measured using 
a Chatillon grip strength meter (Columbus Instruments, OH, US).  Grip strength testing was 
performed once prior to Tx gavage and at 7, 14, 21, 28, 35 and 43 days post gavage.  Mice 
were held by the base of the tail and gently but firmly pulled directly backward along the grid 
allowing contact with only their fore-paws or with all four paws.  At each test-point grip 
strength was recorded five times each for the fore-paws and all four paws and the maximum 
result was recorded. 
2.10.5  Marble bury test 
The marble bury test can be used to examine anxiety and OCD-like behaviours in rodents, 
with an increase in marble burying behaviour indicating increased anxiety (Angoa-Pérez et 
al., 2013; Kedia and Chattarji, 2014).  The protocol was adapted from Deacon et al. (2005).  
Mice were individually placed in a clean Optimice cage (Animal Care Systems, CO, USA) 
containing 5cm deep bedding, that was pressed flat and 10 marbles (1.5cm diameter).  
Marbles were placed on the surface of the bedding, evenly spaced at ~4cm apart.  Individual 
mice were placed in the cage and left undisturbed for 30 min, then returned to their original 
cage.  The number of marbles that were more than 50% submerged in substrate was 
recorded. 
2.10.6  Forced swim test 
The forced swim test protocol was adapted from Can et al. (2012).  A clean glass beaker 
(15cm diameter) was filled with 24 ± 1°C water to a depth of 15cm.  Mice were individually 
placed in the water, back feet first and left to swim for 5 min before being gently dried off and 
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returned to their home cage.  The amount of time spent actively swimming, passively 
swimming, climbing and floating was recorded.  Active swimming was defined as swimming 
with movement of three or more paws, passive swimming involved movement with only one 
or two paws and floating was defined as no movement of any limbs.  Climbing was defined 
as upward movement of the mouse while facing at a 90° angle against glass of the beaker.  
Ethovision software was used to record video, track mice and perform manual scoring of 
behaviours. 
2.10.7  Elevated plus maze 
The elevated plus maze is a measure of anxiety and was performed as previously described 
in Walf and Frye (2005).  Mice were individually placed in the centre of a plus shaped maze 
consisting of two open arms, 30cm x 5cm with a light intensity of 70 lux and two closed arms 
30cm x 5cm x 15cm with a light intensity of 20 lux.  The maze was elevated 50cm from 
ground level.  Mice were positioned in the centre of the maze facing towards an open arm 
and allowed to explore the maze for a single 5 min trial, before being returned to their home 
cage. The time spent in each of the open and closed arms was recorded.  Ethovision 
software was used to record video, track mice and perform manual scoring of behaviours.  
Manually scored behaviours can give a further indication of changes in anxiety-like 
behaviour (Kulesskaya and Voikar, 2014) and included head dipping, when the mouse dips 
its head below the level of the platform; supported rear, when the mouse rears onto its 
hindpaws while supporting its body weight on the maze walls; unsupported rear when the 
mouse rears onto its hindpaws without supporting itself on the maze; and grooming . 
2.10.8  T-maze 
The T-maze protocol was adapted from Deacon and Rawlins (2006).  Mice were individually 
placed in the start arm of a T-shaped maze with 30cm long arms and allowed to make a 
decision as to which of the other ‘choice’ arms it entered.  Once the mouse had entered one 
of the ‘choice’ arms the entrance was blocked off and the mouse allowed to explore the arm 
for 1 min.  The mouse was then removed, the blocked arm reopened and the mouse 
returned to the start arm.  Each mouse was allowed to make a total of 10 decisions during 
the duration of the testing process.  Re-entering the same arm as the previous trial was 
considered an ‘error’ in alternation and the total number of errors made over the 10 trials 
was recorded. 
2.10.9  Open field test 
The open field test measures anxiety and exploratory behaviours (Ennaceur, 2014).  It was 
adapted from (Kulesskaya and Voikar, 2014).  Mice were individually placed in a 30cm x 
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30cm arena, that was divided into a brightly lit centre (250 lux) and a shaded perimeter.  The 
mice were allowed to explore the box for a single 10 min trial, then returned to their home 
cage.  The amount of time spent in the centre and perimeter zones was recorded.  
Ethovision software was used to record video, track mice and perform manual scoring of 
behaviours.  Manually scored behaviours included supported rearing, unsupported rearing 
and grooming.  
2.10.10  Novel object recognition 
The novel object recognition test protocol was adapted from Taglialatela et al. (2009).  Novel 
object recognition testing was performed in the same 30cm x 30cm arena used for the open 
field test.  Mice were habituated to the arena during open field testing, which was performed 
24 hours before the first day of novel object testing.  For novel object testing the lighting was 
reduced to 35 lux in the centre zone.  On the first day of testing mice were individually 
placed into the arena with two identical objects (duplo towers).  Mice were allowed to explore 
the box for ten min, then returned to their home cage.  The amount of time each mouse 
spent interacting with each object was recorded.  24 hours later, the test was repeated but, 
one of the objects replaced with a novel object of similar size, but different shape and colour 
(a duplo figure).  The amount of time each mouse spent interacting with the novel and 
familiar objects was recorded.  Ethovision software was used to record video, track mice and 
perform manual scoring of behaviours.  The position of the two objects was swapped 
between trials on both day 1 and day 2 of testing.  Manually scored behaviours included 
supported rearing, unsupported rearing, climbing of the objects and grooming. 
2.11  Immunohistochemistry 
Cryosections (30µm) were collected as floating sections from brain, spinal cord, eye, spleen, 
liver, kidney, heart, adrenal gland and pituitary gland.  Cryosections of sciatic nerve, 
gastrocnemius, intestine, and bone marrow (tail) were collected directly onto glass 
microscope slides.  Sections were processed for immunohistochemistry as previously 
described (Young et al., 2010), using primary antibodies at concentrations specified in Table 
1. Primary antibody binding was visualised by applying secondary antibodies conjugated to 
Alexa Fluor-488, -568, -594 or -637 (Appendix 2: Table 2).  Tissue was also exposed to 
Hoechst 33342 (Invitrogen; 1:10,000 dilution) to visualise the cell nuclei.  Floating sections 
were mounted onto glass microscope slides and the fluorescence of all slides preserved by 
the application of fluorescent mounting medium during coverslipping (Dako, S3023). 
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2.11  Microscopy 
2.11.1  Light microscopy 
Light microscopy was performed using 40x and 60x air objectives on an Axio Lab.A1 (Zeiss, 
Germany) microscope with a Axiocam ICc5 (Zeiss, Germany) camera and Axiocam (Zeiss, 
Germany) software. 
2.11.2  Live imaging 
Live imaging was performed using a Nikon Eclipse TI microscope (Tokyo, Japan).  The live 
imaging protocol was adapted from Paridaen et al. (2013).  Live videos were recorded for 8-
12 hours using differential interference contrast (DIC), 488 and 568 emission filters and a 
60x water immersion lens.  Images were acquired every 10 min and at 1µm z-plane slices 
with an Andor Zyla camera (Andor Technology, Belfast, Northern Ireland). Cells were 
maintained at 37°C and 5% CO2 during the imaging period.  Videos were analysed using 
NIS Elements software (Nikon, Tokyo, Japan).  
2.11.3  Confocal microscopy 
Confocal images were collected using an UltraView spinning disk confocal microscope with 
Volocity Software (Perkin Elmer, Massachusetts, USA) with standard excitation and 
emission filters for DAPI (Hoechst 33342), FITC (Alexa Fluor-488), TRITC (Alexa Fluor-568) 
and far red (Alexa Fluor-647).  When imaging tissue sections, Hoechst 33342 was used to 
consistently define the region of interest within the tissue section.  For Pdgfrα-CreERT2 
characterisation (Chapter 4), a single z plane image was collected using the 20x air 
objective, and images were stitched together in the x-y planes using Volocity software.  For 
primary cilium quantification in vitro and in vivo, confocal z-plane images were collected at 
0.5µm intervals, using the 40x water and 60x oil objectives, and stitched together (in z-y-z 
planes) using Volocity software.  For all other immunocytochemistry and 
immunohistochemistry, confocal stacks were collected 2µm apart using the 20x air and 40x 
water objectives, and stitched using Volocity software. 
Cell counts were performed manually from exported images, viewing the images in ImageJ 
software version 1.46r (NIH, Washington DC, USA) and Adobe Photoshop CS6.  Images 
were collected from each relevant area, across a minimum of 3 cryosections per mouse, and 
a minimum of 3 biological replicates per treatment condition.   
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2.12  Statistical analysis 
Statistical analyses were performed in GraphPad Prism 6 (GraphPad, La Jolla, CA, USA).  
Data was first tested to determine whether it was normally distributed.  All data was normally 
distributed and were analysed according to need, by performing a two tailed t-test, one-way 
analysis of variance (ANOVA), two-way ANOVA or repeated measures ANOVA, followed by 
a Bonferroni multiple comparisons post-hoc test.  Data are presented as mean ± standard 
deviation (std dev) unless otherwise stated and analyses were performed in n ≥ 3 mice in 
each case.   
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Chapter 3: Kif3a is required for primary cilia assembly by 
OPCs, and regulates OPC proliferation in vitro  
3.1  Introduction 
Developmental and adult OPCs are highly proliferative in vitro (Wu et al., 2011) and in vivo 
(Levison et al., 1999; Horner et al., 2000; Dawson et al., 2003; Lasiene et al., 2009; Clarke 
et al., 2012), and at ~5% of all cells, are the largest proliferative cell population in the mature 
CNS (Dawson et al., 2003).  Despite primary cilia being a feature common to many 
proliferative cell types (reviewed in Goto et al., 2017), assembled and disassembled as the 
cells progress the cell cycle (Han et al., 2008; Spassky et al., 2008; Tong et al., 2014), the 
presence of primary cilia on the surface of OPCs has not been explored.   
Microarray and RNA sequencing studies, comparing gene expression profiles from CNS cell 
types in the early mouse cortex, indicate that OPCs express genes critical to primary cilia 
assembly, such as Kif3a and Ift81, and the Shh receptors, Ptchd2 and Smo, that are known 
to localize at primary cilia (Cahoy et al., 2008; Zhang et al., 2014).  Furthermore, these 
genes are more highly expressed by OPCs than mature, myelinating oligodendrocytes 
(Cahoy et al., 2008; Zhang et al., 2014), suggesting that primary cilia are assembled on 
OPCs and disassembled during differentiation.  Therefore, in this thesis Chapter, I will test 
the hypothesis that primary cilia on the surface of OPCs are dynamic, and assembled and 
disassembled with the cell cycle.     
Kif3afl/- transgenic mice (Marszalek et al., 2000) have been used to interrogate the role of 
primary cilia on a variety of cell types, as they can be used to prevent primary cilium 
assembly in a cell-specific manor.  For example, the deletion of Kif3a from cerebellar granule 
cell precursors, reduces the developmental, Shh-mediated expansion of this progenitor pool 
(Spassky et al., 2008).  This phenotype is similar to that observed in humans diagnosed with 
the ciliopathy known as Joubert syndrome, which results in abnormal cerebellar 
development (Spassky et al., 2008).  When cilia assembly or disassembly was instead 
prevented in radial astrocytes in the hippocampal dentate gyrus of the developing mouse 
brain (Han et al., 2008) (Tong et al., 2014), neurogenesis was compromised. 
In this chapter, I will examine OPCs cultured from early postnatal Pdgfrα-histGFP transgenic 
mice, to determine whether cells of the oligodendrocyte lineage assemble primary cilia in 
vitro.  I will then generate OPC cultures from Pdgfrα-histGFP::Kif3afl/fl mice and treat them 
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with tat-Cre and EdU in order to determine the ability of the primary cilium to regulate OPC 
proliferation. 
3.2  Results 
3.2.1  OPCs can be purified from mixed glial cultures by flow cytometry 
To determine whether cultured OPCs express genes associated with primary cilia assembly 
/ disassembly or signalling, I generated mixed primary glial cultures from the cortex of P0-P3 
Pdgfrα-histGFP transgenic mice (see methods).  In cells derived from Pdgfrα-histGFP mice, 
the Pdgfrα gene promoter drives expression of a histone-targeted form of GFP, such that 
PDGFRα+ OPCs can be identified by their GFP-labelled nucleus.  After 7 DIV the mixed glial 
cultures, containing both GFP+ and GFP-negative cells (Fig. 3.1 a), were enzymatically 
dissociated and treated with PI to identify dying cells.  Using fluorescence activated cell 
sorting, I set forward- and side-scatter gates to exclude cell doublets and debris, and 
fluorescent gates to collect the GFP+ PI-negative healthy OPCs (Fig. 3.1 b).   
The number of cells collected was quantified using a haemocytometer, and the number of 
cells recovered equated to 7.1 ± 4.9 % of the collected events (avg ± std; n=3 cultures).  The 
cells were plated onto PDL-coated glass coverslips at 30,000 cells per well, and were 
cultured for a further 3 days.  At 10 DIV, each culture was fixed by exposure to 4% PFA and 
the identity of the purified cells confirmed by immunocytochemistry.  90 ± 3% of the cells 
identified by Hoescht 33342 staining were GFP+ PDGFRα+ (avg ± std; n=3 cultures), 
confirming that they were indeed OPCs (Fig. 3.1 c).  The remaining cells were negative for 
both GFP and PDGFRα and had the morphological characteristics of astrocytes. 
3.2.2  OPCs express genes associated with primary cilium structure and function  
In order to determine whether OPCs have the potential to assemble primary cilia, 10 DIV 
OPC cultures were fixed and in situ hybridisation performed to detect mRNA coding for 
proteins integral to primary cilium assembly / disassembly or primary cilium-associated 
signalling pathways (Fig. 3.2; blue).  A haemotoxylin (Htx) counterstain was also applied to 
each coverslip to ensure that all cells could be visualised (Fig. 3.2; pink).  An anti-sense 
Pdgfrα RNA probe acted as a positive control for the in situ hybridization protocol.  Pdgfrα 
mRNA was detected in the same proportion of cells known to be OPCs (~91%; Fig 3.2 a, b, 
l).  It was highly expressed in the cell body, but mRNA expression also extended along the 
OPC processes (Fig. 3.2 b).  An anti-sense SNTN RNA probe was used as a negative 
control for this experiment, as SNTN is only expressed by motile cilia, not primary cilia.  As 
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Figure!3.1:!!OPCs!assemble!primary!cilia!in!vitro."
(a)"5"DIV"mixed"glial"cultures"(phase,"greyscale),"derived"from"Pdgfrα?histGFP"mice"
express"GFP"(green).""Arrow"heads"denote"GFP+"cells.""Arrows"denote"GFP?negative"
cells.""(b)"Fluorescence"activated"cell"sorting"dot"plot"for"7"DIV"mixed"glial"cultures"
derived" from"Pdgfrα?histGFP"mice." " Red" box" denotes" GFP+" PI?negative" cells" to" be"
isolated." " (c)" GFP+" cells" purified" from"mixed" glial" at" 7DIV," grown" for" a" further" 3"
days"and"immunostained"to"detect"GFP"(green)"and"Pdgfrα"(red).""Low"(d)"and"high"
(e)"magnification"images"of"10"DIV"OPC"cultures"immunostained"to"detect"Arl13b"
(red)," γ?tubulin" (green)" and"Hoescht" 33342" (HST," blue)." " Arrow" heads" denote" γ?
tubulin+"Arl13b+"primary" cilia." " Small" arrows" indicate"unciliated"basal" bodies" (γ?
tubulin"alone).""(f)"Quantification"of"the"GFP+"OPCs"with"γ?tubulin+"basal"bodies"and"
Arl13b+"γ?tubulin+"primary"cilia"(avg"±"std;"n=3"cultures).""Scale"bars"="20"μm."
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Figure!3.2:!OPCs!express!primary!cilium?associated!genes!
(a,!b)"Low"and"high"magnification"images"of"OPCs"probed"to"detect"Pdgfrα"mRNA"
(purple).""(c,!d)""Low"and"high"magnification"images"of"OPCs"probed"to"detect"Ift81"
mRNA"(purple).""(e,!f)"Low"and"high"magnification"images"of"OPCs"probed"to"detect"
Kif3a"mRNA"(purple).""(g,!h)"Low"and"high"magnification"images"of"OPCs"probed"to"
detect"Ptchd2"(purple).""(i,! j)""Low"and"high"magnification"images"of"OPCs"probed"
Smo"mRNA"(purple).""(k,! l)"Low"and"high"magnification"images"of"OPCs"probed"to"
detect"Sentan"mRNA"(Sntn,"purple)."(m)"Quantification"of"the"proportion"of"cells"in"
each"culture"that"were"positive"for"each"mRNA.""Haematoxylin"counterstain"(pink).""
Black"arrowheads"indicate"representative"mRNA"positive"cells.""Scale"bars"="60μm."
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predicted, even after an extended developing period, I found no evidence that this gene was 
expressed by OPCs (Fig. 3.2 k).  
The first primary cilium-associated gene that I investigated was Ift81, a protein which is 
necessary for maintenance of the cilium cytoskeleton (Lucker et al., 2005).  Ift81 mRNA was 
expressed by all OPCs (~96% of cells; Fig. 3.2 c, d, l).  Like Pdgfrα mRNA, Ift81 mRNA 
appeared to be expressed throughout the cytoplasm, including in the processes, and some 
cells displayed regions of dense expression in the cell body (Fig. 3.2 d).  The Kif3a gene is 
involved in primary cilium assembly (Rosenbaum and Witman, 2002; Huangfu et al., 2003; 
Huangfu and Anderson, 2005), and Kif3a mRNA was highly expressed throughout each 
OPC (~96% of cells; Fig. 3.2 e, f, l), with a small number of discrete sites showing a 
particularly high level of expression within each cell.  As both of these genes are essential 
for primary cilia construction, and the deletion of either gene results in primary cilia ablation, 
these data suggest that OPCs are likely to have a primary cilium assembled on their cell 
surface.   
As components of the Shh signalling pathway localize to the primary cilium, I predicted that 
genes associated with Shh signalling would also be expressed by OPCs.  To investigate this 
possibility, I used an anti-sense PTCHD2 RNA probe and an anti-sense SMO RNA probe to 
examine expression of mRNAs coding for these Shh receptors in OPC cultures.  PTCHD2 
mRNA was expressed by 96 ± 0.56% of cells in these cultures (Fig. 3.2 g, h, i).  Expression 
was evident at low levels throughout the soma and to a lesser extend in the processes (Fig. 
3.2 h).  SMO mRNA was expressed by an equivalent proportion of OPCs (~97% of cells; 
Fig. 3.2 i, j, l), however, this mRNA was distributed throughout each cell (Fig. 3.2j).  The 
expression of Shh signalling genes by OPCs further supports the idea that these cells have 
assembled primary cilia in vitro. 
3.2.3  Only a subset of OPCs have assemble primary cilia in vitro 
As OPCs express genes associated with primary cilium structure and function, I next 
performed immunocytochemistry on 10 DIV Pdgfrα-histGFP OPC cultures, to detect GFP 
(not shown), the cilia markers ADP-ribosylation factor-like protein 13b (Arl13b) (red) and γ-
tubulin (green), and the nuclear marker Hoescht 33342 (blue) (Fig 3.1. d, e).  γ-tubulin is a 
protein present in the basal body, while Arl13b is present in the membrane of the primary 
cilium.  As the basal body is a structure associated with primary cilia assembly, but also 
forms the centrioles during cell division, it was not surprising that ~94% of cultured OPCs 
had a γ-tubulin+ puncta (green) (Fig. 3.1 f).  When viewed at high magnification the γ-tubulin+ 
puncta appeared to consist of two distinct, but closely associated, dots of staining in some 
cells, suggesting that each cell possesses two conjoined centrioles.  This configuration has 
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been reported in other cells, and includes the mother centriole, which forms the basal body 
of the primary cilium, and the daughter centriole (reviewed in Winey and O'Toole, 2014).  A 
low level of Arl13b staining was detected throughout the cytoplasm of some OPCs, but the 
intense Arl13b+ puncta (red), associated with a γ-tubulin+ basal bodies and indicative of 
primary cilia, were only detected on a subset of OPCs (~18% of GFP+ cultured OPCs; Fig 
3.1 f).  The Arl13b+ primary cilia varied in length, with some being quite short and circular 
and others linear, perhaps reflecting different states of assembly and disassembly.    
3.2.4   Generation of a CMV-mCherry-Arl13b plasmid to label primary cilia with a red 
fluorescent protein 
It has been reported that primary cilia are disassembled as cells enter the cell cycle.  As 
OPCs are highly proliferative (Wu et al., 2011), it is therefore possible that those without 
primary cilia were in the process of dividing.  Primary cilia assembly and disassembly has 
been visualized in HEK293T cells in real time by fluorescently tagging the primary cilia using 
a plasmid (CMV-eGFP-Arl13b) to drive expression of an eGFP-Arl13b fusion protein 
(Paridaen et al., 2013).  When HEK233 cells were transfected with the CMV-eGFP-Arl13b 
plasmid (a kind gift from Dr Judith Paridaen, in the Huttner lab, Max Planck Institute, 
Dresden, Germany), eGFP-tagged primary cilia could be visualized on the cell surface (Fig. 
3.3 a).  To instead visualize primary cilia on the surface of histGFP-labelled OPCs, I used 
the DNA sequence coding for Arl13b, to generate CMV-mCherry-Arl13b (Fig. 3.4) and CMV-
Arl13b-mCherry (Fig. 3.5) plasmids, that would instead have mCherry-labelled primary cilia. 
The Arl13b fragment was excised from the CMV-eGFP-Arl13b plasmid by performing a 
restriction digest with the enzymes Pst1 and Kpn1, followed by gel purification of the 
~1300bp band (Fig. 3.3 b).  The CMV-N1-mCherry vector (Clontech, 632523), which has a 
multiple cut site (MCS) at the N-terminal end of the mCherry sequence, and the CMV-
mCherry-C1 vector (Clontech, 632524; Fig. 3.3 c, d), which has an MCS at the C-terminal 
end of the mCherry sequence, were linearized by performing a restriction digest with Pst1 
and Kpn1 (Fig. 3.3 e).  As a precaution, to guard against the self-ligation of any partially 
digested vector products, the linearized DNA was treated with Antarctic Phosphatase (New 
England Biolabs, Ipswich, MA) as per the manufacturer’s instructions.  The Arl13b DNA 
fragment was then ligated into the linearized CMV-mCherry-Arl13b and CMV-Arl13b-
mCherry plasmids and the resulting plasmids transformed into E.coli.   
DNA was purified from ~5 bacterial clones and diagnostic restriction digests performed to 
confirm the successful generation of the CMV-mCherry-Arl13b and CMV-Arl13b-mCherry 
plasmids (Fig 3.3 f).  Glycerol stocks were generated from bacterial clones containing the 
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Figure!3.3:!Visualizing!primary!cilia!in!real5time!
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arrow#heads# denote# eGFP+# primary# cilia.# # (b)#DNA#gel# showing#undigested#CMV<
eGFP<Arl13b# and# Kpn1# /# Pst1# digested# CMV<eGFP<Arl13b,# with# the# liberated#
~1300bp#Arl13b#fragment#(white#box)#and#~4722bp#vector#backbone.# #(c,!d)#HEK#
cells#(DIC,#greyscale)#transfected#with#CMV<mCherry<C1#(red).##(e)#DNA#gel#showing#
undigested# CMV<mCherry<C1# and# CMV<N1<mCherry# plasmids# and# Kpn1# /# Pst1#
linearized#CMV<mCherry<C1#and#CMV<N1<mCherry#plasmids#(red#box).##(f)#DNA#gel#
showing# CMV<mCherry<Arl13b# and# CMV<Arl13b<mCherry,# but# not# CMV<mCherry<
C1,#digested#with#Kpn1#/#Pst1,# liberates#the#Arl13b#fragment#(white#asterisk).# #(g,!
h)#HEK# cells# (DIC,# grey# scale)# transfected#with#CMV<mCherry<Arl13b# (red).# # (i,! j)#
HEK# cells# (DIC,# greyscale)# transfected# with# CMV<Arl13b<mCherry# (red).# # White#
asterisks#denote#primary#cilia.#Scale#bars#represent#15μm.#
!
!
Pst1    Kpn1 +
Pst1   Kpn1
+
+ Antarctic Phosphatase
a
c
b
!
!
!
!
!
!
!
!
Figure!3.4:!!Schematic!of!CMV5mCherry5Arl13b!synthesis!
(a)#Schematic#depicting#the#Kpn1#/#Pst1#restriction#digest#of#CMV<eGFP<Arl13b#to#
excise#Arl13b.#(b)#Schematic#depicting#Kpn1#/#Pst1#restriction#digest#of#CMV<C1<
mCherry#to#linearise#the#vector.##(c)#Schematic#depicting#the#ligation#of#the#
linearised#CMV<C1<mCherry#vector#and#the#Arl13b#DNA#fragment#creating#an#CMV<
mCherry<Arl13b#plasmid.!!!
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Figure!3.5:!Schematic!of!CMV5Arl13b5mCherry!synthesis!
(a)#Schematic#depicting#the#Kpn1#/#Pst1#restriction#digest#of#CMV<eGFP<Arl13b#to#
excise#Arl13b.##(b)#Schematic#of#Kpn1#/#Pst1#restriction#digest#of#CMV<mCherry<N1#
to#linearise#the#vector.##(c)#Schematic#depicting#the#ligation#of#linearised#CMV<N1<
mCherry#and#the#Arl13b#DNA#fragment#to#create#CMV<Arl13b<mCherry.#
! !
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CMV-mCherry-Arl13b and CMV-Arl13b-mCherry plasmids, before progressing to validate 
the ability of each plasmid to fluorescently label primary cilia in a cellular expression system. 
After 24 hours, HEK293 cells transfected with the CMV-mCherry-Arl13b (Fig. 3.3 g, h) or 
CMV-Arl13b-mCherry (Fig. 3.3, i, j) plasmids had very low levels of cytoplasmic mCherry 
expression (Fig. 3.3 g-i), when compared with HEK293T cells transfected with either empty 
vector (Fig. 3.3 c, d).  Consistent with the labelling obtained using the CMV-eGFP-Arl13b 
plasmid, a single point of intense mCherry expression was also observed on a number of the 
transfected cells.  When performing live imaging of the transfected cultures, the mCherry-
labelled primary cilia could be visualized and tracked most readily, in cultures transfected 
with the CMV-Arl13b-mCherry plasmid.  Therefore, this plasmid was used for further 
experiments.   
3.2.5  Primary cilia are disassembled and reassembled as OPCs progress through 
the cell cycle 
In order to determine whether primary cilia are dynamically assembled and disassembled on 
the surface of OPCs as they proliferate, 8 DIV Pdgfrα-histGFP OPC cultures were 
transfected with the CMV-Arl13b-mCherry plasmid.  After 24 hours, 53 OPCs with an 
mCherry+ primary cilium were selected for live imaging at high magnification, collecting 
mCherry, GFP and differential interference contrast (DIC) images every 15 min for 8-12 
hours (Fig. 3.6).  Of the 53 transfected OPCs, only 2 divided during the imaging period, and 
the assembled primary cilium was disassembled immediately prior to nuclear chromatin 
condensation (Fig. 3.6 c, d).  Furthermore, the mCherry+ primary cilium was reassembled by 
a daughter OPC, once cell division was complete (Fig. 3.6 g, h).   
The second daughter OPC did not have an mCherry+ primary cilium immediately after cell 
division (Fig. 3.6 g, h), and this is to be expected.  During cell division the primary cilium is 
disassembled from the basal body, which forms the centriole and is preferentially inherited 
by one daughter cell following a cell division (Paridaen et al., 2013).  That daughter cell can 
use the basal body to immediately reassemble a primary cilium, while the other daughter cell 
must synthesize a basal body before it can assemble a primary cilium.  These data show 
that the primary cilium is disassembled by OPCs as they enter the cell cycle in vitro and 
reassembled once they exit 
3.2.6  Tat-Cre activates the cre-sensitive Rosa26-YFP reporter in vitro  
Having determined that OPCs have primary cilia that are assembled on their surface 
between cell divisions, I next hypothesized that these primary cilia are critical regulators of 
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Figure!3.6:!!OPCs!disassemble!primary!cilium!as!they!enter!the!cell!cycle!
Still% frames% from% a% representative% time0lapse% movie,% depicting% a% dividing% OPC.%%
10DIV% Pdgfrα0histGFP% OPC% cultures% were% transfected% with% CMV0Arl13b0mCherry%
and%imaged%to%visualise%GFP%(green),%Arl13b%(red)%and%DIC%(greyscale).%%A%GFP+%OPC%
before%(a,! b),%during%(c,! d)%and%after%cell%division%(e,% f),%and%after%assembly%of% the%
primary%cilium%by%one%of%the%two%a%daughter%cells%(g,%h).%%Asterisk%denotes%dividing%
cell%and%daughter%cells.%%Arrows%indicate%primary%cilia.%%Scale%bars%=%20μm%
! !
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OPC division in vitro.  To test this directly, I aimed to use a Cre-lox approach to delete the 
Kif3a gene from OPCs, and prevent primary cilia assembly.   
When Cre recombinase is fused to a tat linker peptide (tat-Cre), it is able to cross the cell 
membrane, enter the nucleus, recognize lox-p sites, and facilitate DNA recombination 
(reviewed in Van Duyne, 2015).  To assess the efficacy of this tat-Cre for inducing 
recombination in glial cells, it was added into the culture medium of mixed glial cultures 
generated from Rosa26-YFP cre-sensitive reporter mice, for 90 min, at a concentration of 0, 
0.5 or 1µM.  The cells were fixed at 24, 48 or 72 hours post-treatment and 
immunocytochemistry performed to detect the recombined (YFP+) cells (anti-GFP antibody; 
green), OPCs within the culture (PDGFRα; red) and the nuclear marker Hoescht 33342 
(blue).  Cultures exposed to 0µM tat-Cre (diluent alone) lacked YFP expression at all time-
points (Fig. 3.7 a, f).  YFP-labelled glia, including YFP-labelled OPCs, were visible within 24 
hours of treatment, in cultures exposed to both 0.5µM (Fig. 3.7 b, c, f, h) and 1µM tat-cre 
(Fig. 3.7 d, e, g, h).  ~57% of OPCs became YFP-lablled when exposed to 0.5µM tat-Cre 
and ~88% when exposed to 1µM tat-Cre (Fig. 3.7 f).  This was largely unchanged at 48 and 
72 hour (Fig. 3.7 h).   
3.2.7 Kif3a knockout reduces OPC primary cilium assembly and proliferation in vitro   
Having determined that tat-Cre can effectively induce DNA recombination in cultured OPCs, 
I isolated OPCs from glial cultures grown from early postnatal Pdgfrα-histGFP::Kif3afl/fl 
mouse pups, in which both copies of the Kif3a gene are flanked by loxP sites, rendering 
them susceptible to Cre-mediated gene deletion.  I treated 8 DIV Pdgfrα-histGFP::Kif3afl/fl 
OPCs with 0 (diluent only), 0.5, 1 and 2µM tat-Cre, and cultured them for a further 5 days, 
before generating protein lysates to determine KIF3a expression by western blot (Fig. 3.8 a, 
b).  When KIF3a expression was normalized to β-actin expression, there was no significant 
difference between control cultures (0µM tat-Cre) and those treated with 0.5 or 1µM tat-Cre 
(Fig. 3.8 a, b).  However, when Pdgfrα-histGFP::Kif3afl/fl OPCs were treated with 2µM tat-
Cre, KIF3a expression was reduced to ~43% of controls (Fig. 3.8 a, b).  These data suggest 
that treatment of Pdgfrα-histGFP::Kif3afl/fl OPC cultures with 2µM tat-Cre successfully 
induces Kif3a deletion in vitro.  
To determine whether the deletion of Kif3a prevents primary cilia assembly by cultured 
OPCs, 8-9 DIV Pdgfrα-histGFP::Kif3afl/fl OPC cultures were treated with 0 or 2µM tat-Cre for 
90 min, and cultured for a further 5 days.  The OPCs were fixed and immunocytochemistry 
performed to detect GFP (blue), as well as γ-tubulin (green), Arl13b (red) and Hoescht 
33342 (not shown).  In these control cultures, ~40% of the GFP+ OPCs had an assembled 
primary cilia (Fig. 3.8 c, e) and this was significant reduced in the 2µM tat-Cre treated 
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Figure!3.7:!Tat/Cre!recombines!the!cre/sensitive!Rosa26/YFP!transgene!in!
mixed!glial!cultures!
(a)# Confocal# image# (single# z# plane)# of# a# 10DIV#mixed# glial# culture,# derived# from#
Rosa26AYFP#mice,# immunoAstained# to#detect#YFP# (green),#PDGFRα# (red)#and#HST#
(blue).##Confocal#images#(single#z#plane)#of#Rosa26AYFP#mixed#glial#culture#treated#
with# 0.5μM# tatACre# at# 9DIV# and# fixed# at# 24# (b),# 48# (c)# and# 72# (f)# hours# postA
treatment.# # Cultures# were# immunoAstained# to# detect# YFP# (green),# PDGFRα# (red)#
and# HST# (blue).# # Confocal# images# (single# z# plane)# of# Rosa26AYFP# mixed# glial#
cultures,#treated#with#1μM#tatACre#at#9DIV#and#fixed#at#24#(d),#48#(e)#and#(g)#hours#
post# treatment.# # Cultures# were# immunoAstained# to# detect# YFP# (green),# PDGFRα#
(red)#and#HST#(blue).##(h)#Quantification#of#the#percentage#of#OPCs,#in#mixed#glial#
cultures,# that# became# YFPAlabelled# following# tatAcre# treatment# (avg# ±# std,# n=3#
cultures;#p<0.02,#twoAway#ANOVA#with#Bonferroni#correction).##Large#arrowheads#
indicate#YFP+#PDGFRα+#OPCs.##Arrows#represent#YFP+#PDGFRαAnegative#cells.##Small#
arrowheads#indicate#YFPAnegative#PDGFRα+#cells.##Scale#bars#=#60μm.#! #
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Figure!3.8:!!Deleting!Kif3a!from!cultured!OPCs!reduces!their!proliferation!
#(a)# Image#of#a#western#blot#detecting#KIF3A#protein# in#protein# lysates#generated#
from# diluentA# and# tatACreAtreated# (0.5,# 1,# and# 2μM# tatAcre# for# 90# minutes)# OPC#
cultures# derived# from# PdgfrαAhistGFP# ::# Kif3afl/fl# transgenic# mice.# (b)##
Quantification#of#KIF3a#protein#expression#by#western#blot#(avg#±#std,#n=3#cultures;##
p<0.05,#tAtest).##(c)#Confocal#image#of#diluentAtreated#PdgfrαAhistGFP#::#Kif3afl/fl#OPC#
cultures# stained# to# detect# γAtubulin# (green),# Arl13b# (red)# and# GFP# (blue).# # (d)#
Confocal# image# of# 2μm# tatAcreAtreated# PdgfrαAhistGFP# ::# Kif3afl/fl# OPC# cultures,#
stained#to#detect#γAtubulin#(green),#Arl13b#(red)#and#GFP#(blue).##(e)#Quantification#
of# the#percentage#of#GFP+#OPCs#with#assembled#primary#cilia# in#diluentA#and# tatA
creAtreated# cultures# (avg# ±# std,# n=4# cultures;# # p<0.0001,# tAtest).# # Arrowheads#
represent# assembled# primary# cilia.# # Arrows# represent# Arl13bAnegative# γAtubulin+#
basal# bodies.# # (f/h)# Confocal# image# (single# z# plane)# of# diluentAtreatd# PdgfrαA
histGFP#::#Kif3afl/fl#OPC#cultures#that#received#EdU#for#12#hours#and#were#immunoA
stained#to#detect#GFP#(green),#PDGFRα#(red)#and#EdU#(blue).##(i/k)#Confocal#image#
(single#z#plane)#of#2μM#tatACreAtreated#PdgfAhistGFP/Kif3afl/fl#OPC#cultures,#treated#
with#EdU#for#12#hours,#and# immunoAstained#to#detect#GFP#(green),#PDGFRα#(red)#
and#EdU# (blue).# Arrowheads# indicate#GFP+#PDGFRα+#EdU+# cells.# # Arrows# indicate#
GFP+#PDGFRα+#EdUAnegative#cells.##(l)#Quantification#of#the#percentage#of#OPCs#that#
are#EdU+#after#treatment#with#0μm#or#2μM#tatACre#(avg#±#std,#n=3#cultures;##p<0.05,#
tAtest).##Scale#bars#represent#25μm#(d,#e)#and#50μm#(iAk).###
#
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cultures (Fig. 3.8 c, d, e).  These data likely indicate that the deletion of Kif3a prevents 
primary cilium assembly by OPCs, however a similar phenotype would be observed if Kif3a 
deletion instead increased the rate of OPC proliferation i.e. more cells enter the cell cycle 
and have disassembled primary cilia.   
To examine this possibility, 8-9 DIV Pdgfrα-histGFP::Kif3afl/fl OPC cultures were treated with 
2µM tat-Cre and incubated for 5 days.  For the final 12 hours, EdU was added to the culture 
media.  EdU is a thymidine analog, which is taken up by cells in S-phase of the cell cycle, 
effectively labeling all OPCs that divide during the labelling period.  Immunocytochemistry 
was performed to detect GFP+ (green), PDGFRα+ (red) OPCs, EdU+ proliferating cells (blue) 
and a Hoescht 33342 nuclear stain.  ~59% of PDGFRα+ GFP+ OPCs were EdU labeled in 
diluent treated cultures (Fig. 3.8 f-h, l), compared with only ~22% of PDGFRα+ GFP+ OPCs 
in the tat-Cre treated cultures (Fig. 3.8 i-k, l).  These data indicate that the deletion of Kif3a 
effectively prevents primary cilia assembly on OPCs and reduces the proliferation of these 
cultures.   
3.3  Discussion 
3.3.1  OPCs have assembled primary cilia that are disassembled for cell cycle reentry 
My findings show that ~18% of 10DIV and ~40% of 13 DIV cultured OPCs have assembled 
primary cilia, at any one time.  As primary cilia are only assembled on the surface of OPCs 
not actively dividing (Fig. 3.6 c, d), these data suggest, that a higher fraction of OPCs are 
actively proliferating in 10 DIV cultures, when compared with 13 DIV cultures.  This is 
entirely feasible, as the proliferation rate of OPCs slows daily in vivo (Psachoulia et al., 
2009), and the proliferation rate of OPCs slows as the cultures expand, prior to the onset of 
differentiation (Barres et al., 1994).   
Using live-cell imaging, I was able to follow individual OPCs as they underwent division.  
Prior to cell division, an individual mCherry-labelled primary cilium shortened on the surface 
of the OPC, before becoming a small puncta that moved from the cell surface into the 
nucleus.  mCherry labelling disappeared completely during division, but was reassembled by 
one of the daughter cells upon cell cycle exit.  This observation is consistent with the findings 
of studies conducted in other cell types, that the primary cilium must be disassembled for the 
cell to re-enter the cell cycle, and that once the cilium is disassembled, the basal body 
migrates away from the cell surface and into the cytoplasm where it converts into the 
centriole (Seeley and Nachury, 2010; Garcia-Gonzalo and Reiter, 2012; Kim and Dynlacht, 
2013).  A small amount of Arl13b is contained within a membrane vesicle and associated 
with the centrosome after disassembly, while it migrates to the nucleus, resulting in Arl13b 
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labeling of the migrating basal body (Paridaen et al., 2013).  Once division is complete, the 
centriole is transported back to the cell surface, where it again acts as the basal body for 
primary cilium reassembly (Kobayashi and Dynlacht, 2011; Garcia-Gonzalo and Reiter, 
2012).  It is likely that the second daughter cell, that did not have a visible mCherry+ primary 
cilium, corresponds to the cell that did not inherit the mother centriole.  With every cell 
division, one daughter cell inherits the mother centriole from the parent cell, and can 
immediately assemble a primary cilium, while the other daughter cell must first assemble a 
basal body and subsequently assemble a primary cilium (Paridaen et al., 2013).  Given time, 
it is likely that the second daughter cell would also assemble an mCherry+ primary cilium 
(Paridaen et al., 2013). 
Kif3a deletion from OPCs in vitro, prevented primary cilia assembly and impaired OPC 
proliferation.  Kif3a deletion could reduce proliferation by producing a physical barrier to cell 
cycle re-entry, by keeping the basal body at the cell surface and preventing the centriole 
from migrating to the nucleus.  However, it is also possible that in preventing cilium 
assembly, Kif3a-deletion prevents signalling that would otherwise occur within the primary 
cilium (Schneider et al., 2005; Christensen et al., 2008; Lancaster et al., 2011; Ruat et al., 
2012).  For example, Shh signaling is reliant upon the presence of a primary cilium, and 
Falcón-Urrutia et al. (2015) demonstrated that knocking out Shh signaling, using the Smo 
inhibitor cyclopamine, significantly reduced OPC proliferation in vitro (Falcón-Urrutia et al., 
2015).  It would be particularly interesting to determine whether Kif3a-deleted OPCs are still 
able to undergo Shh-induced proliferation in vitro.  
3.3.2  Does Shh signalling directly influence OPC behaviour? 
I have shown that OPCs express mRNA for the Shh receptors PTCHD2 and SMO (Fig. 3.2).  
These data are consistent with RNA sequencing data, showing that OPCs express Shh-
associated genes (Zhang et al., 2014).  During development, Shh is a key factor regulating 
the differentiation of OPCs from multipotent stem cells in the spinal cord (Zhou et al., 2001) 
and the preoptic area of the developing optic nerve (Merchán et al., 2007).  Shh treatment of 
embryonic stem cells in vitro, also drives their differentiation from pluripotent stem cells into 
OPCs (Shin et al., 2007; Bian et al., 2016).  However, more important for this study, blocking 
Shh signaling in cultured OPCs, by treating with the SMO inhibitor cyclopamine, reduces 
OPC proliferation (Tekki-Kessaris et al., 2001; Falcón-Urrutia et al., 2015).  As cyclopamine 
reduces the proliferation of OPCs, even in the absence of exogenous Shh application 
(Falcón-Urrutia et al., 2015), this suggests that OPCs can themselves produce Shh.  As 
OPCs express Shh mRNA (Zhang et al., 2014), and OLIG2+ cells upregulate Shh protein is 
naturally upregulated within lysolecithin-induced lesions during remyelination (Ferent et al., 
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2013), making it possible that they secreted Shh into the culture medium, where it can act as 
an autocrine or paracrine signal to promote proliferation. 
These data indicate that Shh signalling is important for OPCs, with Shh driving their 
specification from stem cells, as well as encouraging proliferation and differentiation.  Further 
culture experiments could be performed, however, to confirm and further elucidate the exact 
relationship between Shh signalling, the primary cilium and OPCs.  Such as examining the 
response of cultured OPCs to both cyclopamine addition and Kif3a gene deletion.  If the 
simultaneous addition of cyclopamine and deletion of the Kif3a gene is not found to have a 
greater change in proliferation than only the addition of cyclopamine, this indicates that 
preventing primary cilium assembly is only affecting Shh signalling, and not other pathways 
such as PDGFRα or Wnt. Additionally, further experiments should be performed to observe 
the effect of tat-cre treatment on wild-type OPCs in culture, to confirm that proliferation 
changes were the result of preventing cilium assembly rather than an effect of the tat-cre 
itself.      
3.3.3  Do mature oligodendrocytes assemble primary cilia? 
Essentially all OPCs, irrespective of whether they had an assembled primary cilium or not, 
stained for γ-tubulin.  Alone, γ-tubulin is not a marker of primary cilia, as the cilium basal 
body is the same structure that forms the centriole during a cell division (Paridaen et al., 
2013).  However, cultured rat OPCs lose γ-tubulin staining as they differentiate into MBP+ 
oligodendrocytes (Falcón-Urrutia et al., 2015) and the loss of the basal body / centrioles has 
also been reported to occur during the differentiation of other cell types, including some 
neurons (Cunha-Ferreira et al., 2009; Debec et al., 2010).  Cells lacking γ-tubulin, therefore 
likely correspond to cell that are no longer capable of successfully re-entering the cell cycle, 
and the complete loss of γ-tubulin from mature oligodendrocytes, suggests that these cells 
do not assemble primary cilia.  This possibility is further supported by microarray (Cahoy et 
al., 2008) and RNA sequencing (Zhang et al., 2014) gene expression data, indicating that 
OPCs express the major cilium cytoskeleton-associated genes, such as Kif3a, the IFT 
proteins Ift81, Ift57, Ift172 and Ift88, the basal body associated proteins Cep290 and Cep97 
and the cilium membrane associated protein Arl13b more highly than oligodendrocytes. 
3.4  Conclusions 
In this Chapter, I have demonstrated that OPCs in vitro assemble and disassemble primary 
cilia as they progress through the cycle and that disruption of primary cilium assembly in 
vitro, by the deletion of Kif3a, leads to a reduction in proliferation.  I would predict that Kif3a 
deletion will similarly affect OPCs in vivo, where they remain highly proliferative, and by 
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extension, may play a critical role in regulating oligodendrogenesis.  In order to examine this 
relationship, it will be necessary to conditionally delete Kif3a from adult OPCs.  This could be 
achieved using a Pdgfrα-CreERT2 transgenic mouse line, so long as it preferentially induces 
gene deletion in OPCs, without affecting PDGFRα+ cell populations outside of the CNS. 
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Chapter 4: Evaluating tissue-specific recombination in a 
Pdgfrα-CreERT2 transgenic mouse line 
4.1  Introduction 
PDGFR was first identified in 1982, as a protein expressed by fibroblasts and arterial smooth 
muscle cells (Bowen-Pope and Ross, 1982).  It was shown to facilitate normal growth and 
development by regulating critical cell processes including proliferation and differentiation 
(Boström et al., 1996; Soriano, 1997; Fruttiger et al., 1999; Karlsson et al., 1999; Gnessi et 
al., 2000; Karlsson et al., 2000), and mutations in this receptor were strongly associated with 
tumour growth (Hermanson et al., 1992; 1996; Nakamura et al., 1997).  In 1988, it was 
discovered that PDGFR was actually two receptors, named PDGFRα and PDGFRβ, that 
bind dimers of the PDGFs with different affinities (Hart et al., 1988).  PDGFRα is capable of 
binding all PDGFs except PDGF-DD (Hart et al., 1988; Cao et al., 2008), but has a strong 
affinity for the PDGF-A homodimer (Glenn et al., 1982).  In the CNS, PDGFRα is selectively 
expressed by OPCs (Pringle et al., 1992), and its activation by PDGF-AA regulates the 
proliferation, migration and differentiation of this cell type in normal development, as well as 
in response to demyelination (Woodruff et al., 2004). 
The high specificity of PDGFRα expression by OPCs in the CNS, has made the Pdgfrα gene 
promoter useful for manipulating gene expression exclusively in OPCs without affecting 
other CNS cell types.  For example, Rivers et al. (2008) generated a bacterial artificial 
chromosome (BAC) transgenic mouse line, the Pdgfrα-CreERT2 transgenic mouse, which 
expresses Cre recombinase fused to the oestrogen-receptor type II, under the control of the 
Pdgfrα promoter.  Tx administration to adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice 
resulted in ~50% of the OPCs in the brain (Tripathi et al., 2010), ~40% of the OPCs in the 
spinal cord and ~20% of OPCs in the optic nerve being labelled with yellow fluorescent 
protein (YFP; (Young et al., 2013).  A second BAC transgenic Pdgfrα-CreERT2 mouse line 
was subsequently developed by Kang et al. (2010), which achieves Cre-mediated gene 
recombination in ≥ 90% of OPCs in the brain and spinal cord (Kang et al., 2010).  Both 
Pdgfrα-CreERT2 mouse lines have been widely used to label OPCs and trace their progeny 
in vivo.  These studies largely report that OPCs continually generate new myelinating 
oligodendrocytes in the mature healthy CNS, and a small number indicate that OPCs 
differentiate into astrocytes (or astrocyte-like cells) and even Schwann cells in the CNS 
under certain pathological conditions (Richardson et al., 2011). 
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More recently the Pdgfrα-CreERT2 transgenic mouse line produced by Rivers et al. (2008) 
was used to conditionally ablate Myrf from OPCs (McKenzie et al., 2014).  Myrf is not widely 
expressed outside of the CNS, which reduced the likelihood that this strategy would 
inadvertently affect the function of PDGFRα+ cell populations outside of the CNS.  However, 
when using the Pdgfrα-CreERT2 transgenic mouse line to conditionally delete genes with a 
less discrete expression pattern, this is an important consideration.  To assess the ability of 
Pdgfrα-CreERT2 transgenic mice to induce recombination in PDGFRα+ cells within and 
outside of the CNS, we crossed Pdgfrα-CreERT2 transgenic mice (Kang et al., 2010) with 
Rosa26-YFP transgenic mice (Srinivas et al., 2001) and administered Tx to adult Pdgfrα-
CreERT2::Rosa26-YFP offspring.  The pattern of YFP labelling was then examined in a 
variety of tissues.  I report that Pdgfrα-CreERT2 transgenic mice are highly suitable for OPC-
directed gene recombination in the CNS, as they induce robust recombination in OPCs, 
moderate recombination in PDGFRα+ bone marrow stromal cells, and have a minimal effect 
on other PDGFRα+ cell populations. 
4.2  Results 
4.2.1  Pdgfrα-CreERT2 transgenic mice can be used to specifically and efficiently 
induce recombination in OPCs in the CNS 
To confirm that OPCs are the only cell type to undergo recombination in the CNS of Pdgfrα-
CreERT2 transgenic mice, adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice were treated 
with Tx, and perfusion fixed 7 days later (P57+7).  The brain, spinal cord, retina and optic 
nerve were cryosectioned and immunohistochemistry performed to detect cells expressing 
PDGFRα (red), YFP (anti-GFP, green) and the nuclear marker Hoescht 33342 (Fig. 4.1).  
PDGFRα+ OPCs were found throughout the CNS (Fig. 4.1 a-g) with the exception of the 
retina (Fig. 4.1 h).  The density of PDGFRα+ OPCs was equivalent in the cortex (104 ± 27 
cells/mm2), CC (123 ± 20 cells/mm2) and spinal cord (87 ± 17 cells/mm2) (P>0.9 ANOVA; 
Fig. 4.1 m).  The vast majority of OPCs became YFP-labelled in the CNS (Fig. 4.1 n) 
allowing clear visualization of their typical stellate morphology in the cortex (Fig. 4.1 b), CC 
(Fig. 4.1 d) and spinal cord (Fig. 4.1 g).  Few PDGFRα+ OPCs escaped recombination as 
~97% of PDGFRα+ OPCs were YFP-labelled in the cortex, ~96% in the CC, ~92% in the 
spinal cord (Fig. 4.1 n) and ~97% in the optic nerve (75 of 77 YFP+ cells counted).  The 
retina lacked PDGFRα+ OPCs, and no YFP-labelled cells were detected (Fig. 4.1 h, m).   
In addition to YFP-labelled OPCs, we identified a number of YFP+ cells that were PDGFRα-
negative in the brain (Fig. 4.1 e) and spinal cord (Fig. 4.1 g), and these cells had the 
morphological characteristics of oligodendrocytes.  Given that OPCs are known to give rise 
  
Figure 4.1: PDGFRα+ OPCs become YFP-labelled throughout the nervous system of 
adult Pdgfrα-CreERT2 :: Rosa26-YFP transgenic mice 
Cryosections from P57+7 Pdgfrα-CreERT2 :: Rosa26-YFP transgenic mice were immuno-
stained to detect PDGFRα (red), YFP (green) and Hoescht 33342 (HST, blue).  Confocal 
image (single z plane) of the motor cortex at low (a) and high (b) magnification.  Confocal 
image (single z plane) of the corpus callosum (cc) at low (c) and high (d, e) magnification.  
Confocal image (single z plane) of a transverse spinal cord section at low (f) and high (g) 
magnification.  Confocal image (single z plane) of the retina (h).  Confocal image (single 
z plane) of a transverse sciatic nerve section at low (i) and high (j, k) magnification.  
Cryosection from P57+7 Pdgfrα-CreERT2 :: Rosa26-YFP transgenic mouse 
immunostained to detect S100β (red), YFP (green) and HST (blue) (l).  m) The number 
of PDGFRα+ YFP+, PDGFRα+ YFP-negative and PDGFRα-negative YFP+ cells quantified 
from confocal images (single z plane) of nervous system tissue, expressed as the number 
of cells per mm2. n)  The proportion of PDGFRα+ cells that become YFP-labelled 
(PDGFRα+ YFP+ cells / total PDGFRα+ cells x 100) quantified from confocal images 
(single z plane) of nervous system tissue.  Error bars represent mean ± std dev from n=3 
mice.  ** P<0.001, ANOVA.  PDGFRα+ YFP+ cells (and S100β+ YFP+ cells) are denoted 
by arrowheads.  PDGFRα-negative YFP+ cells are denoted by arrows.  Scale bars = 50µm  
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to new oligodendrocytes, producing new differentiated PDGFRα-negative cells even within 1 
week of labelling (Rivers et al., 2008), this was to be expected.  The oligodendroglial identity 
of the YFP+ PDGFRα-negative cells was confirmed by performing immunohistochemistry to 
detect YFP and the oligodendrocyte lineage marker OLIG2.  In the CC all YFP+ cells were 
also OLIG2+ GFAP-negative (639 YFP+ cells analyzed), confirming that the YFP+ PDGFRα-
negative cells identified in this region were indeed oligodendrocytes.  In the cortex, 
essentially all YFP+ cells were OLIG2+, with the exception of very rare YFP+ cells that 
instead co-labelled for the neuronal marker, NeuN (2 of 2035 YFP+ cells analyzed).  A 
similarly small number of cortical neurons are GFP labelled in Pdgfrα-histGFP knock-in 
mice, despite their lack of PDGFRα expression (Clarke et al., 2012).  Therefore, the YFP+ 
NeuN+ cells that we observe may be rare neurons that experience Pdgfrα gene promoter 
activity, but no PDGFRα protein translation.   
These experiments confirm that the Pdgfrα-CreERT2 transgene is expressed by OPCs, and 
that Tx administration efficiently leads to DNA recombination in these cells. 
4.2.2  A small number of PDGFRα+ Schwann cells undergo recombination in the 
sciatic nerve of Pdgfrα-CreERT2::Rosa26-YFP transgenic mice 
To determine whether cells within the peripheral nervous system express PDGFRα and / or 
undergo recombination in adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, we 
processed cryosections from the sciatic nerve to detect PDGFRα (red), YFP (anti-GFP, 
green) and Hoescht 33342 (Fig. 4.1 i-k).  PDGFRα+ cells were detected throughout the 
sciatic nerve, and at the edge of each nerve bundle (Fig. 4.1 i).  Surprisingly, the density of 
PDGFRα+ cells was significantly higher in the sciatic nerve (367 ± 17 cells/mm2) than any of 
the CNS regions examined (P<0.0001, ANOVA; Fig. 4.1m).  However, only ~11% of the 
PDGFRα+ cell population found in the sciatic nerve was YFP-labelled (Fig. 4.1 n).  
Furthermore, only half of the YFP+ cells examined co-labelled for PDGFRα (Fig. 4.1 k, m; 
52% ± 5.7% of YFP+ cells co-expressed PDGFRα), indicating that the Pdgfrα-CreERT2 
transgene also induced recombination in a small number of unidentified cells in the 
peripheral nervous system.  Some Schwann cells in the sciatic nerve have been shown to 
express PDGFRα (Eccleston et al., 1993), and by performing immunohistochemistry to 
detect YFP (green) and the Schwann cell marker S100β (red; Fig. 4.1 l), we determined that 
all of the YFP+ cells present in the sciatic nerve of adult Pdgfrα-CreERT2::Rosa26-YFP 
transgenic mice were Schwann cells.       
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4.2.3  Fewer than 1% of PDGFRα+ cells become YFP-labelled in the endocrine glands 
of adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice. 
To determine whether Tx administration to adult Pdgfrα-CreERT2::Rosa26-YFP transgenic 
mice can induce YFP-labelling in PDGFRα+ cells within the endocrine system, cryosections 
of the adrenal and pituitary glands were examined following immunohistochemistry to detect 
PDGFRα+ (red), YFP (green) and the nuclear marker Hoescht 33342 (Fig. 4.2 a-d).  
PDGFRα+ cells were present throughout the adrenal (Fig. 4.2 a-b) and pituitary (Fig. 4.2 c-
d) glands at a density of 1086 ± 500 cells/mm2 and 2237 ± 282 cells/mm2 respectively (Fig. 
4.2 e).  Of these PDGFRα+ cell populations, only ~0.9% and ~0.4% became YFP-labelled, 
respectively (Fig. 4.2 f).  In addition to the small number of YFP+ PDGFRα+ cells detected, a 
number of YFP+ PDGFRα-negative cells were identified.  In the adrenal gland these cells 
appeared to be clustered (Fig. 4.2 b), whereas in the pituitary gland they were more evenly 
distributed throughout the tissue (Fig. 4.2 d), but were still very rare.  The YFP+ PDGFRα-
negative cells represented 46% ± 24% of the YFP+ cells present in the adrenal gland and 
81% ± 2.6% of the YFP+ cells in the pituitary gland.  These data indicate that while the extent 
of recombination and YFP-labelling in the adrenal or pituitary glands of Pdgfrα-
CreERT2::Rosa26-YFP mice is extremely low, the specificity of this labelling is also poor. 
4.2.4  Less than 1.5% of PDGFRα+ cells in the heart or gastrocnemius muscle 
undergo recombination following Tx administration to adult Pdgfrα-CreERT2::Rosa26-
YFP transgenic mice 
To determine whether cells within the heart or gastrocnemius muscle become YFP-labelled 
in adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, cryosections of each were stained to 
detect PDGFRα+ (red), YFP (green) and the nuclear marker Hoescht 33342 (Fig. 4.3 a-d).  
PDGFRα+ cell populations were identified in the heart (Fig. 4.3 a-b) and gastrocnemius 
muscle (Fig. 4.3 c-d) at a similar density (Fig. 4.3 e) and these cells had a similar 
morphology (compare Fig. 4.3 b, d).  The location and morphology of the PDGFRα+ cells in 
the heart and gastrocnemius muscle, are consistent with that of PDGFRα+ cardiac 
progenitors (Noseda et al., 2015) and PDGFRα+ fibro/adipogenic progenitors (FAPs) 
(Contreras et al., 2016) previously characterized.  In the heart, only ~0.5% of the PDGFRα+ 
cell population became YFP-labelled (Fig. 4.3 a, b, f), which was not dissimilar to the ~1.2% 
of PDGFRα+ cells that became YFP-labelled in the gastrocnemius muscle (Fig. 4.3 a-d, f).  
These data indicate that the Pdgfrα-CreERT2 transgenic mouse does not enable significant 
recombination in either of these cell populations.   
In addition to the YFP+ PDGFRα+ cells identified in the heart and gastrocnemius muscle, we 
detected YFP+ PDGFRα-negative cells (Fig. 4.3 a, d).  In the heart only 44% ± 6.3% of the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: PDGFRα+ cells recombine at low efficiency in endocrine tissue 
Cryosections through the adrenal and pituitary gland of P57+7 Pdgfrα-CreERT2 :: 
Rosa26-YFP were immuno-stained to detect PDGFRα (red), YFP (green) and Hoescht 
33342 (blue).  Confocal image (single z plane) of the adrenal gland at low (a) and high 
(b) magnification.  Confocal image (single z plane) of the pituitary gland at low (c) and 
high (d) magnification.  (e) The number of PDGFRα+ YFP+, PDGFRα+ YFP-negative and 
PDGFRα-negative YFP+ cells quantified from confocal images (single z plane) of the 
adrenal and pituitary glands, expressed as the number of cells per mm2.  (f)  The 
proportion of PDGFRα+ cells that become YFP-labelled (PDGFRα+ YFP+ cells / total 
PDGFRα+ cells, x 100) quantified from confocal images (single z plane) of adrenal and 
pituitary gland.  Error bars represent mean ± std dev from n=3 mice.  PDGFRα+ YFP+ 
cells are denoted by arrowheads.  PDGFRα-negative YFP+ cells are denoted by arrows.  
PDGFRα+ YFP-negative cells are denoted by small arrows.  Scale bars = 50µm 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: PDGFRα+ cells recombine at low efficiency in cardiac and skeletal 
muscle 
Cryosections from P57+7 Pdgfrα-CreERT2 :: Rosa26-YFP transgenic mice were immuno-
stained to detect PDGFRα (red), YFP (green) and HST (blue).  Confocal image (single z 
plane) of the heart at low (a) and high (b) magnification.  Confocal image (single z plane) 
of the gastrocnemius at low (c) and high (d) magnification. (e) The number of PDGFRα+ 
YFP+, PDGFRα+ YFP-negative and PDGFRα-negative YFP+ cells quantified from 
confocal images (single z plane) of the heart and gastrocnemius expressed as the number 
of cells per mm2. (f) The proportion of PDGFRα+ cells that become YFP-labelled 
(PDGFRα+ YFP+ cells/ total PDGFRα+ cells, expressed as a percentage) quantified from 
confocal images (single z plane) of the heart and gastrocnemius.  Error bars represent 
mean ± std dev from n=3  mice.  PDGFRα+ YFP+ cells are denoted by arrowheads.  
PDGFRα-negative YFP+ cells are denoted by arrows.  Scale bars = 50µm 
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YFP+ cells expressed PDGFRα, whereas in the gastrocnemius muscle, recombination was 
more specific with 83% ± 25% of the YFP+ cells co-expressing PDGFRα (Fig. 4.3 e).  These 
data suggest that the Pdgfrα-CreERT2 transgene is ectopically expressed by some cells in 
the heart.  However the extremely low number of YFP+ cells detected in either muscle 
suggests that the Pdgfrα-CreERT2 transgenic mouse is largely ineffective in targeting cells in 
these tissues. 
4.2.5  PDGFRα+ cells are present in the liver, lung, spleen and kidney, and recombine 
at low efficiency in adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice 
To determine whether cells within the liver, lung, spleen or kidney undergo recombination 
and become YFP-labelled in adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, 
cryosections were processed to detect PDGFRα+ (red), YFP (green) and the nuclear marker 
Hoescht 33342 (Fig. 4.4).  PDGFRα+ cells were dispersed throughout the liver (Fig. 4.4 a-b), 
lung (Fig. 4.4 c-d), spleen (Fig. 4.4 e-f) and kidney (Fig. 4.4 g-h).  They were particularly 
numerous in the lung (4023 ± 1400 cells/ mm2) and spleen (5189 ± 236 cells/mm2).  Despite 
each organ containing a higher density of PDGFRα+ cells than any CNS region examined 
(P<0.0003, ANOVA; Fig. 4.4i), the number of YFP+ cells detected was extremely low.  In the 
liver only ~1.2% of the PDGFRα+ cell population expressed YFP (Fig. 4.4 b, j).  This was 
even lower in the other organs, with ~0.7% of the PDGFRα+ cells in the lung, ~0.3% of the 
PDGFRα+ cells in the spleen and ~0.2% of the PDGFRα+ cells in the kidney being YFP-
labelled (Fig. 4.4 j).  The YFP+ PDGFRα+ cells in the liver (Fig. 4.4 b) and kidney (Fig. 4.4 
h) have a distinct fibroblast-like morphology.  This is entirely consistent with previous reports 
that tissue fibroblasts express PDGFRα (Chen et al., 2012; Hayes et al., 2014; Liu et al., 
2014; Horikawa et al., 2015), and more specifically that hepatic stellate cells express 
PDGFRα in the adult liver (Hayes et al., 2014; Liu et al., 2014).  Similarly, in the lung the 
YFP+ PDGFRα+ cells were detected in the alveoli (Fig. 4.4 g), consistent with previous 
reports that the PDGFRα+ lung cells are a subpopulation of lung fibroblasts called alveolar 
fibroblasts (Chen et al., 2012). 
Only 18.8% ± 13% of the YFP+ cells in the liver, 22.9% ± 0.9% of the YFP+ cells in lung, 22% 
±17% of the YFP+ cells in the spleen and 44% ± 3.8% of the YFP+ cells in the kidney co-
expressed PDGFRα (Fig. 4.4 i).  In the liver, the YFP+ cells (both YFP+ PDGFRα+ as well as 
YFP+ PDGFRα-negative cells) were unusually distributed – being rare overall, but when they 
were detected, they always appeared in clusters (as shown in Fig. 4.4 a).  It is unlikely that 
the YFP+ PDGFRα-negative cells detected in the liver, lung, spleen and kidney are the result 
of the proliferation and differentiation of the YFP+ PDGFRα+ cells, as this would require each 
YFP+ PDGFRα+ cell to undergo between one and three cell divisions within the seven day 
 
 
 
 
Figure 4.4: PDGFRα+ cells recombine at low efficiency in the liver, lung, spleen and 
kidney 
Cryosections from P57+7 Pdgfrα-CreERT2 :: Rosa26-YFP transgenic mice were immuno-
stained to detect PDGFRα (red), YFP (green) and HST (blue).  Confocal image (single z 
plane) of the liver at low (a) and high (b) magnification.  Confocal image (single z plane) 
of the lung at low (c) and high (d) magnification.  Confocal image (single z plane) of the 
spleen at low (e) and high (f) magnification.  Confocal image (single z plane) of the kidney 
at low (g) and high (h) magnification. (i) The number of PDGFRα+ YFP+, PDGFRα+ YFP-
negative and PDGFRα-negative YFP+ cells quantified from confocal images (single z 
plane) of the liver, lung, spleen and kidney expressed as the number of cells per mm2.  (j) 
The proportion of PDGFRα+ cells that become YFP-labelled (PDGFRα+ YFP+ cells/ total 
PDGFRα+ cells, expressed as a percentage) quantified from confocal images (single z 
plane) of the liver, lung, spleen and kidney.  Error bars represent mean ± std dev from 
n=3  mice.  PDGFRα+ YFP+ cells are denoted by arrowheads.  PDGFRα-negative YFP+ 
cells are denoted by arrows.  PDGFRα+ YFP-negative cells are denoted by small arrows.   
Scale bars = 50µm 
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labelling and tracing period, which is well above the level of cellgenesis previously reported 
in these tissues (Chang et al., 2008; Parretta et al., 2008; Seyed-Razavi et al., 2013).  The 
more likely explanation is that the majority of YFP-labelling that occurs in these organs is 
non-specific.  We conclude that the Pdgfrα-CreERT2::Rosa26-YFP transgenic mice cannot 
be used to specifically or efficiently induce gene recombination in the PDGFRα+ fiboblast-like 
cell populations in any of these organs. 
4.2.6  PDGFRα+ cells are present in the large and small intestine, and a small 
proportion of them become YFP-labelled in adult Pdgfrα-CreERT2::Rosa26-YFP 
transgenic mice.  
The gastrointestinal tract is organized into distinct layers.  A special population of PDGFRα+ 
cells, with a largely unknown function, has been previously identified within the mucosal 
layer of the intestine (Kurahashi et al., 2013).  PDGFRα+ cells are also present in the 
muscular layer of the intestine where they mediate communication between the enteric 
nervous system and smooth muscle cells (Kurahashi et al., 2011; 2014).  To determine 
whether these cells undergo recombination and become YFP-labelled in adult Pdgfrα-
CreERT2::Rosa26-YFP transgenic mice, cryosections were processed to detect PDGFRα+ 
(red), YFP (green) and the nuclear marker Hoescht 33342 (Fig. 4.5).  We confirm that 
PDGFRα+ cells are present throughout the small intestine.  In particular there was a high 
density of PDGFRα+ cells detected in the lamina propria of the villi (Fig. 4.5 a-c, g).  
PDGFRα+ cells were also detected in the smooth muscle layer (Fig. 4.5 d), but no PDGFRα+ 
were detected in the epithelial cell layer (Fig. 4.5 b).  In the large intestine, PDGFRα+ cells 
were similarly observed in the crypts and smooth muscle (Fig. 4.5 e-f).  However, PDGFRα+ 
cell density was significantly higher in the small (344.3 ± 10 cells/mm2) relative to the large 
(184.9 ± 44.6 cells/mm2) intestine (P<0.002, ANOVA).   
We next determined that YFP+ PDGFRα+ cells were present in the small and large 
intestines, however the proportion of PDGFRα+ cells that became YFP-labelled was quite 
small.  Only ~6.4% of the PDGFRα+ cells in the villi and crypts of the small intestine and 
~5.7% of the PDGFRα+ cells in the smooth muscle layer of the small intestine became YFP-
labelled.  Similarly, only ~2% of the PDGFRα+ cells in the large intestine co-expressed YFP 
(Fig. 4.5 g).  Furthermore, the specificity of the YFP labelling in the intestine may also be of 
concern.  In the villi and crypts of the small intestine 63% ± 22% of the YFP+ cells co-
expressed PDGFRα (Fig. 4.5 b, c, g).  However in the smooth muscle layer only 14% ± 3% 
of the YFP+ cells co-labelled for PDGFRα+ (Fig. 4.5 g).  The YFP+ PDGFRα-negative cells in 
the smooth muscle layer were elongated and had long narrow nuclei, suggesting that they 
were smooth muscle cells.  Therefore, while the Pdgfrα-CreERT2 transgenic mouse can be 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: A proportion of PDGFRα+ cells become YFP- labeled in the bone marrow 
Transverse cryosections taken through the tail of P57+7 Pdgfrα-CreERT2 :: Rosa26-YFP 
transgenic mice were immuno-stained to detect PDGFRα (red), YFP (green) and HST 
(blue).  Confocal images (single z plane) of the bone marrow at low (a) and high (b) 
magnification.  PDGFRα+ YFP+ cells are denoted by arrowheads. Scale bars represent 
100µm (a) and 25µm (b).   
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used to label a small subpopulation of the intestinal PDGFRα+ cell population for lineage 
tracing studies, it would be ineffective for facilitating conditional gene deletion in these cells. 
4.2.7  PDGFRα+ cells are present in the bone marrow and become YFP-labelled 
following Tx administration to adult Pdgfrα-CreERT2::Rosa26-YFP transgenic mice 
Within the bone marrow, PDGFRα+ cells are non-hematopoietic stromal cells (Anthony and 
Link, 2014).  To determine whether these PDGFRα+ cells become YFP labelled in adult 
Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, cryosections were taken through the tail and 
processed to detect PDGFRα (red), YFP (green) and the nuclear marker Hoescht 33342 
(Fig. 4.6).  As expected PDGFRα+ cells were present throughout the bone marrow (Fig. 4.6 
a, b) at high density (3545.7 ± 619.5 cells/mm2).  Furthermore, 37.9 ± 0.8% of these cells 
had undergone recombination and were YFP labeled.  Within the bone marrow, the YFP-
labelling was highly specific, with all YFP-labeled cells expressing PDGFRα+.  These data 
indicate that, outside of the CNS, the most specific and extensive site of recombination and 
YFP-labelling achieved using the Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, is within 
the bone marrow. 
4.3  Discussion 
4.3.1  Pdgfrα-CreERT2 transgenic mice specifically and efficiently induce 
recombination in OPCs in the CNS 
Within the CNS, PDGFRα and the NG2 proteoglycan are both accepted markers for the 
identification of OPCs, as they are co-expressed by >98% of OPCs (Rivers et al., 2008).  
While inconsistent with the protein expression data, Ng2-dsred transgenic mice not only 
label OPCs within the CNS, but also robustly label pericytes (Hall et al., 2014), whereas 
Pdgfrα-CreERT2 transgenic mice have been used to induce Cre-mediated recombination 
soley within OPCs (Rivers et al., 2008; Kang et al., 2010).  In this study we report that 
Pdgfrα-CreERT2 transgenic mice can induce recombination in >90% of OPCs across the 
CNS, ranging from ~91% in the spinal cord to ~97% in the motor cortex (see Fig. 4.1).  
These data are consistent with previous reports in which the administration of Tx to adult 
Pdgfrα-CreERT2::Rosa26-mGFP transgenic mice resulted in the GFP-labelling of ~94% of 
OPCs in the dorsal cortex and ~91% of OPCs in the piriform cortex (Kang et al., 2013).  
Essentially all PDGFRα-negative YFP+ cells observed in the CNS had distinct 
oligodendrocyte morphology and co-labelled for OLIG2, suggesting that they were newly 
differentiated oligodendrocytes, generated by the YFP-labelled OPCs.  More of these cells 
were observed in the CC than the cortex, which is also consistent with previous observations 
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that OPCs within the adult mouse CC proliferate and generate new oligodendrocytes more 
rapidly than those in the cortex (Rivers et al., 2008).   
While these results show that the Pdgfrα-CreERT2::Rosa26-YFP transgenic mouse line is 
highly effective for inducing gene-specific recombination in OPCs throughout the CNS when 
treated with Tx this study did not address any potential leakiness of the system.  Untreated 
Pdgfrα-CreERT2::Rosa26-YFP control mice could be included to determine whether any 
recombination is occurring without Tx administration.  However, if recombination was 
occurring prior to Tx administration it would be expected that fluorescence would be 
identified in a greater number of non-oligodendrocyte lineage cells, which had 
spontaneously recombined prior to differentiating from stem cell populations during 
development. 
We conclude that within the CNS, expression of the Pdgfrα-CreERT2 transgene faithfully 
follows that of endogenous PDGFRα expression, in that it specifically facilitates DNA 
recombination in a high proportion of OPCs.  This transgenic mouse can therefore be used 
to effect gene activation or deletion within OPCs of the CNS, without affecting other CNS cell 
types.  However, its suitability for some experiments, particularly gene deletion experiments, 
is also dependent on the level of recombination (or lack of recombination) achieved in cells 
outside of the CNS. 
4.3.2  The Pdgfrα-CreERT2 transgene enables recombination in a small proportion of 
Schwann cells 
We have determined that a small proportion (~11%) of PDGFRα+ S100β+ Schwann cells, 
and a small number of PDGFRα-negative S100β+ Schwann cells, become YFP-labelled in 
P57+7 Pdgfrα-CreERT2::Rosa26-YFP transgenic mice (see Fig. 4.1).  This reflects a low 
recombination efficiency for the Schwann cell population overall.  However since the vast 
majority of peripheral myelin is laid down by P22 (Garbay et al., 2000), and only a small 
number of Schwann cells are still adding myelin at P57 (Garbay et al., 2000), it is possible 
that the less mature cells are preferentially labelled using the Pdgfrα-CreERT2 transgenic 
mouse.  Irrespective of their stage of maturation, this is the first report of Schwann cell 
labelling in the sciatic nerve of Pdgfrα-CreERT2 mice.  A previous study, using an alternative 
Pdgfrα-CreERT2 mouse line, achieved recombination in the sciatic nerve following a crush 
injury, but the labelled cells were not Schwann cells (Zawadzka et al., 2010).  However, 
given the small proportion of Schwann cells that became YFP-labelled in the Pdgfrα-
CreERT2 mouse line used for this study, and the known capacity of peripheral nerves to 
regenerate following an injury (Makwana and Raivich, 2005; Mietto et al., 2015), it is unlikely 
that using the Pdgfrα-CreERT2 transgenic mouse for conditional gene ablation, irrespective 
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of the gene, would seriously impact peripheral nerve function or result in a detectable or 
long-lived Schwann cell phenotype.     
4.3.3  Pdgfrα-CreERT2 transgenic mice induce recombination in a novel PDGFRα+ cell 
population in the intestine 
A unique population of PDGFRα+ cells reside in the mucosal layer of the gastrointestinal 
tract (Kurahashi et al., 2013).  These cells have long, thin cell bodies and processes, and are 
found in the laminar propria where they form a sheath that extends along the length of the 
crypts, immediately below the epithelial cell layer.  Many of the PDGFRα+ YFP+ cells 
detected in the villi and crypts of the small and large intestine of Pdgfrα-CreERT2::Rosa26-
YFP transgenic mice belong to this population of cells.  Interestingly, it has been suggested 
that these subepithelial PDGFRα+ cells may be able to remodel or change their phenotype 
depending upon cell culture conditions (Kurahashi et al., 2013), and this could be a possible 
explanation for the occasional YFP+ PDGFRα+ cells in the villi of the small intestine that are 
morphologically distinct from most of this population (see Fig. 4.5 c).  However, little is 
known about this newly discovered cell type and its in vivo differentiation capabilities.  
In the muscle layers of the small and large intestine, PDGFRα+ cells are a subtype of 
interstitial cell, also known as “fibroblast-like” cells (Kurahashi et al., 2011). These cells are 
located near the terminals of enteric motor neurons and communicate information from the 
enteric nervous system to the smooth muscle cells of the intestine via gap junctions 
(Kurahashi et al., 2011; 2014).  In Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, Tx 
administration induced recombination and YFP-labelling in a very small proportion of 
PDGFRα+ cells in any muscle type.  The intestinal smooth muscle had the highest level of 
recombination with ~5.7% of PDGFRα+ cells becoming YFP labeled, while in the cardiac and 
skeletal muscle <2% of PDGFRα+ cells recombined.  Morphologically the PDGFRα+ cell 
population in the smooth muscle is similar to the PDGFRα+ cell populations identified in the 
heart and gastrocnemius muscle (compare Fig. 4.3 b, d with Fig. 4.5 d), which is particularly 
interesting as a number of studies have indicated that the PDGFRα+ cells in the heart 
(Chong et al., 2013; Noseda et al., 2015) and skeletal muscle (Oishi et al., 2013; Pannérec 
et al., 2013) are progenitor populations.   
While few of the PDGFRα+ cells in the heart and small intestinal smooth muscle underwent 
recombination, these regions contained a relatively high proportion of YFP+ PDGFRα-
negative cells.  One possible explanation for these cells is that the YFP+ PDGFRα+ cells 
represent immature cell populations which, like the OPCs, rapidly divide and mature into 
cells that no longer express PDGFRα.  Even though the PDGFRα+ cells in the heart are 
multipotent progenitors (Chong et al., 2013), their rate of proliferation and differentiation 
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could not account for the number of YFP+ PDGFRα-negative cells detected (Senyo et al., 
2013).  Alternatively, in the intestinal smooth muscle, it is possible that YFP could pass from 
recombined YFP+ PDGFRα+ cells through the gap junctions to give the appearance of YFP-
labelling in PDGFRα-negative cells.  However, this seems unlikely as there does not appear 
to be a close physical association between these two cell populations.  The most likely 
explanation is that the Pdgfrα-CreERT2 transgene lacks a regulatory element that controls 
the expression of Pdgfrα – one that is not required to regulate gene expression in the CNS, 
so that it is mis-expressed, resulting in the direct recombination of small numbers of 
PDGFRα-negative cells in these tissues. 
4.3.4  PDGFRα+ stromal cells in the bone marrow become YFP-labelled more 
efficiently than any other PDGFRα+ cell population outside of the CNS 
The bone marrow is a major site of haematopoiesis.  However, surrounding the islands of 
hematopoietic cells, is an extensive network of stromal cells that includes the PDGFRα+ cells 
of the bone marrow.  The PDGFRα+ stromal cells comprise the perivascular CXCL12-
abundant reticular (CAR) cells and the PDGFRα+ Sca1+ (PαS) cells (Anthony and Link, 
2014).  CAR cells are adipo-osteogenic progenitors that secrete factors essential for 
haematopoietic stem and progenitor cell maintenance (Sugiyama et al., 2006; Omatsu et al., 
2010; Ding et al., 2012), while PαS cells are a population enriched in bone marrow 
mesenchymal stem cells (Morikawa et al., 2009).  Following Tx administration to adult 
Pdgfrα-CreERT2::Rosa26-YFP transgenic mice, ~38% of PDGFRα+ bone marrow stromal 
cells become YFP-labelled, and the recombination of cells in this region was highly specific, 
as all YFP+ cells were PDGFRα+.  These data indicate, that the Pdgfrα-CreERT2 transgenic 
mouse induces a significant level of gene recombination in PDGFRα+ bone marrow stromal 
cells in vivo, and could be useful for lineage tracing studies of this population.  Furthermore, 
if researchers plan to use Pdgfrα-CreERT2 transgenic mice to achieve conditional gene 
deletion from OPCs in the CNS, they should also consider that the gene will also be deleted 
from cells in this population.  
4.3.5  Few PDGFRα+ fibroblasts become YFP-labelled in Pdgfrα-CreERT2::Rosa26YFP 
transgenic mice 
We identified PDGFRα+ cell populations in all of the tissues and quantified the level of 
recombination (YFP-labelling) achieved using Pdgfrα-CreERT2 transgenic mice.  The 
majority of PDGFRα+ cell populations identified were fibroblasts (Horikawa et al., 2015).  
PDGFRα is an established marker for some fibroblast cell populations.  For example, in situ 
hybridisation previously indicated the presence of Pdgfrα mRNA in the lung (Boström et al., 
1996), and a GFP reporter line was then used to visualize these cells (Ntokou et al., 2015), 
77 
 
and determine that PDGFRα expression identifies alveolar fibroblasts (Chen et al., 2012).  
Hepatic stellate cells, a fibrotic cell type in the liver, have also been shown to express 
PDGFRα (Hayes et al., 2014; Liu et al., 2014).  Furthermore, the overexpression of PDGFRα 
has been linked to fibrosis in many of the organs examined in this study, such as the lung, 
kidney and liver (Bonner, 2004; Hayes et al., 2014).  In each of the tissues that contained 
PDGFRα+ fibroblasts, very few of these cells became YFP-labelled in P57+7 Pdgfrα-
CreERT2::Rosa26-YFP transgenic mice.  The low level of recombination in these populations 
and poor specificity for recombination in these areas, suggests that these mice will have 
limited application for studying these cell types.  Furthermore, if researchers plan to use the 
Pdgfrα-CreERT2 transgenic mouse to achieve conditional gene deletion from OPCs in the 
CNS, they are unlikely to experience unexpected effects in the lungs, liver, kidney or spleen.    
4.4  Conclusions 
Pdgfrα-CreERT2 transgenic mice are an effective tool for selectively achieving highly specific 
recombination in PDGFRα+ OPCs of the CNS.  However, outside of the CNS, these mice fail 
to induce significant recombination in any PDGFRα+ cell population, with the exception 
PDGFRα+ stromal cells in the bone marrow.  These data indicate that Pdgfrα-CreERT2 
transgenic mice could be used to conditionally delete Kif3a from OPCs, to prevent cilia 
assembly in vivo, without producing significant adverse phenotypes outside of the CNS. 
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Chapter 5: Kif3a impairs OPC proliferation and 
oligodendrogenesis in vivo  
5.1  Introduction 
Having demonstrated that primary cilia assembly is dramatically reduced when Kif3a is 
deleted from OPCs in vitro (Chapter 3), and that Pdgfrα-CreERT2 transgenic mice 
preferentially achieve DNA recombination in PDGFRα+ OPCs (O’Rourke et al., 2016), I now 
aim to use Pdgfrα-CreERT2 transgenic mice to conditionally delete Kif3a and prevent primary 
cilium assembly by OPCs in vivo.  The experiments presented in this Chapter will determine 
whether the primary cilium is necessary for OPC proliferation and oligodendrogenesis in the 
adult mouse brain.   
The targeted deletion of Kif3a, a vital component of the primary cilium cytoskeleton, from 
specific cell types in vivo, has been achieved previously, by intercrossing Kif3afl/fl transgenic 
mice (Marszalek et al., 2000) with transgenic mice that express Cre recombinase in the 
target cell population.  For example, deletion of Kif3a from proliferative cell types, including 
kidney epithelial cells (Ma et al., 2013), osteoblasts (Temiyasathit et al., 2012) and cardiac 
myocytes (Slough et al., 2008), consistently led to decreased proliferation.  In the CNS, the 
deletion of Kif3a from cerebellar granule cell precursors resulted in reduced proliferation and 
retarded cerebellar development (Spassky et al., 2008).  Furthermore, the loss of primary 
cilia assembly by neural progenitors, in the developing dentate gyrus, achieved by the 
deletion of Kif3a, resulted in reduced precursor proliferation and an underdeveloped dentate 
gyrus (Han et al., 2008).  In adulthood, deletion of the Kif3a gene from B1 neural stem cells, 
reduced neurogenesis in the ventral SVZ (Tong et al., 2014).  These data indicate that 
deleting Kif3a can selectively disrupt primary cilia function on proliferating cell populations in 
vivo. 
As OPCs continue to proliferate and generate new oligodendrocytes throughout life (Rivers 
et al., 2008; reviewed by Wang and Young, 2014), it follows that these cells will be highly 
reliant on signalling at the primary cilia to perform their function.  Therefore, I hypothesize 
that the deletion of Kif3a from OPCs in vivo will result in a reduction in proliferation, as seen 
in vitro (see Chapter 3).  I also hypothesise, that by preventing cilium assembly, I will halt 
adult oligodendrogenesis, and this will allow me to determine whether ongoing 
oligodendrogenesis is essential for the maintenance of motor or cognitive performance, as 
well as mood regulation. 
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5.2  Results 
5.2.1  OPCs but not oligodendrocytes assemble primary cilia in the adult mouse 
brain 
In order to determine whether cells of the oligodendrocyte lineage assemble primary cilia in 
vivo, 30µm cryosections were generated from the brains of P60 Sox10-GFP mice, in which 
GFP is under the control of the Sox10 promoter, and all cells of the oligodendrocyte lineage 
are GFP-labelled (Kessaris et al., 2005).  Immunohistochemistry was performed to detect 
cells of the oligodendrocyte lineage (GFP; blue) and determine the proportion that expressed 
the primary cilia markers Arl13b (red) and γ-tubulin (green) within the CC (Fig. 5.1 a-c).  
~7% of GFP+ cells had assembled primary cilia at P60 (Fig. 5.1 a-c, g) - a proportion 
strikingly similar to the fraction of SOX10+ cells that are OPCs in the CC at that age (Rivers 
et al., 2008).  
To determine whether the GFP+ ciliated cells were OPCs or oligodendrocytes, cryosections 
were collected from P60 C57Bl6 mice and immunohistochemistry performed to detect OPCs 
(PDGFRα, blue) and primary cilia (Arl13b, red; γ-tubulin, green).  ~72% of PDGFRα+ OPCs 
were ciliated (Fig. 5.1 d, g), suggesting that they made up the majority of the Sox10-GFP+ 
ciliated cells, and implying that, like mature Schwann cells (Yoshimura and Takeda, 2012), 
mature oligodendrocytes do not have assembled primary cilia.  To confirm this, I performed 
immunohistochemistry on cryosections from Plp-CreERT2::Rosa26-YFP transgenic mice 
(P57 + 7), in which immature and mature oligodendrocytes, but not OPCs, are YFP-labelled, 
and found that the vast majority (~98%) of YFP+ callosal oligodendrocytes did not have 
Arl13b+ γ-tubulin+ primary cilia assembled on their surface (Fig. 5.1 e, g).  As OPCs can 
directly differentiate into OLs (Hughes et al., 2013), this process must require disassembly of 
the primary cilium during or at the conclusion of differentiation.  Considering this, it is 
possible that the ~2% of YFP+ cells that were ciliated, are differentiating oligodendrocytes, or 
correspond to the relatively stable population of immature (ENPP6+) oligodendrocytes (Xiao 
et al., 2016). 
5.2.2  In vivo, adult OPCs disassemble their primary cilia to re-enter the cell cycle. 
Having determined that OPCs, but not oligodendrocytes, have assembled primary cilia, I 
next aimed to determine whether OPCs disassemble their primary cilia as they progress 
through the cell cycle in vivo, as they do in vitro (see Chapter 3).  In vivo, OPCs proliferate 
asynchronously, such that a fraction of the population is transitioning through the S and M 
phases of the cell cycle, at any given time (Young et al., 2013), and I hypothesise that 
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Figure'5.1:'Primary'cilia'are'disassembled'as'OPCs'enter' the'cell'cycle,'and'
are'not'assembled'on'oligodendrocytes'
(a<c)#Confocal#image#(single#z1plane)#of#the#CC#of#a#P60#Sox101GFP#mouse#immuno1
stained# to# detect# GFP# (blue),# Arl13b# (red)# and# γ1tubulin# (green).# # (d)# Confocal#
image# of# the# CC# of# a# P60# C57Bl6# mouse# immuno1stained# to# detect# GFP# (blue),#
Arl13b# (red)# and# γ1tubulin# (green).# # (e)# Confocal# image# (single# z1plane)# of# the#
corpus# callosum# of# a# P57+7# Plp1CreERT# ::# Rosa261YFP#mouse# immunostained# to#
detect# GFP# (blue),# Arl13b# (red)# and# γ1tubulin# (green).# # (g)# Quantification# of# the#
proportion#of#Sox10+,#PDGFα+#and#Plp+#cells#in#the#CC#with#assembled#primary#cilia#
(avg# ±# stdev,# n=3# per# group;# p<0.0001,# one1way# ANOVA# with#
Bonferroni.correction).# # (h)# Confocal# image# (single# z1plane)# of# the# CC# of# a# P60#
C57Bl6#mouse,#given#EdU# for#6#hours#and# immuno1stained#to#detect#GFP#(green),#
PDGFRα#(red)#and#HST#(blue).# # (i)#Confocal# image# (single#z1plane)#of# the#CC#of#a#
P60#C57Bl6#mouse#given#EdU#given#EdU#for#6#hours#and#immuno1stained#to#detect#
EdU#(blue),#Arl13b#(red)#and#γ1tubulin#(green).##Arrows#indicate#cells#without#cilia.##
Circles#indicate#assembled#primary#cilia.##Scale#bars#represent#20μm.###! !
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actively dividing OPCs account for the OPCs that lack an assembled primary cilia in vivo.  To 
examine this possibility, EdU was administered to P60 C57Bl6 mice (as per (Wang et al., 
2016)), to identify all cells entering S phase of the cell cycle over a 6-hour period.  OPCs in 
the CC divide approximately once a week, and have an S phase of 19 ± 7 hours (Young et 
al., 2013) and an m phase of 1.2 ± 0.2 hours (Psachoulia et al., 2009).  Therefore, very few 
OPCs that are entering or exiting S phase, will successfully complete their cell cycle within 
the 6-hour labelling period.  While a large number of EdU+ PDGFRα-negative cells could be 
identified within the lateral extension of the SVZ (presumably neural progenitor cells and 
neuroblasts), the small number of EdU+ cells identified within the CC proper, were PDGFRα+ 
OPCs (94 of 95 EdU+ cells) (Fig. 5.1 h).  Furthermore, EdU+ cells within the CC lacked 
Arl13b+ γ-tubulin+ primary cilia (80 of the 81 EdU+ cells examined across n=3 mice) (Fig. 5.1 
i, j), indicating that OPCs disassemble their primary cilia to enter the cell cycle in vitro and in 
vivo. 
5.2.3  OPCs lacking Kif3a do not assemble primary cilia 
To determine whether primary cilia assembly was not only associated with, but essential to 
cell cycle transition, delete Kif3a from OPCs in vivo, I administered Tx to P57 Kif3afl/fl 
(control) and Pdgfrα-CreERT2::Kif3afl/fl (Kif3a-deleted) mice (Fig. 5.2 a).  After 14 days 
(P57+14), the mice were perfusion fixed and genomic DNA extracted from the hindbrain, 
and used to confirm Kif3a deletion by PCR analysis of the Kif3a gene.  The successful 
amplification of a ~480bp product from the gDNA of Kif3afl/fl and Pdgfrα-CreERT2::Kif3afl/fl 
and, confirmed the presence of brain cells containing the Kif3afl/fl allele.  However, 
amplification of a smaller DNA product (~100bp), solely from the gDNA of Tx-dosed Pdgfrα-
CreERT2::Kif3afl/fl mice, that was absent from naïve Pdgfrα-CreERT2::Kif3afl/fl and Tx-dosed 
Kif3afl/fl mice, confirmed the presence of cells, from which Kif3a had been deleted (Fig. 5.2 
b).   
Kif3a deletion would be predicted to impair primary cilia assembly by OPCs.  To investigate 
this directly, P57 Pdgfrα-CreERT2::Rosa26-YFP (control) mice and Pdgfrα-CreERT2::Rosa26-
YFP::Kif3afl/fl (Kif3a-deleted) transgenic mice received Tx to fluorescently label OPCs and 
their progeny, and compare their behaviour with and without Kif3a, respectively.  The 
proportion of YFP+ cells with assembled primary cilia (Arl13b, red and γ-tubulin, green) was 
quantified in the CC from P57+7 to P57+30.  In control mice, the proportion of YFP+ cells 
that was ciliated decreased over time, with >70% of YFP+ cells having assembled primary 
cilia at P57+7 and P57+14 (Fig. 5.3 a, b, i), but only ~47% of YFP+ being ciliated by P57+30 
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Figure!5.2:!Schematic!of!approach!to!conditionally!delete!Kif3a!from!OPCs!in!vivo!
(a)# Schematic# of# transgenic# cre2lox# stragegy# to# conditionally#delete#Kif3a# form#OPCs.##
(b)#Genomic#DNA#was#extracted#from#the#hindbrain#of#adult#Pdgfrα2CreERT2#::#Rosa262
YFP# ::# Kif3afl/fl# littermates,# that# received# Tx# (n=2)# or# not# (n=1).# # Using# primers# to#
amplify# a# region# of# the# Kif3a# gene,# it# was# possible# to# detect# the# presence# of# bands#
corresponding# to# Kif3a# gene# deletion# in# the# Tx2treated#mice,# that# was# absent# in# the#
untreated#mouse.##!
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Figure!5.3:!Deleting!Kif3a!from!OPCs!prevents!cilium!assembly!in!vivo!
Confocal# image# (single# z2plane)# of# the# CC# of# control# (Pdgfrα2CreERT2# ::# Rosa262YFP)#
mice#at#P57+7#(a),#P57+14#(b),#P57+30#(c)#and#P57+60#(d),#immuno2stained#to#detect#
YFP#(blue),#Arl13b#(red)#and#γ2tubulin#(green).##Confocal#image#(single#z2plane)#of#the#
CC# of# Kif3a2deleted# (Pdgfrα2CreERT2# ::# Rosa262YFP# ::# Kif3afl/fl)# mice# at# P57+7# (e),#
P57+14#(f),#P57+30#(g)#and#P57+60#(h),# immuno2stained#to#detect#YFP#(blue),#Arl13b#
(red)#and#γ2tubulin#(green).##(i)#Quantification#of#the#proportion#of#YFP+#cells#in#the#CC#
with# assembled# primary# cilia# (avg# ±# stdev,# n=3# per# group;# p<0.001,# two2way#ANOVA#
with# Bonferroni# correction).# # Arrows# indicate# assembled# primary# cilia.# # Arrowheads#
indicate#basal#bodies#without#assembled#primary#cilia.##Scale#bars#=#10μm.#! !
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(Fig. 5.3 c, i).  This decline can be readily explained by the growing fraction of YFP+ cells 
that became oligodendrocytes (Rivers et al., 2008).   
In the CC of Kif3a-deleted mice, fewer YFP+ cells were ciliated, relative to control mice, at 
every time point examined.  At P57+7 the proportion of YFP+ cells that was ciliated dropped 
from ~76% in control mice to ~17% in Kif3a-deleted mice (Fig. 5.3 e, i), and a similar 
reduction was observed at P57+14 (Fig. 5.3 f, i).  Furthermore, the proportion of YFP+ cells 
with cilia remained constant over time in the Kif3a-deleted mice, with  ~15% of YFP+ cells 
still having assembled cilia in P57+30 mice (Fig. 5.3 g, i).  These data indicate that deletion 
of the Kif3a gene from OPCs successfully prevents primary cilia assembly in vivo, and 
renders the OPCs more stable, neither dividing nor differentiating over time.   
5.2.4  Proliferation is impaired in Kif3a-deficient adult OPCs 
Kif3a-deleted OPCs would still have the capacity to disassemble their primary cilia and enter 
the cell cycle.  However, as each callosal OPC divides once every ~10 days (Rivers et al., 
2008), I would predict that at P57+25 days, all OPC would have divided and subsequently 
failed to reassemble a primary cilia – thereby blocking their capacity to undergo subsequent 
cell divisions.   
To determine whether OPCs lacking Kif3a were capable of dividing, P57+25 control and 
Kif3a-deleted mice received EdU via the drinking water for 5 days, before being perfusion 
fixed at P57+30.  Brain cryosections were immunolabelled to detect YFP (blue), PDGFRα 
(green) and EdU+ (red), and the fraction of OPCs that had undergone division (EdU+ 
PDGFRα+/ total PDGFRα+), was quantified in the CC and motor cortex.  Consistent with 
previous reports (Psachoulia et al., 2009; Young et al., 2013), the fraction of OPCs 
incorporating EdU, was higher in the CC (~65% of PDGFRα+ OPCs were EdU-labelled; Fig. 
5.4 a, e) than the motor cortex (~11%; Fig. 5.4 b, e) of control mice.  While this was also 
true for the Kif3a-deleted OPCs, with ~45% of callosal PDGFRα+ OPCs incorporating EdU 
(Fig. 5.4 c, e) relative to only  ~6% in the motor cortex (Fig. 5.4 d, e), the rate of EdU 
incorporation was significantly reduced in both brain regions, relative to controls.  
Surprisingly, deleting Kif3a from OPCs, and preventing cilia assembly, did not prevent all 
OPCs from dividing, but significantly reduced the proportion that could.   
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Figure!5.4:!Deleting!Kif3a!from!OPCs!reduces!proliferation!in!vivo!
Confocal(image((single(z0plane)(of(the(CC(of(Kif3afl/fl((control)((a)(and(Pdgfrα0CreERT2(::(
Kif3afl/fl( (Kif3a0deleted)( mice( (b)( that( received( EdU( via( their( drinking( water( from(
P57+25(to(P57+30,(immuno0stained(to(detect(PDGFRα((green)(and(EdU((red).((Confocal(
image( (single( z0plane)( of( the( primary( motor( cortex( (MC)( of( control( (a)! and( Kif3a0
deleted((b)(mice,( that(received(EdU(via( their(drinking(water( from(P57+25(to(P57+30,(
immuno0stained( to( detect( PDGFRα( (green)( and( EdU( (red).( ( (e)( Quantification( of( the(
proportion(of(EdU+(PDGFRα+(cells( in(the(CC(and(MC(of(control(and(Kif3a0deleted(mice(
(avg( ±( stdev,( n=3( per( group;( p<0.002,( two0way( ANOVA( with( Bonferroni( correction).((
Arrows( represent( PDGFRα+( EdU0negative( cells.( ( Arrowheads( indicate( PDGFRα+( EdU+(
cells.((Scale(bars(=(30μm.!!!
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5.2.5  Kif3a-deficient adult OPCs have a reduced capacity to generate new 
oligodendrocytes 
As OPC proliferation was reduced in Kif3a-deleted mice, it should follow that OPCs produce 
fewer new oligodendrocytes.  To establish the rate at which newborn oligodendrocytes are 
added to the brain following the conditional deletion of Kif3a from OPCs, coronal brain 
cryosections from P57+7, 14 or 30 day control and Kif3a-deleted mice were processed to 
detect YFP (green), as well as the OPC marker, PDGFRα (red) and the nuclear stain 
Hoescht 33342 (blue).  In control and Kif3a-deleted mice, >90% of OPCs in the CC and 
motor cortex at P57+7, P57+14 and P57+30 (n=3 per group, P=0.7, ANOVA with Bonferroni 
multiple comparisons test).  However, the Kif3a-deleted OPCs generated half as many new 
oligodendrocytes (YFP+, PDGFRα-negative) in the motor cortex and CC, when compared 
with controls, over time (Fig. 5.5).  For example, at P57+14, ~30% of YFP+ cells were 
PDGFRα-negative in the CC of control mice, compared with only ~15% in the same region 
of Kif3a-deleted mice (Fig. 5.5 b, e, m), suggesting that Kif3a deletion significantly impairs 
oligodendrogenesis.  Similarly, in the motor cortex, where oligodendrogenesis occurs more 
slowly than the CC (Young et al., 2013), ~15% of the YFP+ cells were oligodendrocytes in 
control mice, compared with only ~8% in Kif3a-deleted mice (Fig. 5.5 h, k, n).  This relative 
reduction in oligodendrogenesis was also maintained at P57+30 in the CC (Fig. 5.5 c, f, m) 
and motor cortex (Fig. 5.5 i, l, n).  The reduction in numbers of new oligodendrocytes was 
accompanied by a reduction in the density of newborn oligodendrocytes in both the CC and 
motor cortex at 7, 14 and 30 d (n=3 per group, P=0.03, two-way ANOVA with Bonferroni 
multiple comparisons test).  These data suggest that mice in which OPCs can not assemble 
primary cilia, not only have a reduced rate of OPC proliferation, but ultimately have fewer 
new oligodendrocytes added to the brain.  
5.2.6  Deleting Kif3a from OPCs decreases oligodendrogenesis, but has no short-
term effect on gait parameters, grip strength or the optokinetic reflex of mice 
Adult-born oligodendrocytes play a role in complex motor memory acquisition (McKenzie et 
al., 2014), but it has also been suggested that they could play an important role in 
maintaining CNS function (Birey et al., 2015; Schneider et al., 2016).  As deleting Kif3a from 
OPCs ultimately leads to reduced oligodendrogenesis, it has the potential to impact normal 
CNS function.  To examine the possibility, that the conditional deletion of Kif3a from OPCs 
would progressively impact motor performance, young adult control (Kif3afl/fl) and Kif3a-
deleted (Pdgfrα-CreERT2::Kif3afl/fl) mice were subjected to a gait analysis (Fig 5.6 a-h), a grip 
strength assessment (Fig 5.6 i) and optomotor testing (Fig 5.6 j), prior to, and for up to 6 
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Figure!5.5:!!Deleting!Kif3a!from!OPCs!reduces!oligodendrogenesis!in!vivo!
Confocal(image(of(the(CC(of(control((Pdgfrα4CreERT2(::(Rosa264YFP)(mice(at(P57+7(
(a),( P57+14( (b)( and(P57+30( (c),( immuno4stained( to(detect(YFP( (green),( PDGFRα(
(red)(and(HST((blue).((Confocal(image(of(the(CC(of(Kif3a4deleted((Pdgfrα4CreERT2(::(
Rosa264YFP( ::(Kif3afl/fl)(mice(at(P57+7( (d),( P57+14( (e)( and(P57+30( (f),( immuno4
stained(to(detect(YFP((green),(PDGFRα((red)(and(HST((blue).((Confocal(image(of(the(
motor( cortex( of( control( P57+7( (g),( P57+14( (h)( and( P57+30( (i)( mice( immuno4
stained(to(detect(YFP((green),(PDGFRα((red)(and(HST((blue).(Confocal(image(of(the(
motor(cortex(of((Kif3a4deleted(P57+7((j),(P57+14((k)(and(P57+30((l)(mice(immuno4
stained(to(detect(YFP((green),(PDGFRα((red)(and(HST((blue).(((m)(Quantification(of(
the( proportion( of( YFP+( cells( in( the( CC( that( have( differentiated( into(
oligodendrocytes.( ( (n)(Quantification(of( the(proportion(of(YFP+(cells( in( the(motor(
cortex(that(have(differentiated(into(oligodendrocytes.(((avg(±(stdev,(n=3(per(group;(
p<0.0014,( two4way( ANOVA( with( Bonferroni( correction).( ( Arrows( indicate( YFP+(
PDGFRα+( cells.( ( Arrowheads( indicate( YFP+( PDGFRα4negative( cells.( ( Scale( bars( =(
20μm((a4f)(and(100(μm((g4l).((! (
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Figure! 5.6:! ! Acutely! reducing! oligodendrogenesis! does! not! affect! motor! or!
visual!performance!
Control( (Kif3afl/fl)(and(Kif3a4deleted( (Pdgfrα4CreERT2( ::(Kif3afl/fl)( littermates(were(
tested( for(gait,(grip( strength(and(optokinetic( response(prior( to(Tx(administration(
(P5742( days)( and( weekly( from( P57+7( to( P57+43.( ( (a)( Posture( plot( of( a( mouse(
running(at(26cm/s(on(a(gradient(of(3°(showing(the(front(right((RF),(front(left((LF),(
right(hind((RH)(and(left(hind((LH)(limbs.(((b)(Quantification(of(the(swing(time(of(the(
front( right( (FR)( limb( of( control( and( Kif3a4deleted( mice( over( the( testing( period.(
Values(recorded(at(26cm/s(and(at(a(gradient(of(43°.(((c)(Quantification(of(the(stride(
time( of( the( FR( limb( of( control( and( Kif3a4deleted( mice( over( the( testing( period.((
Values(recorded(at(26cm/s(and(at(a(gradient(of(43°.(((d)(Stride(frequency(of(the(FR(
limb(of(control(and(Kif3a4deleted(mice(over(the(testing(period.((Values(recorded(at(
26cm/s(and(at(a(gradient(of(43°.(((e)(Quantification(of(the(brake(time(of(the(FR(limb(
of( control( and( Kif3a4deleted( mice( over( the( testing( period.( ( Values( recorded( at(
26cm/s(and(at(a(gradient(of(43°.(((f)(Quantification(of(the(stance(time(of(the(FR(limb(
of( control( and( Kif3a4deleted( mice( over( the( testing( period.( ( Values( recorded( at(
26cm/s(and(at(a(gradient(of(43°.( ((g)(Quantification(of(the(swing(time(of(the(front(
right( (FR)( limb(of(control(and(Kif3a4deleted(mice(over( the( testing(period.( (Values(
recorded( at( 18cm/s,( 22cm/s( and( 26cm/s( and( at( a( gradient( of( 43°.( ( (h)(
Quantification(of(the(swing(time(of(the(front(right((FR)(limb(of(control(and(Kif3a4
deleted(mice(over(the(testing(period.((Values(recorded(at(26cm/s(and(at(a(gradient(
of(0°,(43°(and(3°.(((i)(Quantification(of(the(grip(strength(of(the(forelimbs(and(all(four(
limbs( of( control( and( Kif3a4deleted(mice( over( the( testing( period.( ( Graph( contains(
data(pooled(for(both(genders.(((j)(Quantification(of(head(turns(of(control(and(Kif3a4
deleted( mice( over( the( testing( period( during( clockwise( and( anticlockwise( drum(
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weeks after Tx administration.  Prior to Kif3a deletion, the motor performance of each 
treatment group was equivalent (Fig. 5.6).   
Many studies which have observed a decrease in myelin deposition have also observed 
accompanying changes in gait (Carson et al., 2015; LoPresti, 2015), additionally, increasing 
oligodendrocytes progenitor production has been shown to prevent gait changes which 
occur as a result of hypoxia-ischemia (Dizon et al., 2011).  This suggests that OPC 
proliferation and myelination play an important role in normal CNS function and gait 
regulation.  To examine gait, mice were placed on a DigigaitTM treadmill and video-recorded 
as they walked.  9 distinct movies were recorded per mouse, as they walked at 3 different 
speed settings (18, 22 and 26 cm/s), as some changes in gait are only evident at increased 
speeds (Crone et al., 2009).  As incline has also been shown to aggravate gait changes in 
rodent models (Hampton et al., 2011), mice were also analyzed walking on a flat surface, on 
an incline and a decline (flat i.e. 0°, a 3° incline and a 3° decline), at each speed.   
Each video was analyzed to quantify gait parameters, particularly stride time (the time taken 
to complete one stride), stride frequency (the average number of times a paw contacts the 
treadmill per second), swing time (the portion of the stride where the paw is moving forward 
but is not in contact with the treadmill), brake time (the time between initial paw contact with 
the belt and the maximal paw contact) and stance time (the portion of the stride in which the 
paw remains in contact with the belt).  When control mice were running at 26cm/s, there was 
no significant difference identified in the stride time, stride frequency, swing time, brake time 
or stance time, measured at 0° +3° or -3° (n=6 per group, P=0.6, two-way ANOVA with 
Bonferroni multiple comparisons test).  Similarly, at 26 cm/s there was no significant 
difference identified in the stride time, stride frequency, swing time, brake time or stance time 
of Kif3a-deleted mice walking at a 0° +3° or -3° (n=6 per group, P=0.5, two-way ANOVA with 
Bonferroni multiple comparisons test).  These data suggest that altering the angle of running 
did not affect any of the parameters in either control or Kif3a-deleted animals.   
Interestingly, when running on an incline of 0°, there was no significant difference in the 
stride time, swing time, brake time or stance time of control mice running at 18cm/s, 22 cm/s 
and 26cm/s speeds (n=6 per group, P>0.9, two-way ANOVA with Bonferroni multiple 
comparisons test) at any time over the testing period.  However, a significant increase in 
stride frequency was detected with increasing running speed (n=6 per group, P=0.04, two-
way ANOVA with Bonferroni multiple comparisons test), which would be expected, as a 
greater number of strides would be required to keep up with the accelerating treadmill.  
Larger changes in gait parameters in control mice would be expected with further 
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acceleration.  Stride time, stride frequency, swing time, brake time and stance time, were not 
significantly different between control male and control female mice, when run at an incline 
of 0° at 18cm/s, 22cm/s or 26cm/s, at any testing period (n=3 per group, P=0.2, two-way 
ANOVA with Bonferroni multiple comparisons test).  This was also the case for Kif3a-deleted 
mice (n=3 per group, P=0.1, two-way ANOVA with Bonferroni multiple comparisons test).  As 
a result, male and female mice were pooled for DigigaitTM analysis, although there were 
equal numbers of male and female mice for each genotype. 
When running at a 0° incline (i.e. flat) gait parameters including stride time, stride frequency, 
swing time, brake time and stance time did not differ between control and Kif3a-deleted mice 
over time, when mice were moving at 18, 22 or 26cm/s (n=6 per group, P>0.3, two-way 
ANOVA with Bonferroni multiple comparisons test).  When running at -3° (Fig. 5.6 b-f) or 
+3°, there was similarly no effect of genotype or treatment time at 18, 22 or 26cm/s (+3°; n=6 
per group, P>0.05, two-way ANOVA with Bonferroni multiple comparisons test).  These data 
suggest that acutely reducing oligodendrogenesis, by deleting Kif3a from OPCs, does not 
result in a change in gait.  
As a second measure of motor performance, the grip strength test was used to measure of 
both muscle strength and fine motor coordination (Deacon, 2013).  Muscle strength is 
required to create the force necessary to pull back on the bars, but this is not possible 
without the fine motor coordination to grasp the bars.  It would not be expected that the 
deletion of Kif3a exclusively from OPCs in the CNS would affect muscle mass, but it may 
affect the conduction velocity of CNS neurons which innervate the muscles responsible for 
grasping.  Grip strength is affected in models of CNS demyelination such as EAE (Jones et 
al., 2008) suggesting that proper myelination is important for maintenance.   
Grip strength was tested using a Chatillon grip strength meter.  Mice were gently but firmly 
pulled along a metal grid allowing contact with either all four limbs or just the forelimbs.  At 
each timepoint, grip strength was measured five times per mouse, and the maximum force 
measured was recorded and normalised to body weight [grams-force / gram body weight 
(GF/g)].  Grip strength differed significantly between male and female control mice, with 
males having a lower normalised forelimb grip strength (n=7 per group, p 0.0024, two-way 
ANOVA with Bonferroni multiple comparisons test) and overall normalised grip strength (n=7 
per group, p 0.0002, two-way ANOVA with Bonferroni multiple comparisons test).  Grip 
strength was consistent over time in the control group, with female mice maintaining a 
forelimb strength of ~6.5 GF/g and an overall grip strength of  ~12 GF/g, and males 
maintaining a forelimb strength of ~6.0 GF/g and an overall grip strength of ~10 GF/g.  This 
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pattern was also observed in the Kif3a-deleted group, with female and male measures of 
grip strength being equivalent to controls at each time-point (Fig. 5.6 i, n=7 per group, 
P>0.05, two-way ANOVA with Bonferroni multiple comparisons test).  These data indicate 
that reducing oligodendrogenesis by deleting Kif3a does not impair fine motor performance 
or strength by P57+43 suggesting that acutely reducing adult oligodendrogenesis, is not 
sufficient to impair grip strength. 
Demyelinating diseases which affect the optic nerve have been shown to result in visual 
impairment, including impairment in the optokinetic response in both rodents (Matsunaga et 
al., 2012) and humans (Raz et al., 2011).  The optic nerve is a CNS region that is almost 
fully myelinated in adulthood, but continues to gain new myelinating oligodendrocytes 
throughout life (Young et al., 2013).  This suggests that preventing oligodendrogenesis may 
affect myelin maintenance in the optic nerve, resulting in visual defects.   
To test visual acuity, I measured the optomotor response of control and Kif3a-deleted mice.  
Each mouse was placed on a podium inside a rotating drum, that is patterned with black and 
white vertical stripes.  If the mouse can see the drum rotate in a CW or CCW direction, it will 
move its head to follow the rotation, and then quickly return its head to the centre, before 
following the motion again (Abdeljalil et al., 2005).  The number of optomotor head turns was 
counted over a 2 min period.  Both control and Kif3a-deleted mice showed a gradual 
improvement in performance over time, with the number of head turns increasing in both the 
CW and CCW directions, between P57+7 and P57+21 (Fig. 5.6 j).  However, there was no 
significant difference in performance, between control and Kif3a-deleted mice at any time-
point examined (Fig. 5.6).  There was also no difference in the performance of male and 
female mice (n=7 per group, P>0.05, two-way ANOVA with Bonferroni multiple comparisons 
test). These data suggest that deleting Kif3a from OPCs, and reducing oligodendrogenesis 
for 5 weeks, is insufficient to perturb CNS regulated motor and visual system function.   
5.2.8  Deleting Kif3a from OPCs decreases oligodendrogenesis, but has no effect on 
short-term memory, anxiety or depression 
Studies have shown that CNS myelination is important for the regulation of short-term 
memory, particularly working memory (Zhang et al., 2012; Kim et al., 2015).  In a cuprizone 
model of demyelination, working memory is impaired, however, this can be reversed by 
treatment with Quetiapine, which stimulates oligodendrocyte production (Zhang et al., 2012).  
This suggests that oligodendrogenesis is important for repairing demyelination-induced 
deficits in short-term memory, and loss of oligodendrocyte production may affect short-term 
memory acquisition.   
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Short-term memory performance was assessed using the T-maze.  The T-maze tests 
working memory, and was chosen due to the fact working memory has often shown to be 
affected in models of demyelination (Zhang et al., 2012; Kim et al., 2015).  Individual control 
and Kif3a-deleted mice were placed in the start arm of the T-maze and allowed to move into 
the left or right arm, before being blocked in the chosen arm.  When the mouse is returned to 
the start arm of the T-maze, in which all arms are open to it, its novelty-seeking nature, 
naturally inclines the mouse to choose and enter the unexplored or opposite arm of the 
maze (Deacon and Rawlins, 2006).  This process is called spontaneous alternation.  Each 
mouse was returned to the start arm and allowed to choose 10 times, and the number of 
errors in alternation was equivalent between the control and Kif3a-deleted mice.  However, 
the error rate recorded for the control mice was unexpectedly high, with mice only alternating 
correctly ~50% of the time, which does not reflect any discrimination.  Control mice would be 
expected to correctly spontaneously alternate >80% of the time (Deacon and Rawlins, 
2006).  Therefore, short-term memory was additionally examined using the novel object 
recognition test. 
The novel object recognition test, is a two-day test that examines the ability of mice to 
recognise the difference between novel and familiar objects.  On day 1, mice are placed in 
an arena containing two identical objects, and they are free to interact with those objects 
over a 10 min period.  On day 2, they are returned to the arena, but one of the objects has 
been replaced with a new ‘novel’ object.  A mouse with intact short-term memory will spend 
more time exploring the novel object (Taglialatela et al., 2009).  Both control and Kif3a-
deleted mice were able to recognise the novel object, and spent more time exploring the 
novel object relative to the familiar object (Fig. 5.7 i, j, k).  Furthermore, the amount of time 
spent interacting with the novel object was equivalent between the control and Kif3a-deleted 
mice (Fig. 5.7 i, j, k), indicating that by P57+43, the conditional deletion of Kif3a from OPCs, 
had not affected short-term memory formation and retrieval. 
Changes in myelin deposition are associated with an increased anxiety in humans and 
anxiety-like behaviour in rodents.  Adolescent humans, with generalized anxiety, have white 
matter abnormalities that can be detected by DTI (Liao et al., 2014).  Similarly, mice with 
reduced oligodendrogenesis, as a result of OPC ablation, show an increase in anxiety-like 
behaviour, when tested using the open-field test and elevated plus maze (Birey et al., 2015).  
By contrast, preventing oligodendrogenesis by deleting Esco1 and preventing OPC 
proliferation, does not alter anxiety-like behaviour in the open field test (Schneider et al., 
2016).  In order to determine whether reducing oligodendrogenesis by deleting Kif3a affects 
anxiety-like behaviour, the performance of control and Kif3a-deleted mice was evaluated in 
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Figure!5.7:!Reducing!oligodendrogenesis!by!conditionally!deleting!Kif3a!from!
OPCs!does!not!alter!short?term!memory,!anxiety!or!depressive!behaviours!
Control' (Kif3afl/fl)' and' Kif3a1deleted' (Pdgfrα1CreERT2' ::' Kif3afl/fl)' littermates'
received' Tx' at' P57,' and' underwent' cognitive' testing' from' P57+36' to' P57+43.''
Representative'elevated'plus'maze'(EPM)'tracks'from'control'(a)'and'Kif3a1deleted'
(b)'mice.''(c)'Quantification'of'the'proportion'of'time'spent'in'the'open'arms'of'the'
EPM' by' control' and' Kif3a1deleted'mice' (avg' ±' stdev,' n=15' per' group;' p>0.05,' t1
test).''Representative'open'field'(OF)'tracks'from'control'(d)'and'Kif3a1deleted'(e)'
mice.''(f)'Quantification'of'the'proportion'of'time'spent'in'the'centre'zone'of'the'OF'
arena'by'control'and'Kif3a1deleted'mice' (avg'±' stdev,'n=15'per'group;'p>0.05,' t1
test).''(g)'Quantification'of'the'proportion'of'marbles'buried'by'control'and'Kif3a1
deleted'mice'in'the'marble'bury'test'(avg'±'stdev,'n=15'per'group;'p>0.05,'t1test).''
(h)' Quantification' of' the' proportion' of' time' spent' actively' swimming,' passively'
swimming'and' floating'by'control'and'Kif3a1deletedl'mice' in' the' forces'swim'test'
(avg' ±' stdev,' n=15' per' group;' p>0.05,' t1test).' ' Representative' novel' object'
recognition' (NOR)' heat' maps' from' control' (i)' and' Kif3a1deleted' (j)' mice.' ' (k)'
Percentage'of'time'spent'interacting'with'the'novel'object'on'day'2'of'the'NOR'test'
by'control'and'Kifa1deleted'mice'(avg'±'stdev,'n=15'per'group;'p>0.05,'t1test).'
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the elevated plus maze, open field and marble bury tests.  The elevated plus maze 
comprises two enclosed and two open arms raised off the ground.  Each mouse is placed in 
the centre, and allowed to explore for five mins, and the proportion of time spent in the open 
and closed arms calculated.  An uninhibited, less anxious mouse (increased risk-taking 
behaviour) will spend more time in the open arms (Walf and Frye, 2005).  Mice in the control 
and Kif3a-deleted groups spent the majority of their time in the closed arms, only spending 
~5% of their time in the open arms of the maze (Fig. 5.7 a-c).  Very few mice (2 of 30, one 
each of Kif3a-deleted and control) ventured to the end of the open arm suggesting that 
inhibiting oligodendrogenesis by deleting Kif3a does not result in altered risk taking 
behaviour. 
During the open field test, mice were placed in a 30cm x 30cm box with a brightly lit centre 
and shadowed edges, and allowed to explore for 5 min.  Mice with heightened anxiety-like 
behaviour spend less time in the centre and more time at the perimeter, while mice with 
reduced anxiety-like behaviour explore the centre more often.  Across the 5 min period, 
control and Kif3a-deleted mice behaved similarly (Fig. 5.7 d-f), with mice in both groups 
favouring the perimeter but spending ~15% of the time exploring the central zone of the box.  
This suggests that the conditional deletion of Kif3a from OPCs does not produce an anxiety-
like phenotype.   
Next, each control and Kif3a-deleted mouse was placed in a box containing 5cm deep 
substrate and ten marbles.  The more marbles they bury over a 30 min period, the greater 
their anxiety-like phenotype (Deacon and Rawlins, 2005; Angoa-Pérez et al., 2013).  All 
control and Kif3a-deleted mice tested buried some of the marbles, and when the number 
buried was quantified, there was no significant difference between genotypes (Fig. 5.7 g), 
supporting our conclusions from the previous two tests, that deleting Kif3a from OPCs has 
no effect on anxiety-like behaviour. 
Preventing oligodendrogenesis during neonatal development has previously been shown to 
result in an increase in anxiety-like behaviour in mice (Chen et al., 2015).  Additionally, 
mood-associated disorders, such as anxiety (Liao et al., 2014) and depression (Regenold et 
al., 2007; Williams et al., 2015) have been linked with abnormal myelin deposition in 
humans.  This suggests that oligodendrogenesis, and its role in adult myelination, may be 
important for mood regulation in anxiety-like and depressive behaviours.  To examine the 
possibility that Kif3a deletion from OPCs and the resulting reduction in oligodendrogenesis, 
leads to a change in depressive behaviour, control and Kif3a-deleted mice undertook a 
forced swim test.  Each mouse was placed in a beaker, containing 15cm deep water, and 
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they were forced to swim for 5 min.  The amount of time spent in active swimming and 
passive floating was recorded, as mice in a state of elevated depression will commit the 
minimal effort required to stay afloat (Can et al., 2012).  The amount of time that mice in the 
control and Kif3a-deleted groups spent passively swimming or floating was equivalent, at 
~5% (Fig. 5.7 h).  These data indicate that preventing OPC proliferation and effectively 
halving oligodendrogenesis over a 6 week period, does not influence depressive behaviour 
in mice. 
The data in this chapter indicate that OPCs in the adult mouse brain assemble primary cilia, 
but mature oligodendrocytes do not, indicating a regulatory role of the primary cilium on 
OPCs, which is not necessary in mature, myelinating oligodendrocytes.  Additionally, the 
primary cilium is not assembled on OPCs that are actively dividing, suggesting that it is 
disassembled as they enter the cell cycle and assembled again after cell-cycle exit.  
Preventing primary cilium assembly in OPCs, by deleting Kif3a, results in reduced OPC 
proliferation in addition to reduced oligodendrogenesis.  This acute reduction in 
oligodendrogenesis is not sufficient to affect gait, grip strength or optokinetic response and 
does not affect short-term memory, anxiety or depressive behaviours by P57+43.  This 
suggests the reduction in oligodendrogenesis does not affect CNS function in the short-term. 
5.3  Discussion 
5.3.1  Primary cilia regulate OPC proliferation in vivo 
Essentially all OPCs have assembled primary cilia on their surface, with the exception of 
OPCs that are transitioning through the cell cycle.  This conclusion is supported by a number 
of observations: (i) that ~7% of Sox10-GFP+ cells in the CC of adult mice have an 
assembled Arl13b+ primary cilia extending from a γ–tubulin+ basal body, a proportion similar 
to the fraction of Sox10-GFP+ cells that would be PDGFRα+ OPCs (Rivers et al., 2008); (ii) 
that ~75% of PDGFRα+ OPCs in the CC of adult mice have assembled primary cilia at any 
one time, and (iii) that OPCs acutely labelled with EdU in vivo, identifying them as cells that 
have entered or have very recently exited s-phase of the cell cycle, do not have assembled 
primary cilia.  These data are further supported by the time-lapse imaging data, presented in 
Chapter 3, that demonstrate the disassembly of primary cilia by OPCs in vitro, as they enter 
the cell cycle.   
As the primary cilium is associated with a number of signalling pathways that influence cell 
proliferation (reviewed in Michaud and Yoder, 2006), it is perhaps unsurprising that a primary 
cilium is assembled on the surface of immature OPCs.  In many cell types, including 
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proliferative HEK cells, the primary cilium is maintained on the surface of the cell and 
disassembled before a cell division occurs (Paridaen et al., 2013).  Once the cilium has been 
disassembled the centrosomes migrate away from the cell surface and organise the mitotic 
spindle during division, before being trafficked back to the cell surface for primary cilium 
assembly once division is complete.  As the primary cilium plays two major roles in the 
regulation of cell division: (i) it receives proliferative signals that tell the cell to divide, and (ii) 
it stops uncontrolled cell division by preventing mitosis when assembled, preventing cilium 
assembly can either reduce proliferation, due to the loss of proliferative signals such as Shh 
(Han et al., 2008; Spassky et al., 2008; Temiyasathit et al., 2012; Tong et al., 2014), or it can 
increase proliferation as cell-cycle re-entry is no longer regulated by the cilium (Lin et al., 
2003; Hoang-Minh et al., 2016).   
The Kif3afl/fl mouse model has previously been used in vivo to knock down cilia assembly in 
cells in the embryonic mouse heart (Slough et al., 2008) and the developing and adult 
kidney (Ma et al., 2013).  Progenitor cell types in the CNS, have also previously been 
targeted, including cerebellar granule cells (Spassky et al., 2008), neural progenitors in the 
developing dentate gyrus (Han et al., 2008) and B1 neural progenitors in the adult ventral 
SVZ (Tong et al., 2014). The conditional deletion of Kif3a from the DNA of OPCs in adult 
mice, resulted in fewer OPCs having assembled primary cilia in the CC from as early as 
P57+7 and this phenotype was still evident at P57+30.  By P57+25, the loss of primary cilia 
assembly in Kif3a-deleted mice was clearly accompanied by a decrease in the number of 
OPCs that incorporated EdU, relative to control mice.  This could be the result of OPCs 
dividing more slowly in the CC and motor cortex of Kif3a-deleted mice, or could be the result 
of OPCs failing to enter the cell cycle.  Therefore, the predominant effect of preventing 
primary cilium assembly by OPCs in vitro and in vivo, is impaired proliferation, suggesting 
that the primary cilium plays a critical role in driving cell division by OPCs.        
A number of signalling pathways localize to the primary cilium (reviewed in Michaud and 
Yoder, 2006) that are known to regulate OPC proliferation.  For example, in vitro, OPCs 
express genes associated with Shh signalling (Chapter 3), which has been shown to be 
important for OPC generation during embryonic development (Tekki-Kessaris et al., 2001), 
and to regulate OPC proliferation in vivo (Ferent et al., 2013) and in vitro (Ortega et al., 
2013).  Shh signalling is also reliant on the primary cilium in vertebrates (reviewed in Goetz 
and Anderson, 2010).  Alternative signalling pathways that could influence OPC proliferation 
via the primary cilium, include Wnt and PDGFRα.  Wnt signalling can occur at the primary 
cilium of other cell types (Gerdes and Katsanis, 2008) and has been shown to promote OPC 
migration, have no effect on proliferation, and discourage oligodendrogenesis (Fancy et al., 
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2009; 2011; 2014; Tsai et al., 2016).  As my data suggest that signaling at the primary cilium 
increases OPC proliferation and promotes oligodendrogenesis, it is unlikely that disrupted 
Wnt signaling can account for the phenotype.  PDGF-AA binding to PDGFRα is critical for 
OPC survival and an important regulator of OPC proliferation (Espinosa-Jeffrey et al., 2009) 
(reviewed in Grade et al., 2013).  PDGFRα has also been shown to accumulate at the 
primary cilium in NIH3T3 fibroblasts in response to serum starvation, increasing the receptor 
density and suggesting that the primary cilium can be utilized to make PDGFRα signalling 
more efficient (Schneider et al., 2005).  It is unlikely, however, that PDGFRα signalling in 
OPCs would be affected by the loss of the primary cilium due to the fact the extensive 
expression of PDGFRα on the cell surface of the OPC would likely compensate for its loss – 
unless the signal mediated at the cilium is distinct from that transduced elsewhere on the cell 
surface. 
5.3.2  Primary cilia are not associated with differentiated oligodendrocytes 
Unlike OPCs, mature oligodendrocytes do not have assembled primary cilia on their surface.  
The vast majority of Sox10-GFP+ cells are mature oligodendrocytes, yet only 7% had 
assembled primary cilia.  The idea that oligodendrocytes do not have assembled primary 
cilia is also supported by the fraction of YFP+ cells with assembled primary cilia decreasing 
with increasing time from Tx administration, in Pdgfrα-CreERT2::Rosa26YFP transgenic 
mice.  At P57+7, when the majority of YFP+ cells are OPCs (O’Rourke et al., 2016), ~75% of 
YFP+ cells had assembled primary cilia, but this fraction reduced over time to only ~50% of 
YFP+ cells by P57+30.  The number of YFP+ cells with assembled primary cilia decreases as 
the number of YFP+ oligodendrocytes increases. Furthermore, ~98% of YFP+ 
oligodendrocytes labelled in the CC of Plp-CreERT2::Rosa26-YFP transgenic mice are not 
ciliated.  Why a small fraction of YFP+ oligodendrocytes might have primary cilia is unclear, 
but it is possible that the YFP+ ciliated cells are newly differentiated oligodendrocytes, that 
had upregulated plp mRNA expression at the time of Tx administration, and are in the 
process of disassembling their primary cilia for differentiation, and correspond to the small 
population of premyelinating, immature oligodendrocytes (sometimes called ENPP6 cells; 
(Xiao et al., 2016) that can be found throughout the CNS at any given time (Trapp et al., 
1997). 
Cells of the oligodendrocyte lineage are not the only neural cells that appear to have cilia 
assembled on the surface of the immature cells, but disassembled during differentiation.  
Schwann cells are the myelinating cells of the peripheral nervous system.  In mouse dorsal 
root ganglion neuron and Schwann cell co-cultures, a high proportion of the proliferative pre-
myelinating Schwann cells have assembled primary cilia, but primary cilia are rarely 
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detected on the mature myelinating Schwann cells (Yoshimura and Takeda, 2012).  As 
myelinating Schwann cells and oligodendrocytes are postmitotic cells, the primary cilium 
may be disassembled as this type of signalling is no longer required.  It is certainly not 
uncommon for cells to lose their capacity to assemble primary cilia as they differentiate from 
a proliferative progenitor cell type to a post-mitotic cell type, and many post mitotic cells lose 
their basal bodies after differentiation (Cunha-Ferreira et al., 2009; Debec et al., 2010).  This 
is not always the case, as some differentiated cell types, including neurons and astrocytes, 
have assembled primary cilia (Arellano et al., 2012; Kasahara et al., 2014).  However, my 
data indicate this is a feature common to both post-mitotic, myelinating cell types. 
5.3.3 Deleting Kif3a from OPCs reduces oligodendrogenesis, but does not affect 
motor function, anxiety or depressive behaviour 
OPCs continually proliferate and differentiate into oligodendrocytes throughout life (Rivers et 
al., 2008).  A reduction in oligodendrogenesis was observed in Kif3a-deleted mice from 
P57+14, in both the CC and motor cortex.  In the CC and motor cortex, the percentage of 
OPCs that had differentiated was halved from control to Kif3a-deleted mice at P57+14 and 
P57+30.  Furthermore, Kif3a is not involved in primary cilia disassembly, its absence from 
OPCs is unlikely to affect the capacity of an OPC to directly differentiate into an 
oligodendrocyte, or the capacity of an OPC exiting the cell cycle from initiating differentiation.  
As the overall density of OPCs was also unaffected by Kif3a-deletion, depletion of the 
progenitor pool was not a factor contributing to reduced oligodendrogenesis.  However, a 
loss of signaling at the primary cilium may play a direct role, as blocking Shh signalling in 
vitro, by treating differentiating rat primary OPC cultures with the Smo inhibitor cyclopamine, 
impairs their differentiation and decreases branching complexity (Falcón-Urrutia et al., 2015), 
indicating that Shh signalling at the primary cilium could also drive oligodendrocyte 
differentiation.  
The specificity of the transgenic mouse line used has been extensively characterised by the 
experiments performed in chapter 4 (O’Rourke et al., 2016) and has been found to be highly 
effective and specific, targeting >95% of OPCs in all CNS tissues.  The deletion of Kif3a was 
targeted OPCs throughout the whole CNS, it can therefore be expected that the deletion of 
Kif3a would result in a system wide reduction in OPC proliferation and oligodendrogenesis, 
affecting brain regions responsible for motor performance and vision, but also those involved 
in cognition, anxiety, and depression.  OPCs throughout the CNS proliferate and 
differentiate.  The rate of OPC proliferation differs between different CNS regions, at P60 
complete turnover of the OPC population in both the CC and the spinal white matter taking 
less than 10 days, around 20 days in the optic nerve and around 30 days in the spinal grey 
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matter and motor cortex (Young et al., 2013).   The rate of oligodendrogenesis is also 
variable throughout the CNS, but new oligodendrocytes are continuously being born and 
myelinating, even in regions that already have high levels of myelination such as the optic 
nerve (Young et al., 2013).  While not all brain regions have been specifically quantified it 
would be expected that OPCs in these regions would behave in the same manner as the 
rest of the CNS, undergoing continuous proliferation and differentiation.  It would also be 
expected that they would rely on the same proliferative signals, and would respond to 
deletion of Kif3a in the same manner. 
An area of significant interest in the myelin biology field at present, is understanding the 
purpose of adult oligodendrogenesis (Waly et al., 2014; Wang and Young, 2014).  Herein, I 
demonstrate that acutely reducing OPC proliferation and oligodendrogenesis, by 
conditionally deleting Kif3a from adult OPCs in mice, did not affect motor function, as 
assessed by grip strength and gait analysis.  By contrast, reducing oligodendrogenesis by 
selectively deleting the cell cycle regulator, Esco2, from all cells of the oligodendrocyte 
lineage in adult mice, induced cell death in proliferating OPCs (Schneider et al., 2016).  
Oligodendrogenesis was also affected, being reduced to ~30% over an 8 week period 
(Schneider et al., 2016).  Within just 4 weeks, the performance of Esco2-deleted mice was 
impaired in the balance beam test, and by 6 weeks, in the grid walk test (Schneider et al., 
2016).  By contrast, preventing oligodendrogenesis, by deleting Myrf, a transcription factor 
necessary for the initiation and regulation of new myelin production, had no effect on rotarod 
performance by 1 month post gene-deletion (McKenzie et al., 2014).  The rotarod and 
balance beam / grid walk tests all measure balance and motor coordination.  While some 
motor-impaired mouse strains have been shown to perform better on static balance tests, 
like the balance beam, while others have been shown to perform better on moving 
substrates, such as the rotorod (reviewed in Deacon, 2013), it is more likely that this 
discrepancy can be explained by having a greater understanding of the contribution of OPCs 
versus newborn oligodendrocytes to motor performance maintenance.  Schneider et al. 
(2016) demonstrated  ~2/3 reduction in oligodendrogenesis when deleting Esco2, deletion of 
Kif3a reduced oligodendrogenesis by ~1/2.  Although the reduction in oligodendrogenesis 
observed in my study was smaller, the difference is too small to explain such a large 
discrepancy in motor phenotypes.  It would be valuable to extend the period of analysis to 
determine whether sustained Kif3a-deletion could produce a motor deficit.   
In addition to examining motor performance, I examined the importance of 
oligodendrogenesis in mood regulation, particularly anxiety and depression.  I determined 
that conditionally deleting Kif3a from OPCs did not influence anxiety over a 6 week period, 
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when assessed by the elevated-plus maze, the open field test and the marble bury test.  
These data are consistent with the phenotype produced by conditionally deleting Esco2 from 
OPCs in adult mice, which did not affect their performance in the open field test over a 14 
week period (Schneider et al., 2016).  By contrast, reducing oligodendrogenesis by 
selectively expressing iDTR, the diphtheria toxin receptor, in adult NG2+ cells, and ablating 
them by administering the diphtheria toxin A-chain, reduced the amount of time mice spent 
exploring the centre of the open field arena and reduced the amount of time mice spent in 
the open arms of the elevated plus maze, after only 7 days – suggesting that the ablation of 
OPCs can dramatically and rapidly produce an anxiety phenotype (Birey et al., 2015).  This 
may not be the result of compromised oligodendrogenesis, but perhaps mediated by the loss 
of an alternative OPC function, or, for example, microglial activation in response to OPC 
death.      
Similarly, 6 weeks after Kif3a deletion, control and Kif3a-deleted mice performed similarly in 
the forced swim test, indicating that they did not display depressive behaviour.  However, 
just 7 days of NG2-cell ablation was sufficient to impair performance in the sucrose 
preference test, which is an alternative measure of depressive state, and 9 days was 
sufficient to detect a decrease in social interaction (Birey et al., 2015).  In comparison to the 
iDTR approach, Esco2 and Kif3a gene deletion remove fewer OPCs from the CNS, 
suggesting that OPCs may play an important role in mood regulation, which is distinct from 
their role in oligodendrogenesis.     
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Chapter 6: Discussion and future directions 
Data presented in this thesis indicate that a subpopulation of OPCs have primary cilia 
assembled on their surface at any one time.  This is because primary cilia disassemble just 
prior to cell cycle entry, and reassemble upon cell cycle exit.  Furthermore, primary cilia play 
a critical role in regulating OPC proliferation and oligodendrogenesis, such that preventing 
primary cilia assembly provides a means to further probe OPC biology, and gain critical 
insight into the biological functions enabled by adult oligodendrogenesis.   
In Chapter 3, I was able to visualize primary cilia assembly and disassembly by cultured 
OPCs.  It would be interesting to extend this study, not only to collect additional movies and 
perform a more detailed analysis of this phenomenon, but also to extend the imaging period.  
It would be informative to show that the second daughter cell does assemble a basal body 
and primary cilium given more time, and to visualize asymmetric and symmetric divisions, to 
confirm that OPCs destined to differentiate upon cell cycle entry, never reassemble a 
primary cilium.  Furthermore, while I was able to demonstrate that primary cilia are critical for 
OPC proliferation in vitro, it would be interesting to determine how influential Shh signaling is 
at the primary cilium at different stages of the cell cycle, and at different stages of 
differentiation.  OPCs produce Shh (Ferent et al., 2013; Zhang et al., 2014), and Shh 
signaling regulates oligodendrogenesis (Wang and Almazan, 2016; Sanchez and Armstrong, 
2018) - now Kif3a-deletion and primary cilia ablation provides a means to further interrogate 
the importance of the primary cilia for Shh regulation of cells in this lineage. 
While it is well established that OPCs reside throughout the adult CNS, and continuously 
divide and differentiate to produce new oligodendrocytes (reviewed in Richardson et al., 
2011).  The potential function of adult oligodendrogenesis has been much debated.  In 
humans, learning complex motor tasks, such as juggling (Scholz et al., 2009) or playing a 
musical instrument (Lee et al., 2003), is associated with changes in imaging parameters, that 
suggest myelin deposition is increased in the brain regions activated by the task.  While this 
may be the result of increased oligodendrogenesis, the scale of continued oligodendrocyte 
generation in the human brain (Yeung et al., 2014) seems too small to account for a role in 
life-long learning.  
In Chapter 4, I determined that Pdgfrα-CreERT2 transgenic mice efficiently target DNA 
recombination to OPCs in the CNS.  However, these mice also induce a low level of specific 
and non-specific DNA recombination in cells in other tissues and organs (O’Rourke et al., 
2016).  While many of these cells would also have primary cilia, and similarly experience 
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Kif3a-deletion in Pdgfrα-CreERT2::Kif3afl/fl transgenic mice, I would not expect Kif3a deletion, 
in a very small subset of any single peripheral cell population, to affect motor, cognitive or 
mood measures, making these mice largely suitable to assess the behavioral consequences 
of Kif3a deletion in OPCs.  However, Pdgfrα-CreERT2 transgenic mice did achieve highly 
specific DNA recombination in a subset of PDGFRα+ stromal cells in the bone marrow, and it 
would be interesting to carry out a histological examination of these cells to determine 
whether they have assemble primary cilia that are also lost in Pdgfrα-CreERT2::Kif3afl/fl 
transgenic mice.     
In Chapter 5, I determined that the deletion of Kif3a from OPCs in vivo impaired OPC 
proliferation and approximately halved adult oligodendrogenesis.  There have been a 
number of studies in recent years, which have taken different genetic approaches to either 
remove OPCs from the mature CNS or decrease oligodendrogenesis, in order to understand 
its function.  Consequently, we now know that oligodendrogenesis is an important regulator 
of complex motor learning in mice (McKenzie et al., 2014).  In the short-term, preventing 
oligodendrogenesis, by deleting Myrf from OPCs does not affect motor performance as 
assessed by the rotor rod test, but does delay motor skill acquisition, with both their 
maximum and average speeds being significantly decreased on the complex running wheel 
(McKenzie et al., 2014).  However, Myrf-deletion after learning did not affect memory 
retrieval (McKenzie et al., 2014).  In this study, oligodendrogenesis in Myrf-deleted animals 
was ~10% that of controls, which is significantly greater reduction than then ~50% reduction 
in the Kif3a-deleted mice.  While the phenotype may not be as robust, it would be interesting 
to determine whether a 50% reduction in oligodendrogenesis is sufficient to produce 
complex learning deficits.   
While the role of oligodendrogenesis had already been examined for complex learning, a 
role in short-term formation or working memory had not been, despite the fact that 
demyelination has been shown to be associated with reductions in short-term memory, 
particularly working memory (Zhang et al., 2012; Kim et al., 2015).  I assessed the short-
term and working memory performance of control and Kif3a-deleted mice in the T-maze, and 
the novel object recognition test and found no significant difference in the performance of 
control and Kif3a-deleted animals within 6 weeks of gene deletion.  While these data 
suggest that oligodendrogenesis is not important for short-term and working memory, these 
experiments are far from conclusive.  Perhaps a 50% decrease in oligodendrogenesis is not 
sufficient to produce a phenotype, or perhaps oligodendrogenesis would need to be blocked 
for a longer period of time, to ensure the depletion of the pool of immature oligodendrocytes, 
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that can be rapidly mobilized during learning (Sampaio-Baptista et al., 2013; McKenzie et al., 
2014).    
Recent studies have shown that the addition of new oligodendrocytes is important for normal 
motor function (Birey et al., 2015; Schneider et al., 2016).  If adult-born oligodendrocytes 
play a role in replacing damaged or dying oligodendrocytes (Wang and Young, 2014).  While 
I detected no change in motor and optomotor performance by P57+43 in Kif3a-deleted mice, 
this is a phenotype that would be predicted to develop slowly and over an extended period of 
time.  Therefore, this study is still ongoing to determine whether sustained blockade of 
oligodendrogenesis can eventually lead to a motor degenerative phenotype. 
Preventing oligodendrogenesis has also been shown to alter anxiety-like behaviour (Birey et 
al., 2015).  In addition to motor and cognitive phenotypes, people with MS often have 
comorbid depression and unstable moods (Seyed Saadat et al., 2014).  Recent studies have 
also shown an association between changes in white matter and an alteration in anxiety or 
depressive state.  Transcriptional profiling of patients diagnosed with major depressive 
disorder indicated dysregulation of a number of oligodendroglial-associated genes (Aston et 
al., 2005).  Additionally an increase in deep white matter lesions are detected in people with 
unipolar and bipolar depression (Regenold et al., 2007).  Adolescents with generalized 
anxiety have also been shown to have white matter abnormalities by DTI (Liao et al., 2014).  
While I observed no change in anxiety or depressive state in my acute study, the strong 
evidence linking myelin loss with changes in anxiety and depressive state, suggests this may 
develop with sustained Kif3a-deletion.   
By demonstrating that primary cilia are present on the surface of OPCs but absent from 
mature, myelinating oligodendrocytes and preventing cilium assembly reduces both OPC 
proliferation and oligodendrogenesis, this thesis improves our understanding of the 
relationship between the primary cilium and the oligodendrocyte lineage.  I also determined 
that preventing cilium assembly and reducing oligodendrogenesis did not affect normal CNS 
function by 7 weeks post gene-deletion.  However, further studies are required to elucidate 
the exact signalling pathways that rely upon the primary cilium in OPCs, and to observe the 
effect of Kif3a-deletion and reduced oligodendrogenesis over the longer term. 
! !
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Appendix 1: Solutions 
Common Laboratory Reagents 
0.01M Phosphate Buffered Saline (PBS) 
MilliQ water       850ml   
90.0g/L Sodium chloride     100ml  
28.0g/L Di-sodium hydrogen orthophosphate   40ml   
31.2g/L Sodium di-hydrogen orthophosphate  10ml  
 
Blocking Solution for Immunohistochemistry and Immunocytochemistry 
FCS       1ml   
Triton-x100      10µl    
PBS        top up to 10ml     
 
Solutions for DNA Extraction 
DNA Extraction Buffer 
1M Tris-HCL (pH8.5)     12ml 
0.5M EDTA (pH8.0)     1.2ml 
5M NaCl      4.8ml 
10% SDS      0.2% 
Note: Autoclave before adding SDS 
 
Culture media 
OPC complete cell culture media (50mL) 
      Add   Final Conc. 
DMEM      42ml   - 
PDGFR-AA     20μl   20ng/ml 
bFGF      5μl   10ng/ml 
CNTF      25μl   10ng/ml 
NAC      50μl   5μg/ml 
NT3      5μl   1ng/ml 
Biotin      10μl   1ng/ml 
Forskolin     25μl   10μM 
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Penicillin/Streptomycin (100x)  500µl   10X 
B27      1ml   2% 
10X SATO stock    5ml   1X 
 
Top up to 50 ml with DMEM and filter sterilise.  Store at 4°C for up to one week. 
 
10X SATO stock (100mL) 
      Add   Final Conc.  
Insulin (10mg/ml in glacial acetic acid) 100mg   50μg/ml 
Progesterone (1mg/ml in EtOH)  60μg   600ng/ml 
Transferrin     100mg   1mg/ml 
BSA      100mg   1mg/ml 
Sodium Selenite (1mg/ml in 0.1N NaOH) 40μg   400ng/ml 
Putrescine     16mg   160μg/ml 
Top up to 100ml with DMEM and filter sterilise.  Store in 5ml aliquots at -80°C. 
 
Live imaging media (10ml) 
      Add   Final Conc. 
PDGFR-AA     2μl   20ng/ml 
bFGF      0.5μl   10ng/ml 
CNTF      2.5μl   10ng/ml 
NAC      5μl   5μg/ml 
NT3      0.5μl   1ng/ml 
Biotin      1μl   1ng/ml 
Forskolin     2.5μl   10μM 
Penicillin/Streptomycin (100x)  50µl   10x 
B27      100µl   2% 
10X SATO stock    500µl   1x 
Glutamax     100 µl   4mM 
Top up to 5ml with flurobrite DMEM and filter sterilise. 
 
Western blot solutions 
RIPA buffer (10ml) 
Add   Final Conc. 
MQ water     8190μl   - 
1M Tris-HCl (pH 7.4)     500μl   50mM 
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5M NaCl     300μl   150mM 
10% NP-40     1mL   1% 
Sodium deoxycholate    100mg   1% 
10% SDS     10μl   0.1% 
Protease inhibitor tablets   1 per 10ml  - 
Aliquot and store at -20°C 
 
Transfer buffer 
      Add   Final Conc. 
20X Bolt MES transfer buffer   50ml   1x 
methanol (or ethanol)    100ml   10% 
Bolt Antioxidant    1ml   1% 
MQ water     Top up to 1L  - 
 
LB and LB agar 
      Add   Final Conc. 
Tryptone     5g   1% 
Yeast extract     2.5g   0.5% 
NaCl      5g   1% 
Make up to 500ml with MQ water and autoclave on the liquid cycle. 
* To make LB agar add 5g bacteriological agar before autoclaving (1% agar) 
 
In situ solutions 
10x ‘salts’ solution 
NaCl      2M 
EDTA      50mM   
Tris-HCL pH7.5    100mM 
Sodium dihydrogen phosphate (NaH2PO4)  50mM 
Sodium phosphate, dibasic (Na2HPO4) 50mM 
DEPC-treated, autoclaved and stored at room temperature. 
 
Hybridisation solution 
‘Salts’       1x 
Formamide      50% 
Yeast tRNA (phenol/chloroform precipitated) 0.1mg/ml 
Dextran sulphate     10% (w/v) 
100 
 
Denhardt’s      1x 
Aliquot and store at -20°C 
 
20x SSC 
NaCl      175.3g 
Sodium Citrate (Tribasic: Dihydrate)  88.2g 
MilliQ      to 1L 
 
In Situ wash solution (500ml) 
      Add   Final Conc. 
Formamide     250ml   50% 
20x SSC     25ml   1x 
Tween 20     500μl   0.1% 
 
5x MABT 
Maleic Acid     116.1g 
NaCl      87.7g 
NaOH Pellets     ≈77g 
Tween 20 (20%)    50ml 
MilliQ      to 2L 
 
In Situ blocking solution   
5x MABT     100ml    
Blocking reagent    50g 
MQ water     top up to 500ml.  Aliquot and store at -20°C. 
 
2x Pre-staining buffer 
5M NaCl     4ml 
1M MgCl2     10ml 
1M Tris pH 9.5    20ml 
Tween20     0.2ml  
MilliQ      Top up to 100ml 
 
Staining buffer 
      Add   Final Conc. 
2x Pre-staining buffer    15ml   1x 
NBT      30μl   0.1% 
101 
 
BCIP      30μl   0.1% 
10% PVA (w/v in MQ)    Make up to 30ml 5% 
 
Appendix 2  
Table 1. Primary antibodies (immunofluorescence) 
Antibody Concentration Supplier 
Goat  anti-Pdgfrα 1:100 R & D systems 
Rat  anti-GFP 1:2000 Nacalai Tesque 
Rabbit  anti-GFP 1:200 Synaptic Systems 
Mouse  anti-γ-tubulin 1:500 Sigma 
Rabbit  anti-Arl13b 1:200 Protein Tech 
Rabbit anti-S100β 1:500 Dako 
Rabbit anti-GFAP 1:500 Dako 
Mouse anti-NeuN 1:600 Millipore 
 
Table 2. Secondary antibodies (Immunofluorescence) 
Antibody Wavelength Supplier Cat # 
Donkey anti-Goat 568 Invitrogen A-11057 
Donkey anti-Goat 594 Invitrogen A-11058 
Donkey anti-Rat 488 Invitrogen A-21208 
Donkey anti-Mouse 647 Invitrogen A-21208 
Donkey anti-Rabbit 488 Invitrogen A-21206 
Donkey anti-Rabbit 568 Invitrogen A-10042 
Donkey anti-Rabbit 647 Invitrogen A-31573 
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Donkey anti-Guinea Pig 568 Invitrogen A-11075 
 
Table 3. Antibodies (western blot) 
Primary Conc. Cat # Secondary Conc. Cat # 
Rb anti-Kif3a 1:2000 Abcam 
ab11259 
Anti-Rb 
HRP 
1:5000 Dako 
P0448 
Ms anti-β actin 1:15000 Sigma 
A2228 
Anti-Ms 
HRP 
1:5000 Dako 
P0447 
 
Appendix 3 
Table 4. Transgenic mice 
Mouse Model Use 
Pdgfrα-histGFP 
and  
Pdgfrα-histGFP::Kif3afl/fl 
The Pdgfrα-histGFP mice are used to generate 
mixed glial and OPC primary cultures. All OPCs 
express histone-targeted, nuclear GFP.  Cells 
generated from mice carrying the Kif3afl/fl 
transgene, allow Kif3a to be deleted from the 
cultured cells. 
Sox10-DTA-GFP (referred to as 
Sox10-GFP) 
All OPCs and oligodendrocytes have cytoplasmic 
GFP in these mice.  These mice were used to 
determine whether cells of the oligodendrocyte 
lineage had primary cilia in vivo. 
Rosa26-YFP This cre-sensitive reporter line was used to 
generate primary glial cultures and determine 
whether tat-cre addition to the culture medium was 
sufficient to activate YFP expression. 
Plp-CreERT2::Rosa26-YFP The addition of Tx to these mice results in the 
YFP-labelling of all oligodendrocytes.  These mice 
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were used to determine whether primary cilia were 
assembled by oligodendrocytes in vivo. 
Pdgfrα-CreERT2::Rosa26YFP  
and  
Pdgfrα-CreERT2 :: Rosa26-YFP 
:: Kif3afl/fl 
The administration of Tx to Pdgfrα-CreERT2 :: 
Rosa26YFP transgenic mice fluorescently tags 
PDGFRα+ cells, including OPCs.  Furthermore, 
the tag is retained by all new cells they produce – 
allowing the quantification of oligodendrogenesis 
in vivo.  When these mice also carry the Kif3afl/fl 
transgene, they also allow the deletion of Kif3a 
from OPCs and all of the cells they produce.  
These mice were used to determine the effect of 
Kif3a-deletion on oligodendrogenesis in vivo.   
Pdgfrα-CreERT2::Kif3afl/fl 
and  
Kif3afl/fl 
 
The addition of Tx to Pdgfrα-CreERT2::Kif3afl/fl 
transgenic mice causes the deletion of Kif3a from 
OPCs and all cells they subsequently produce.  
Mice only containing the Kif3afl/fl transgene do not 
experience gene deletion and act as controls.  
These mice were examined to determine the 
behavioural consequence of conditional Kif3a 
deletion. 
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